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S U M M A R Y
The Belgian National Report 2000 is divided in 4 Parts.  The Part I deals with policy and legislation
(Chapter 1) ; the Part II give an overview of the epidemiological situation (Ch. 2 to 7); the Part III is
related to demand reduction interventions (Ch. 8 to 11) and the Part IV presents more in depth
information on national policy and strategy (Chapter 12), cocaine (Ch. 13) and infectious diseases
(Ch. 14).  Various annexes, list of abbreviations and bibliography are listed at the end of the report.
In 2000, an inter-ministerial working group has been set up in order to define a new drug policy.  The
group is co-ordinated by the Minister of Public Health and involves directly the Ministers of Justice and
of Internal Affairs, closely collaborating  with Ministers of Community and Region governments
involved in the drug issue.  The new drug will be soon presented to the parliament.
GLOBAL APPROACH, LEGISLATION AND POLICIES
The Belgian legislation does not distinguish the applied penalties neither according to the types of
drugs (“hard” or so-called “soft” drugs), nor to the quantities of the seized drugs. Only the concepts of
possession, group use and trafficking are considered and are applied by the judicial authorities
according to criteria applicable to each individual case.  Nevertheless in 1997, the Parliament and the
Council of Ministers adopted the conclusions of a working group on the drug problem : the law
enforcement on drugs was consequently adapted specifying e.a. that the penal justice must be an
‘ultima ratio’ in case of serious public nuisance.
Some changes were initiated.  Between an approach strictly repressive and at the opposite a full
tolerance policy, a third way should exist called 'normalisation' policy.  The policy priorities were
redefined: prevention and reduction of drug use, decrease of the number of new drug users, protection
of  the community and its members who are facing the drug phenomenon and its consequences,
provision of care to drug users and readiness to guarantee them a better life despite their drug use.
Without changing the law, a directive/circular (1998) modifies the action of the judicial authorities.  For
the first time, a distinction is established between possession of cannabis for personal use and other
illegal drugs with non acceptable risk for health.  The possession of cannabis for personal use remains
an offence but to which the lowest prosecution priority should be given.
The supply, the sale and the delivery of materials with the aim to prevent infectious diseases (it means
e.a. the implementation of 'needle exchange' programmes) was made possible by a new law (1998).
The obligations proceeding from the UN 1971 convention on psychotropic substances (regarding
Table III and IV, including e.a. benzodiazepins, meprobamate, MDMA, MBDB, barbiturics) were
completely integrated in the national legislation in 1998.
In 1999 the law related to road traffic was modified extending the list of substances concerned from
alcohol  to other psychoactive substances that could influence driving skills (THC, amphetamines,
MDMA, MDEA, MDBD, cocaine…).
The policy of Internal Affairs is embedded in a crime prevention philosophy. A financial framework to
support the municipalities with a high criminality rate was created. Those municipalities have to set up
projects aiming at drug treatment and prevention.
In the Communities and Regions a growing effort is made to get a global prevention: the focus is
mainly health and welfare oriented.  Several evolutions are clear: development of a policy plan,
increasing education and expertise of prevention workers, improved co-ordination of prevention
activities from a health perspective, further development of local crime prevention initiatives with focus
on drug prevention, enlarged provision in training, community approach.  Many organisations and
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municipalities have developed prevention and/or care and cure activities in different fields: social
services, workplaces, youth organisations, schools, peer groups, harm reduction, leisure time.
Treatment is offered by three types of services : inpatient centres (e.g. psychiatric centres,
therapeutic communities, crisis intervention centres), outpatient centres (centres for mental health, day
care centres, medico-social care centres, low threshold services) and primary care (general
practitioners, welfare organisations, etc.).  There is a tendency to lower the admittance level of the
treatment centres.  The focus of treatment has been broadened: not only abstinence but also harm-
reduction and methadone maintenance.
ACTORS
The Belgian political structures required an interministerial conference  (different departmental
staffs) in order to co-ordinate the different departments involved in the drug issue.  There are a lot of
key actors on the one hand at federal level : the Ministry of Justice, the Ministry of Foreign Affairs, the
Ministry of Internal Affairs and the Ministry of Social Affairs and Public Health, and on the other hand
at federate levels : the communities and regional governments (Flemish, French and German-
speaking Communities, Brussels-Capital Region).
Belgium is an observer at the United Nations Narcotics Commission and has ratified international
conventions on narcotics, psychotropic substances and illegal trafficking. Belgium is among the
UNDCP contributors (United Nations Drug Control Programme).  The aspects of repression and
supply reduction are an exclusive federal competence.  Community and Regional governments also
have international relationships and collaborations: EMCDDA, WHO (as national counterparts of
European alcohol action plan / WHO-Europe), Pompidou working groups, European Union projects
(Intereg-, Euregio-, Multicity- projects), European Drug Prevention Week …
The Belgian Focal Point, located at the Scientific Institute of Public Health, is the Belgian
representative in the REITOXa European network settled down by the EMCDDA.  The BIRN (Belgian
Information Reitox Network) was created in 1995 and links the National Focal Point with the 4 Sub-
Focal Points : ASL (Arbeitsgemeinschaft für Suchtvorbeugung und Lebensbewältigung) for the
German-speaking Community, CCAD (Comité de Concertation sur l’Alcool et les autres Drogues) for
the French Community, CTB-ODB (Concertation Toxicomanies Bruxelles - Overleg Druggebruik
Brussel) for the Brussels-Capital Region, ‘VAD (Vereniging voor Alcohol en andere Drug problemen)
for the Flemish Community.
The Focal and Sub-Focal Points are getting in touch with a lot of partners from different fields (justice,
police, toxicological laboratories, universities and other research centres, prevention and harm
reduction organisations, therapeutic communities and other treatment actors…) exchanging
information, collecting and analysing data and disseminating results, research reports, guidelines,….
Since drugs are high on the agenda in the media and political arena, the general public requests more
information about various issues.
SOURCES, AVAILABILITY AND QUALITY OF INFORMATION
Progressively the overview of the epidemiological situation on drugs is improving.  The framework of the
EMCDDA, the identification of priorities and related guidelines are a real support.  Although monitoring
systems and epidemiological researches have been carried out, the global description of the situation
and the alterations in drug consumption and drug related problems remain incomplete.  The school
population is the group where drug use is the best documented.  Regarding adults, treated patients,
judicial and police activities, reliable data are necessary in order to assess the actual prevalence of
drug use and particularly the problematic use.
In general the data quality of the school surveys is good.  Most of them are conducted by or in close
co-operation with experienced research institutions or universities, repeating regularly surveys using
the same methodology and the same tools, conducted in the framework of the WHO HBSC cross
national survey.  Little by little research team produce comparable data for specific age groups.    So
at present comparisons can be made on the level of the Flemish Community between 1994, 1996 and
                                                
a REITOX : Réseau Européen d'Information sur les drogues et TOXicomanies /  European network linking
EMCDDA and National Focal Points for the exchange of information on drugs and drug addictions.
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1998 9. In the French Community, the trends of the behaviour of youngsters from 1986 to 1994 (and
1998) have been analysed and published 10.  A very large survey aiming to evaluate drug  policy at
school was conducted in 1999 in the Flemish Community 11.
Meanwhile more harmonisation between the other studies conducted in the different areas of the
country is necessary.  For example, the concept of ‘regular’ use is defined very differently in the
various studies.
On the other hand, we should stress on the competition of multiple geographically limited surveys
making uneasy to carry out the large standardised HBSC surveys : indeed more and more schools do
not agree to participate in the HBSC survey because of recent participation in a local school survey.
Information on the situation of drug use in the general adult population is partial but developing : since
1996, a CATI health monitoring survey 7 has been started in the French Community (including
questions on cannabis and cocaine) whereas a CATI survey was conducted in Flanders in 1995 6.
The 2001 national Health Interview Survey will include a few questions on cannabis and XTC use.
There are very few surveys involving other subgroups (youngsters out of school , ethnic minorities,…)
: however the situation in prison is better documented despite the methodological constraints.
Further efforts should be made to realise local and national estimates on the prevalence of hard drug
(ab)users (or hard users).  Also insight and detection of new trends in drug (ab)use is important.  In
general more research is needed aimed at the social context of drug use, mechanisms of drug
(ab)use, …  No cohort research has been carried out.
Some results of official statistics become available (for example, RCM/MKG and RPM/MPG), but
analysis of most official statistics is not regularly carried out or not published (hospital data, mortality
data, pharmacological data, judicial data,..).  The data on deaths related to drug use from the National
Institute of Statistics are still olddated and the number of overdoses provided by police services is not
fully reliable.  Information on infectious diseases (HIV, hepatitis B and C) is available : methodological
aspects of these studies and harmonisation are under discussion.
The federate entities (Communities, Region of Brussels-Capital) each developed their own system of
registration of treatment demand 33,34,35.  One observes a progressive harmonisation 32 and at least an
increasing compatibility between registration systems for drug users used within traditional and even
less traditional services e.g. low threshold services for methadone distribution or street corner work.
Epidemiological data on the treatment demands are progressively harmonised but the coverage of the
registration systems is not enough documented : this prevents us from obtaining reliable figures at
national level.  Efforts should be continued in order to make possible general utilisation studies.
SOME RESULTS…
In the motivating framework of the collaborative European information network on drugs (REITOX)
supported by  the EMCDDA, methods for the collection of comparable and reliable information are
being developed. Epidemiological key-indicators were selected.  At Belgian  level, several ad hoc
working groups based on the experience and skills of the different partners were set up.
Its uneasy to summarize results as very often some restrictions should be mentioned and results
should be considered with caution.  Nevertheless major trends are observed.  The recent surveys
confirm the increase of the use of recreative drugs among youngsters and probably also among
adults.
It can be globally observed that, in 1998-99 around 25% of 15-16 years aged students has tried an
illegal substance at least once; the frequency of use increases with age reaching its maximum figure
(around 40%) among 17-18 year old boys having used drug at least once; around 20% of 17-18 aged
boys are ‘regular’ users (use at least one drug during the last month).  Cannabis derivatives are the
products used most by young people.  XTC is the second product used with a slight increasing trend :
1998-99 surveys reported 4-6% of 15-16 year-old students stating at least one use.
Among 18-49 years aged adults of the French Community, 21% (1998-99) to be compared to 10% in
1996-97) stated to have experienced cannabis at least once.  Among Flemish adults aged 18-65 years
(1995 data), 6% stated to have at least once used an illicit drug.
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It is quite difficult to estimate (and even to define) the problematic drug use at the moment.  A study
conducted in 1999 but based on 1995 data estimated the number of intravenous users as 20,200
among the 15-54 years aged (corresponding to a prevalence rate of 3.6/1000).
Anonymous data on 7,958 patients treated in centres participating in the VAD, CCAD and CTB-ODB
registration systems were collected : these data were aggregated at national level.  In 1996, more than
14,000 stays in general or psychiatric hospitals were connected to problematic drug use.
Among users treated in centres of the French Community, a decreasing trend of intravenous
administration is observed : from 30 and 34% in 1993-94 to 20% in 1999.  The decrease does not
seem to be due to a change in behaviour of heroin users but is actually related to a relative decrease
of heroin users among all demanders for treatment (and a proportional increase of patients treated for
another substance among which cannabis).  A street snowball survey conducted in 1998 reports a
current injecting rate (at least once during the last 6 months) of 43% of drug users (comparable to
1996).  Other studies report global lower figures : of course, the extent of IV route varies largely
between groups and subgroups of users and patients.
Intravenous drug use (IVDU) represents 3% of the HIV transmission causes for the period 1998-99
(decreasing trend mainly from 1985 to 1995 and then stable).  Some information on prevalence of
infectious diseases among drug users are available but should be improved. They could show a
decreasing trend of HIV infection among drug users (low prevalence compared to some other
European countries as Spain, Italy).  In 1998, CCAD and VAD data show a proportion of HIV-
seropositive among IVDUs demanding for treatment around 2%.  HBC and HCV infections seems
stable but at higher levels : respectively 24% (HBC) and 38-52% (HCV) of tested IVDUs (having
injected at least once) were infected respectively by hepatitis B or C.  However, these studies
investigate sometimes different types of users and using different definitions of IVDU making
comparisons quite uneasy.  Harmonisation is required. Cohorts of drug users should be set up and
followed up.
The data on deaths related to drugs from the National Institute of Statistics are delayed and the
numbers of overdoses provided by police services are not fully reliable.  The police data on arrests
and seizures are depending from the resources engaged : nevertheless one observes a three-fold
increase (particularly evident for years 1991-1992) of the  number of persons taken in for questioning
about drug-related affairs : from 3,917 in 1985 to 19,482 in 1993 and then relatively stable).  The
figures indicates that cannabis is involved in 2/3 of cases (stable for 1995-99).  Almost ¾ of cases are
related to possession for personal use.  Judicial statistics about sentences are not available on a
regular basis.
The prices of cannabis and cocaine are stable over the last years.  One observed a diminution of the price
of heroin and XTC pills between the years 1993-1995.  The youngsters state that cannabis is easily
available anywhere ; even adults reported a high accessibility to cannabis (65%) and cocaine (40%).
There is consistency between trends of some indicators : for example, increasing cannabis use among
youngsters and also in adults, consistency between the various school surveys, high level of HCV among
IVDUs reported by all studies, etc.  Nevertheless  reliability of most data remain relatively poor and should
be improved in order to take decisions on solid basis.
Regarding demand reduction, a lot of interventions were set up but still often without any planned
evaluation.  In Belgium, the culture of evaluation is not developed in this field.  A collaborative project
was initiated at European level : EDDRA (Exchange on Drug Demand Reduction Actions) is a project
of the EMCDDA/REITOX aiming to develop a data base presenting an inventory of prevention and
harm reduction projects conducted in Europe and focusing on their evaluative component.  Belgian
partners are involved.
An early warning system on new synthetic drugs is being developed in Belgium.  A network of
toxicological laboratories for substance analyses was set up.  Work on establishing a second network
for the collection of socio-cultural information, and a third network of clinical laboratories, which carry
out analyses on blood and urine, is in progress.  The aim is to provide  timely and regular results not
only on new drugs but also on all kinds of substances circulating and on the various trends in
consumption.  The Belgian system is integrated in a larger European Joint Action.  The issue of pill
testing is in discussion but controversed.
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CURRENT CONSTRAINTS AND PRIORITIES FOR THE FUTURE
In recent years, collaboration between the treatment demand network and the judicial system
increased. Specifically for young first time offenders, a practice of 'therapeutical advice'  was further
installed and developed in a number of judicial districts.
In general the widening of the treatment network with more attention to low-threshold services and
differentiated treatment goals (abstinence, reduction, substitution, maintenance) continued.
On a political level ambiguous signals are launched towards the general public : on the one hand the
1998 directive/circular 'softening' the prosecution policy for cannabis users and on the other hand an
official political statement of 'just say no'.  This leads to a great deal of confusion among youngsters
and parents.
Globally, the following constraints were identified :
· Lack of long term strategy and of consultation at political, intermediary and field workers
levels
At a political level, Belgium has known many policy papers on drugs in the last few years.  Different
ministers have made action plans.  The federal government has launched a 10-point plan on drugs
and the Communities have their own policy statements.  However there is no agreement between the
different policy papers, nor between the different government levels.  The interministerial conference
on drugs, which is needed in this complex political structure, has only met once in the last three years.
At the intermediary co-ordination level, there is one co-ordinating agency at the Flemish Community
level, one at the French Community, another one in the Brussels Region and a fourth organisation
coordinating actions in the German-speaking Community.
Each Flemish province has a provincial prevention forum and at the local level, there are prevention
boards in major cities, from a crime prevention perspective. New health promoting structures
(LOGO's) are set up at an intermediary level (250.000 - 400.000 inhabitants) to implement the health
targets of the Flemish Government. Neither alcohol nor drug abuse are one of the five targets at this
moment.
However, there is no structural link in the different regions of the country between the various levels
(Community, provinces and local).  Communication and co-ordination are based on personal
preferences and good will.
One should hope that the works conducted by the Minister of public health will lead to an improved
coordination and integration of the various policies.
At the level of field workers, due to the diverse initiatives and the short term contracts in which they
take place, there is lack of continuity and as a result, co-ordination between the field workers is too
often scattered or absent.
· Over-demand of prevention activities and its consequences
Drug problems are high on the political agenda and as a result, many sectors request prevention
activities.  Different initiatives are being set up, yet they lack clear aims and there is no structure to
continue the project in the long run.
Activities with high visibility are often preferred in order to get funding. Many activities are one-shot
activities and there is no co-ordination between them.
The high demands result in huge pressure for prevention workers and field workers.  Little by little
there is a growing group of well-trained prevention workers although the pressure on their output often
prevents them from spending required time in training and improving quality.
Despite the growth of the number of prevention workers over the last couple of years, there is no
guarantee for a better outcome, as long as there is a lack of general framework which outlines the
long term aims of prevention.
· Limited means dedicated to prevention and demand reduction
The expectations towards prevention are very high, considering the limited outcome of treatment
programmes.  However, compared to the budgets for treatment, those dedicated to prevention are
very small.  In addition, most budgets are on a one-year project basis, which, in absence of a long-
term strategy, does not provide an efficient prevention.
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· Lack of harmonisation of the information and need of epidemiological surveillance
An important effort is urgent in order to obtain harmonised reliable data.  The development of an high
quality information system (collection, analysis, interpretation, dissemination) is essential in order to
enlarge the knowledge on the nature, the extent and the change in drug use in term of prevalence,
incidence, mortality, morbidity, social consequences, but also about attitudes and  behaviours.
Qualitative and quantitative information is necessary.
As most initiatives are originated by the field in order to respond to urgent problems and as their
funding is often temporary, the collection of the epidemiological data is often an additional task
perceived as extremely time consuming.  Incentives should be found : feed-back is the minimal
requirement but other benefits will help : as access to documentation, trainings, automated production
of reports…  The various expertises of the field actors are absolutely necessary in the interpretation of
the data.
From a public health point of view, reliable epidemiological information on the prevalence of drug use
in the different groups of the population, on the patterns of use, on the demand reduction initiatives, on
their specific targets and on their outcomes will permit better determining the objectives, priority
interventions and target groups and to correctly assess their impact.  Moreover, standardized
information will provide the possibility to compare the situation in different areas, to compare the
outcomes of different types of intervention and to identify the most-efficient programmes.
Regarding demand reduction and treatment centres, a lot of interventions and actions were set up but
often without any evaluation.  Specifically, there is a very important need to evaluate and monitor the
practice of (methadone) maintenance and substitution treatment.
As there are many interventions as well in prevention as in care activities, there are numerous sources
of information for the data collection.  Also at data collection level, any counter-productive competition
should be prevented : a strategy for the data collection should be defined.  Harmonised indicators for
the evaluation of demand reduction interventions and co-ordination should be implemented and a
minimal harmonised data set should be collected.
· Lack of evaluation and lack of resources for research
There is a growing demand of decision makers and also professionals them-selves for evaluation and
for evidence-based approach towards prevention and treatment.  At present, most attention is given to
certain quantitative indicators mainly  those indicating the number of activities (process evaluation).
Qualitive indicators are also being identified and tools developed to evaluate mainly in the field of
prevention.
Several researches and evaluations of policies, treatment facilities, treatment or prevention
programmes, research on specific at risk groups (prisoners, youngsters out of school)  are currently
running.  More research is needed into trends in drug use, characteristics of groups of users, 'soft use'
and 'hard use', informal control mechanisms, causal factors, effectiveness of repressive measures,
direct and indirect costs of drug use,…
In all cases dissemination of results and of experience is crucial as unfortunately there are often not
easy access because not officially published or not disseminated (grey literature).
In summary, the PRIORITIES FOR THE FUTURE seem :
· to develop consultation and co-ordination between the different authorities, between the
different levels and between the various actors
· to clearly define the aims of the proposed actions, and particularly to develop a strategy in
a long run perspective
· to set up a drug epidemiological surveillance and a strategy for the data collection, to
reinforce the existing structure (Focal and Sub-Focal Points) and to support the
development of collaborations
· to better support quantitative and qualitative research and particularly to evaluate the
impact of preventive and assistance measures as well as repressive measures
· to improve the epidemiological information and especially to estimate the prevalence of
problematic drug use
· to monitor and evaluate the demand reduction interventions and the various treatments,
and particularly the methadone substitution maintenance treatment
· to open perspective on alcohol, medicines and illicit drug use as a global problem.
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PART I.  NATIONAL AND LOCAL POLICIES AND STRATEGIES :
INSTITUTIONAL & LEGAL FRAMEWORKS
Chapter 1. Developments in Drug Policy and Responses
1.1.  Political framework in the drug field
1.1.1 Summary
In 2000, an inter-ministerial working group was set up in order to re-design the drug policy in Belgium.
The group is coordinated by the federal Minister of Health and involves the federal Ministers of Justice
and of Internal Affairs : this group works in close collaboration with Community and Region Ministers.
The proposals for a new drug plan will be submitted by the federal government  at the end of the year
2000.
At the moment, the Belgian legislation does not distinguish the applied penalties neither according to
the types of drugs (“hard” or so-called “soft” drugs), nor to the quantities of the seized drugs. Only the
concepts of possession, group use and trafficking are considered and are applied by the judicial
authorities according to criteria applicable to each individual case.  Nevertheless in 1997, the
Parliament and the Council of Ministers adopted the conclusions of a working group on the drug
problem : the law enforcement on drugs was consequently adapted specifying e.a. that the penal
justice must be an ‘ultima ratio’ in case of serious public nuisance.
Some changes were initiated.  Between an approach strictly repressive and at the opposite a full
tolerance policy, a third way should exist called 'normalisation' policy.  The policy priorities were
redefined: prevention and reduction of drug use, decrease of the number of new drug users, protection
of the community and its members who are facing the drug phenomenon and its consequences,
provision of care to drug users and readiness to guarantee them a better life despite their drug use.
Without changing the law, a directive/circular (1998) modifies the action of the judicial authorities.  For
the first time, a distinction is established between possession of cannabis for personal use and other
illegal drugs with non acceptable risk for health.  The possession of cannabis for personal use remains
an offence but to which the lowest prosecution priority should be given.
The supply, the sale and the delivery of materials with the aim to prevent infectious diseases (it means
e.a. the implementation of 'needle exchange' programmes) was made possible by a new law (1998).
The obligations proceeding from the UN 1971 convention on psychotropic substances (regarding
Table III and IV, including e.a. benzodiazepins, meprobamate, MDMA, MBDB, barbiturics) were
completely integrated in the national legislation in 1998.
The policy of Internal Affairs is embedded in a crime prevention philosophy. A financial framework to
support the municipalities with a high criminality rate was created. Those municipalities have to set up
projects aiming at drug treatment and prevention.
In the Communities and Regions a growing effort is made to get a global prevention: the focus is
mainly health and welfare oriented.  Several evolutions are clear: development of a policy plan,
increasing education and expertise of prevention workers, improved co-ordination of prevention
activities from a health perspective, further development of local crime prevention initiatives with focus
on drug prevention, enlarged provision in training, community approach.  Many organisations and
municipalities have developed prevention and/or care and cure activities in different fields: social
services, workplaces, youth organisations, schools, peer groups, harm reduction, leisure time.
Treatment is offered by three types of services : inpatient centres (e.g. psychiatric centres,
therapeutic communities, crisis intervention centres), outpatient centres (centres for mental health, day
care centres, medico-social care centres, low threshold services) and primary care (general
practitioners, welfare organisations, etc.).  There is a tendency to lower the admittance level of the
treatment centres.  In 1996, medico-social relief centres for illicit drug users were initiated by the
federal ministry of Internal Affairs.  The focus of treatment has been broadened: not only abstinence
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but also harm-reduction and methadone maintenance.  In 1999, there are 8 ‘MASS-MSOC’ centres
offering low threshold facilities located in the large cities of the country (an evaluation of their activities
is in progress).  A case management approach is considered in order to improve the coordination of
these various treatment facilities and to make easier the provision of a follow-up assistance to the
patients.
1.1.2 Objective and priorities of the national drug policy
1.1.2.1 Brief historical background
Apart from the signing of international treaties, the drug policy was dealt with from a “health care”
perspective since the seventies.  Specialised therapeutic communities and outpatient centres were set
up to deal with problematic drug users, and in a second phase, psychiatric hospitals established drug-
specific wards, in addition to their alcohol treatment centres.  Out-patient centres for mental health
care also deal with illegal drug problems.
The interventions, co-ordination bodies,… were already initiated at the end of the 70ies or later
depending on the regions.  Globally the call for demand reduction strategies was heard in the
80ies in a general approach of addiction prevention.
In the French Community, the CCAD co-ordinated the prevention activities since 1978.  From
September 2000, this task has been given to another organization : EUROTOX.  Currently, the drug
prevention activities are focused on prevention and harm reduction in the field of "addiction" (alcohol
and other drugs) which is developed by several facilities subsidised by the French Community's Health
Authorities. Various global or specific programmes and initiatives were set up or supported: ALTO b
(network of GPs working with drug addicts), a network of organisations taking care of drug addicts in
Brussels and Liège, etc…
In the Flemish Community, there is a global approach for prevention and to a much lesser extent for
treatment (as treatment is mainly financed by the federal government).  The Flemish government has
organised its policy through a ‘covenant’ which is signed between the Flemish minister of Health and
the co-ordinating agency VAD.  VAD is the umbrella organisation that co-ordinates prevention and
treatment institutions since 1981.
Specialized umbrella organisations were set up later in the Brussels Capital Region and in the
German-speaking Community.  "Brussels Drug Addiction Concertation" (CTB/ODB) is the Brussels-
Capital Region's "drugs" programme. Its object covers the entire drug use problem (demand
reduction), which does not prevent concertation with those responsible for the policy for reducing the
supply on the territory.  The Brussels programme began in October 1992.  Recently an eleventh point
regarding harm reduction has been added to its programme.
In the German-speaking Community, the ASL is an autonomous NGO since 1997.  It was part of the
Centre for Mental Health since 1980 (the Centre has two sites).  The goals of the ASL are to make the
entire population aware of the dangers of addiction of all kinds and to improve the quality of life of the
population.
Since the beginning of the 90ies, drug use became more visible in certain youth cultures.
Politics and media reacted firmly.  Drugs became high on the political agenda from a variety of
perspectives: health perspective, safety and crime prevention, repression, and welfare.  Different
ministers laid down a policy paper on the drug issue.
Through initiatives of the federal government (ministry of Internal Affairs), local initiatives were set up
to tackle the drug problem from a crime prevention perspective.  More, efforts were made to extend
and broaden the treatment centres as well.  Some health professionals (psychologists,..) are paid by
                                                
b ALTO (Alternatives aux Toxicomanies) is a global programme of the French Community aiming at the
diversification and  the co-ordination of resources of prevention of damages related to drug addiction.
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the ministry of Justice and integrated in mental health care centres staffs.  All this resulted in a
diversity of treatment centres with special attention to easy accessibility of new centres.
1.1.2.2 Recent background (1995-1998)
The Belgian political structures required an interministerial conference (around 15 different cabinets) in
order to co-ordinate the different departments involved in the drug issue (set up in 1992).
In 1994, a consensus conference was set up with the medical world to reach a consensus about
methadone maintenance : according to conditions included in the Consensus document, substitution
treatments have been made ‘judicially’ possible.
In 1996, a federal parliamentary working group was set up to study the drug problem, in particular the
situation of soft drugs.  Many experts from the field of prevention, treatment and repression were
heard.  The conclusions of this working group have been adopted by the Parliament in June 1997.
The Council of Ministers approved the conclusions of the working group. Penal justice must be an
‘ultima ratio’ and may only intervene in case of serious societal damage or disturbance; a distinction
should be made between the prosecution for possession of cannabis for personal use on the one
hand and retail drug trade to provide financial benefits on the other hand.  The lowest priority should
be given to the prosecution by judicial authorities to possession of cannabis for personal use.
In 1998, according to the decision of the Federal Parliament, a directive/circular modified the action of
judicial authorities: a distinction was established between the possession of cannabis and other illegal
drugs with non acceptable risk for health, and the access to needle exchange was made possible  (the
drug law it-self -even regarding cannabis- was not changed).  Legislation to define substitution
treatment is in preparation at the Federal Parliament.
1.1.2.3 Current objectives and principal components
The proposals of the interministerial working group are expected in November 2000.
In the mean time, the current philosophy can be summarised as follows :
The three main tools of the drug policy are prevention, treatment and repression. Between an
approach strictly repressive and a tolerance policy, a third way should exist, called 'normalisation'
policy. Meanwhile it doesn't mean that drug use could become normal or usual in our society.
A realistic and modern policy against drugs must fit with the following priorities:
1. The main objective is to prevent and reduce drug use  and to decrease the number of new drug
users.
2. The second priority is to protect the community and its members who are facing the drug
phenomenon and its consequences. This concerns also the drug addicts who should be helped to
guarantee them a better life despite their drug use.
3. It is not possible, nor hoped that the justice is the only way for social regulation. Before the justice
works, the drug users should have the possibility to take up solutions among a large panel of
treatment methods.
4. It should be avoided that drug users who, apart from possessing drugs, committed no
other infringement, get into prison.
5. The judicial approach, particularly imprisonment, should be the 'ultimum remedium' in order to
deal with problematic use of drug.
6. If we want to adapt the drug policy to the context of the societal evolution, regular evaluations of
the results of the applied measures are needed.
The Belgian legislation does not distinguish the applied penalties neither according to the types of
drugs (“hard” or so-called “soft” drugs), nor to the quantities of the seized drugs. Only the concepts of
possession, group use and trafficking are considered and are applied by the judicial authorities
according to criteria applicable to each individual case.
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Meanwhile the practical enforcement of the legislation is changing.  The crime policy for drug
addicts was harmonised by a common directive/circular signed by the attorneys general and the
Justice Minister on 26 May 1993.  From 8 May 1998 this directive was revised based on the
conclusions of a report of a working group of the Federal Parliament adopted on 5 June 1997 (see
1.2).  The full text is Annex X.
The law was not changed and the directive only modifies the action of judicial authorities : for the first
time (April 1998), a distinction is established between possession of cannabis for personal use
and other illegal drugs with non acceptable risk for health.  The possession of cannabis for
personal use remains an offence but the lowest prosecution priority should be given.
It means that in case of single or occasional use of cannabis, a simplified policeman's report is to be
filled in and (as in all other cases of drug offence) the drug has to be seized.
Regarding the retail sale, the judicial prosecution to be taken will be differentiated according to the
intents: either sale to provide for funding its own use or on the contrary with the intention to make
profit.
The issue of assisted medical deliverance of heroine in Belgium still remains under discussion.
1.1.3 Basic elements of drug policy at national, regional, local level
1.1.3.1 Main actors
The Belgian political structures required an interministerial conference  (different departmental
staffs) in order to co-ordinate the different departments involved in the drug issue.  There are a lot of
key actors on the one hand at federal level : the ministry of Justice, the ministry of Foreign Affairs, the
ministry of Internal Affairs and the ministry of Social Affairs and Public Health, and on the other hand
at federate levels : the communities and regional governments (Flemish, French and German-
speaking Communities, Brussels-Capital Region) (see Part IV Key issue).
It is the objective of the interministerial current working group initiated by the Minister of Health in 2000
to re-design the drug policy and to co-ordinate the approaches of the various governments (federal,
Communities, Regions) and their ministers.
In January 2000, the Belgian government and the Minister of Justice circulated a 'federal plan for
security and for penitentiary policy (the extended version of the text is available on the ministry of
Justice's web site c).  The plan will be supported by scientific contributions and aims at two general
objectives: an actual decrease of all forms of criminality and a considerable increase of the low rate of
elucidation of offences.  Some issues of the plan are dedicated to drug related matters.  The specific
objective is defined as 'to limit the public nuisances and the criminality related to the drug market and
traffic'.  There is a obvious willingness to develop diversion to treatment and alternative measures and
to make easier the links between the judicial system and the health care system.
Belgium is an observer at the United Nations Narcotics Commission and has ratified international
conventions on narcotics, psychotropic substances and illegal trafficking. Belgium is among the
UNDCP contributors (United Nations Drug Control Programme).  The aspects of repression and
supply reduction are an exclusive federal competence.  Community and Regional governments also
have international relationships and collaborations: EMCDDA, WHO (as national counterparts of
European alcohol action plan / WHO-Europe), Pompidou working groups, European Union projects
(Intereg-, Euregio-, Multicity- projects), European Drug Prevention Week …
The Belgian Focal Point, located at the Scientific Institute of Public Health, is the Belgian
representative in the REITOX d European network settled down by the EMCDDA.  The BIRN (Belgian
Information Reitox Network) was created in 1995 and links the National Focal Point with the 4 Sub-
Focal Points : ASL (Arbeitsgemeinschaft für Suchtvorbeugung und Lebensbewältigung) for the
                                                
c http://www.just.fgov.be/html/nb2.htm  in Dutch  or  http://www.just.fgov.be/html/fb2.htm   in French.
d REITOX : Réseau Européen d'Information sur les drogues et TOXicomanies /  European network linking
EMCDDA and National Focal Points for the exchange of information on drugs and drug addictions.
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German-speaking Community, CCAD (Comité de Concertation sur l’Alcool et les autres Drogues) up
to August 2000 and EUROTOX from September 2000 for the French Community, CTB-ODB
(Concertation Toxicomanies Bruxelles - Overleg Druggebruik Brussel) for the Brussels-Capital Region,
‘VAD (Vereniging voor Alcohol en andere Drug problemen) for the Flemish Community.  (see Annex
B).
The Focal and Sub-Focal Points are getting in touch with a lot of partners from different fields (justice,
police, toxicological laboratories, universities and other research centres, prevention and harm
reduction organisations, therapeutic communities and other treatment actors…) exchanging
information, collecting and analysing data and disseminating results, research reports, guidelines,….
In 1999 and 2000, a feasibility study on the transformation of the Belgian Focal Point in a Belgian
monitoring centre  for drugs was performed.  This study includes an evaluation of the BIRN activities and
gives recommendations for the transformation 1.
1.1.3.2 Main outlines of the drug policy
Given the federal structure of Belgium, there are several policies in relation to the drug problems,
according to the competency of each different levels.  Different departments have their own policy
papers and documents. As a result, different approaches may be dealing with the drug problem in
different sectors and geographical areas.  On the other hand, depending on the perspective, different
philosophies are being held.
As a whole, there is room for prevention, harm reduction, treatment and repression.
Globally the interventions are coming from :
- health services : treatment in in-patient and out-patient centres.  There is a tendency to lower the
admittance level of the treatment centres.  The focus of treatment has been broadened: not only
abstinence, but also harm-reduction;
- outreach work : it is being used as a methodology to reach drug users in their own setting.  This
group of workers fit in many different projects and sectors, although they are not yet recognised as an
independent sector;
- social services : they claim a larger role in the approach of drug problems.  Not only the medical or
health perspective, but a holistic approach towards the drug users and their problems is getting more
attention;
- prevention activities which are being set up within the context of socio-cultural organisations, local
communities, etc;
- prevention programmes conducted in education.  Primary and especially secondary schools are
most popular.  Most programmes are directed at teachers and other workers of the education
community, who fulfil a role as prevention workers towards young people. There is a growing tendency
for primary schools to implement drug prevention programmes.
- other sectors in which prevention programmes are being introduced: the workplace, youth work,
leisure time sector, welfare sector...
- police and justice system (prisons) fulfilling their role in repression.  Prevention is another function of
the police force.
PREVENTION receives a growing attention in Belgium.  At federal level, the policy from Internal
Affairs is embedded in a crime prevention philosophy. A financial framework to subsidise the
municipalities with a high(er) criminality rate was created.  These municipalities have to set up
projects.  Among these, drug projects are set up in a context of crime prevention.  These projects are
both aiming at drug treatment and prevention.
In the Communities and Regions a growing effort is made to get a global prevention: the focus is
mainly health and welfare oriented.  A lot of organisations and municipalities have developed
prevention, harm-reduction and/or care and cure activities in different fields: workplaces, youth
organisations, schools, peer groups, leisure time.
In Belgium, TREATMENT of drug addiction is offered in three types of services :
· inpatient centres (psychiatric centres, therapeutic communities, crisis intervention centres)
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· outpatient centres (centres for mental health care, day care centres, medico-social care centres)
· general care (GPs, welfare organisations, etc.).
Specialised residential treatment centres (therapeutic communities and crisis intervention centres)
offer inpatient treatment for a limited number of persons.  Residential treatment centres have also
developed outpatient aftercare treatment provision.  Other residential treatment centres (psychiatric
hospitals) traditionally focused on alcohol problems.  Some of them have expanded their focus
towards illicit drugs.  In outpatient treatment centres (centres for mental health care), people can get
help for problems of dependence.  The day-care centres are relatively recent in the treatment scene
(since 92 - 93).  Mostly they work with illicit drug users.
In 1996, medico-social relief centres for illicit drug users (MASS/MSOC) were initiated by the federal
ministry of Internal Affairs.  These 8 active centres are low threshold services and are located in
Antwerp, Brussels, Charleroi, Genk, Ghent, Liège, Mons and Ostend.  Existing therapeutic
communities and crisis intervention centres received ‘expansion of their capacity’.
The breakdown between these three types varies from one region to another.
In Flanders, treatment of people with illicit drug problems is offered by a variety of services.  Since the
beginning of the nineties (92 - 93) a growing number of services has been established.  In addition,
those services already working towards illicit drug users expanded (are expanding) their offer.
General practitioners seem to engage more often than in the past in treatment of illicit drug users.  It is
unclear to what extent people rely on this offer of treatment.
In the French Community, the role devoted to general practitioners in the care of problematic drug
users is particularly striking. Their role is one of the components of the global intervention programme
called ALTO (for more information see issue 14.18).
Most of Brussels treatment facilities are non-residential (specialised centres, GPs, specialised
emergency units, mental health care centres).
In the German-speaking Community, the centre of mental health is the main institution in charge of
non-residential treatments of drug users (including methadone substitution treatment) : several
psychiatrists also offer ambulatory treatment.   Residential treatments are offered in the psychiatric
unit of the general hospital, but most patients are treated outside of the geographical area of the
German-speaking Community.  Due to linguistic reasons, most of in-patient treatments are given in
residential centres located in Germany.
Drug Policy in The Flemish Community
A policy plan was developed in which 8 areas of work are defined to implement a Flemish drug
policy 1999-2001.  The plan contains different actions in each area of work, with indicators for
measuring its realisation (evaluation).
The policy paper 2000-2004 of the Flemish minister of Health, published in December 1999 defines
prevention of drug misuse as one of the priorities of the present government in the coming years.  The
policy paper refers to the Flemish drug policy plan and stresses a continuation of the actual approach
(which was developed by a different minister).
The prevention activities focus on the development of local drug policies (in communes and local
communities and in different sectors and organisations) and on the training of key persons in various
sectors of society (schools, workplace, leisure time, youth work, adult education) to empower them to
develop a prevention  policy in their setting.  Local networks are set up to develop a coherent
approach at the local level.
The 8 areas of work that are defined in the Flemish drug policy plan 1999-2001 are:
² Information
² Sensibilisation
² Co-ordination of prevention and treatment
² Representation
² Consultancy and support
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² Training and education
² Development of concepts and methods
² Data collection and research
At provincial level, the areas of work are defined in order to strengthen the Flemish drug policy (the
areas are in the field of co-ordination, implementation of concepts, data collection), but they leave
room for additional local and regional needs and priorities.
1.1.3.3 International co-operation
FEDERAL LEVEL
The aspects of repression and supply reduction are an exclusive federal competence. The ministry of
Foreign Affairs is the main responsible. Regarding specifically relationships with the UN (e.g.
UNDCP), they are co-ordinated by the ministry of Justice that passes the specific demands through to
the different administrations or organisations concerned.
· Belgium is an observer at the United Nations Narcotics Commission and has ratified the International
Convention on Narcotics (New York, 1961) and its Protocol (Geneva, 1972), the Convention on
psychotropic substances of 1971 and the Convention against illegal trafficking of 1988.
· Belgium is among the UNDCP contributors. In particular, it participates in agriculture reconversion
projects in Colombia and Vietnam.
· Belgium has set up a network of liaison officers in order to increase law enforcement, in particular in
the area of narcotics.
The Focal Point (see 3.1.1) is the Belgian representative in the REITOX European network settled
down by the EMCDDA.
Reporting to and from the Group Pompidou passes along the Permanent Correspondent (see 3.1.1)
who sends the international information demands to the relevant persons or departments.
FEDERATE LEVELS
Community and Regional governments have international relationships: EMCDDA, WHO (as national
counterparts of European alcohol action plan / WHO-Europe), Pompidou working groups, European
Union projects (‘Intereg Projects’, ‘Euregio projects’, ‘Multicity project–Liège’), European Drug
Prevention Week…
- Flemish community
· Sub-Focal Point EMCDDA (via VAD)
· National counterparts of European alcohol action plan (WHO-Europe) (VAD)
· Programmes of the EU DG V, European Drug Prevention Week (VAD) , EU Interegio projects:
province of east Flanders and South Holland, and province of west Flanders and north of France,
EU Eurregio projects: provinces of Limburg and Liège, Germany and The Netherlands.
· Pompidou group (via national representative at federal level)
- French Community
· Sub-Focal Point EMCDDA (via CCAD/EUROTOX)
· National counterparts of European alcohol action plan (WHO-Europe) (CCAD)
· Pompidou working groups: Epidemiology Group (CCAD), First Treatment demand (CCAD),
“Multicity report –Liège” (CCAD-cellule Drogues ULg)
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· Programmes of the European Union (DG V), EU “Interegio Projects” : Prove. Heinous and France,
European network for AIDS prevention in prison.
- Brussels Region
· Sub-Focal Point EMCDDA (via CTB-ODB)
· Pompidou working groups
· European Drug Prevention Week
· Specific agreements with European cities or regions.
- German-speaking Community
· Sub-Focal Point EMCDDA (via ASL)
· Pompidou working groups
· European Drug Prevention Week
· Specific agreements with European cities or regions : the ASL collaborates on a regular basis with
prevention institutions of various countries of the European Union and of oriental Europe.  The EU
awarded a European project to the ASL, notably in order to implement primary prevention at the
local level of the participating countries.
1.2.  Policy Implementation, legal framework and prosecution (Legislation and
enforcement)
1.2.1 Law and regulations (drug-related issues about health, social affairs, youth,
justice, drug control, etc.)
The Belgian legislation does not distinguish the applied penalties neither according to the types of
drugs (“hard” or so-called “soft” drugs), nor to the quantities of the seized drugs. Only the concepts of
possession, group use and trafficking are considered and are applied by the judicial authorities
according to criteria applicable to each individual case.  Although the law was not changed, a directive
(April) modifies the action of judicial authorities : for the first time, a distinction was established
between possession of cannabis for personal use and other illegal drugs with non acceptable
risk for health (see 1.2.1.2). The directive and its enforcement are currently being evaluated.
1.2.1.1 Drug laws
The first international convention on opium has been signed at The Hague the 23/01/1912.  The basic
Belgian law relating to the traffic in toxic substances, hypnotics, narcotics, disinfecting and antiseptics
dates back to 24 January 1921. This law was completely revised regarding narcotics, by the Law of 9
July 1975. This law mainly deals with repressive issues and has to be completed by health issues.
The Law of 14 July 1994, modifying this basic law, introduced a distinction in penalties covering toxic
substances, disinfectants and antiseptics on the one hand, and narcotics and psychotropic substances
likely to cause dependence, on the other hand.
A Royal Decree dated 31 December 1930, continually revised in order to be updated, defines the
substances covered by the aforementioned law.  The Royal Decree currently in force dates 22
January 1998.
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The Royal Decree dated 22 January 1998 (published on 14/01/99) updates the list of substances
covered. The obligations proceeding from the UN 1971 convention on psychotropic substances
(regarding Tables III and IV) were integrated in the national legislation.
The existing measures were extended to various groups a.o. : benzodiazepins, meprobamate, MDMA,
MBDB,  barbiturics, amfepramone, …
(The full text of the Royal Decree can be found on the website of the ministry of Justice at:
http://www.just.fgov.be/cgi/t).
1.2.1.2 Driving and drug consumption
The law of March 16, 1999 (published on March 30, 1999)  modifies the law of 16th of march 1968
related to road traffic,  extending the list of substances concerned from alcohol  to other psychoactive
substances that could influence driving skills.  These new substances are the following: THC,
amphetamines, MDMA, MDEA, MDBD, morphine, cocaine or benzoyllecgonine.
(The full text of the law can be found on the website of the ministry of Justice at:
http://www.just.fgov.be/cgi/t).
Based on a physical examination positive, a urine analysis can be performed.  The maximum admitted
concentrations fixed by this law are as  follows :
THCCOOH : 50 ng/ml
Amphetamine, MDMA, MDEA, MBDB : 1000 ng /ml
Morphine : 300 ng /ml
Benzoylecgonine : 300 ng /ml
1.2.1.3 Harm reduction and access to injection material
The supply, the sale and the delivery, even free of charge, of syringe and needle with the aim to
prevent infectious diseases (e.a. the implementation of 'needle/syringe exchange' programmes) was
made possible outside of the pharmacies by an new law dated 17/11/1998 and published in the
Moniteur belge/Belgisch Staatsblad on 23/12/1998 (the full text of the law can be found on the website
of the ministry of Justice (Moniteur belge/Belgisch Staatsblad) at:
http://www.just.fgov.be/html/fd2_w3.htm (box:1998022758).  This law modifies the places where
syringes can be obtained. The law specifies also that the distribution or exchange of syringes can no
longer be considered as supporting or facilitating illicit use of drug and can not be prosecuted as such.
The Royal Decree published on 6th of July 2000, allows health and social workers from specialised
treatment facilities to exchange needles and syringes.  This service must be accompanied by the
distribution of information on HIV, hepatitis, on access to tests and  to treatment facilities (The full text
of the Royal Decree can be found on the website of the ministry of Justice at:
http://www.just.fgov.be/cgi/t).
Before this law, only medical doctors and pharmacists were allowed to exchange or to sell needles
and syringes.  If this law is an improvement and legalises a practice that was already generalised in
the French Community of Belgium for more than five years, it has its limitations. On one hand, it is too
restrictive as only workers from a specialised treatment facility are concerned.  Secondly, there are no
provision made for processing of used material.
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1.2.1.4 The directive of April 1998
Although the law was not changed, the practical enforcement of the legislation is moving.  The
crime policy for drug addicts was harmonised by a common directive/circular signed by the attorneys
general and the Justice Minister on 26 May 1993.  From 8 May 1998 this directive was revised based
on the conclusions of a report of a working group of the Federal Parliament adopted on 5 June 1997
(see 1.2).  The full text is Annex X.
The law was not changed and the directive only modifies the action of judicial authorities : for the first
time (April 1998), a distinction is established between possession of cannabis for personal use
and other illegal drugs with non acceptable risk for health.  The possession of cannabis for
personal use remains an offence but the lowest prosecution priority should be given.
It means that in case of single or occasional use of cannabis, a simplified policeman's report is to be
filled in and (as in all other cases of drug offence) the drug has to be seized.
Regarding the retail sale, the judicial prosecution to be taken will be differentiated according to the
intents: either sale to provide for funding its own use or on the contrary with the intention to make
profit.
1.2.1.5 Infringements
Taking into account the practical enforcement of the legislation described above, the main
infringements remain:
- the production, import, export, manufacture, keeping (i.e. store under the required conditions,
labelling), transport, possession, sale and offer for sale, acquisition either free of charge or
against payment, of toxic, hypnotic, disinfectant or antiseptic substances (as well as the
cultivation of plants from which these substances can be extracted), without authorisation,
excluding the purchase and possession justified by a medical prescription. The same rule
applies to all psychotropic substances liable to produce drug dependence, and not only to
narcotics and hypnotics
- the use of substances in a group
- aiding and abetting the use of substances, for money or otherwise, either by providing
premises, or by any other means
- instigation to use (pushing)
- the act of procuring or attempting to obtain narcotics or psychotropic substances by using a
forged prescription, a false claim, a forged signature or any other fraudulent means the act
committed by a medical or veterinary professional, or by someone in a paramedical
profession, of over-prescribing, or administering medication containing controlled substances
likely to lead to, maintain or aggravate a condition of dependence the act of refusing or
obstructing site visits, inspections or sample taking.
1.2.1.6 New substances under control
The Royal Decree dated 22 January 1998 (published on 14/01/99) updates the list of substances
covered. The obligations proceeding from the UN 1971 convention on psychotropic substances
(regarding Tables III and IV) were integrated in the national legislation.
The existing measures were extended to various groups e.a. : benzodiazepins, meprobamate, MDMA,
MBDB,  barbiturics, amfepramone, …
(The full text of the Royal Decree can be found on the website of the ministry of Justice (Moniteur
belge/Belgisch Staatsblad) at: http://www.just.fgov.be/html/fd2_w3.htm (box:1998022699).
1.2.1.7 Precursors
Precursors are used for the chemical synthesis of various drugs.  European legislation on precursors
has been integrated into the Belgian legislative texts by virtue of the Royal Decree of 26 October
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1993, published in the Moniteur Belge/Belgische Staatsblad (Official Journal) of 22 December 1993,
and the offences covered by the penalties provided by the law of 24 February 1921 and the article 231
of the law on customs.
This Decree also designates the authorities in charge of enforcement: a Co-operation agreement was
signed by Customs Authorities and the Department of Narcotic Drug of the General Pharmaceutical
Inspectorate e of the ministry of Public Health.
The "Precursors" cell, set up as a result of this agreement, is made up of members of both
departments and is responsible for:
- delivering general authorisations;
- delivering export certificates;
- monitoring intra-community transactions (notification must be given five days prior to all shipments)
in the case of art.1 substances.
Customised software has been developed for this purpose.
1.2.1.8 Legal basis for substitution treatments
An official reference document related to the methadone substitution treatment was prepared by the
experts of the Sub-Committee on Addiction of the Hygiene High Council (Health Council - ministry of
Social Affairs, Public Health and Environment) and published in 1994 2.  The four-page document
' Consensus Conference sur la Méthadone/Consensusconferentie over Methadon ' (Consensus
Conference on methadone substitution treatment) presents the benefits and limits of the methadone
treatment and the indications and rules to be followed.
A follow-up of the 'Consensus Conference on methadone substitution treatment' has been organised.
Between 1997 and 1999, about one hundred experts discussed the state of Art of methadone
substitution treatment in the light of recent developments in Belgium 3.   Therapeutic efficiency of
methadone has been reassessed.
The limited and minor changes in the 'Conférence de Consensus' document underline its very high
acceptance/adoption by all actors in the field of the drug addiction therapy.  Reductions of heroin use,
of IV use, of the spread of the HIV virus and of the mortality related to opiates use, are the major
results generally attested by all Belgian practitioners through their professional experience.  Some
minor changes only have been brought to the original text of the “ Consensus Conference ” and
recommendations have been issued to strengthen the development of this therapeutic orientation in
the interest of the patient, his/her surroundings and the Community in general.  These
recommendations focus on therapeutic practice and relationships between practitioners and
evaluation.
Medical delivery of heroin is not used for treatment of addiction in Belgium.  The most advanced
initiative is a written project protocol approved by the local academic (Université de liège) and medical
(Commission médicale provinciale / 'Provincial Council of Doctors') authorities in Liège.  Before its
implementation the protocol still has to be approved by the 'National Council of Doctors'. No progress
had been made in the recent months.  When approved it is intended to extend similar projects in
Antwerp and Brussels.
1.2.1.9 Confidentiality of the data
Individual privacy rights are guaranteed by the 'Privacy Act' of 8 December 1992 and the Royal
Decrees pertaining to this law.  An adaptation of the Belgian law to the 1995 European Directive was
made in 1998.  Several aspects regarding scientific research are improved, but at the moment, the
Decrees of execution of the new law are not yet completed.
                                                
e Ministère de la Santé Publique, Service des stupéfiants de l’Inspection générale de la pharmacie/Ministerie
voor Volksgezondheid, Dienst verdovende middelen van de Algemene farmaceutische inspectie.
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1.2.2 Prosecution policy, priorities and objectives in relation to drug addicts, occasional
users, drug related crime
Criminality linked with drugs increases at all levels of the judicial system : preliminary investigation,
prosecution, sentence and enforcement of the penalty.  The increasing number of people being
imprisoned for drug offence demonstrates this reality well.  The strictly repressive approach has been
completed : at the various levels of the judicial process, practical possibilities to direct a drug addict to
a care centre were developed as well as measures making possible to avoid the imprisonment.
This Section presents also a synthesis of judicial alternative measures, available at the moment in
Belgium, related to the drug problem.
1.2.2.1 Prosecutions
PENALTIES
Basic penalties  
For all of the above infringements, penalties include imprisonment for a period of three months to five
years and/or a fine of 200,000 to 20,000,000 BEF (5,000 to 500,000 EURO).
- AGGRAVATING CIRCUMSTANCES
A number of aggravating circumstances are foreseen which turn the infringements into crimes.  The
severity of the penalties varies:
a) according to the age of the victim:
- minor aged 16 : imprisonment;
- minor over 12, but under 16 : 10 to 15 years imprisonment;
- minor under 12 :  15 to 20 years imprisonment.
b) in relation to the consequences of the infringement :  if the use of the drug, as a consequence of the
offence, causes the victim:
- a disease which appears incurable, a permanent disability, the total loss of an organ or
serious mutilation : imprisonment (maximal duration not specified);
- death : from 10 to 15 years imprisonment.
c) in relation to the traffic implication:  if the offence is committed as part of the main or accessory
activities of a partnership: 10 to 20 year imprisonment.
- ACCESSORY PENALTIES
A broad range of accessory sentences are also foreseen:
a) prohibition and closure: the judge may:
- temporarily or permanently prohibit the offender from practising medicine, veterinary  medicine, or
working in one of the paramedical professions;
- order the closure and/or forbid the running of a business where the offences were committed.
A new law  (17/11/1998) extends the possibility to close bars and other places where infringements
(use, traffick) where committed. Previously the sentence was restricted to a person: consequently,
after the simple change of the name of the manager of the bar, actually its activities could restart.
Indeed it was opposite to the spirit of the law that aimed the place (bar,…) and not the person.
b) seizure: notwithstanding the common law provisions, the judge may:
seize property which was used or was destined to be used in committing the offence, even if such
property does not belong to the guilty person.
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- REPEAT OFFENDERS
In case of an offence being repeated within five years, sentences for minor offences may be doubled
and those for major offences increased according to article 54 of the Penal Code.
Sentences delivered abroad for these offences are also taken into account when establishing if it is a
repeated offence.
CAUSES FOR LENIENCY
Article 6 of the law of 24 February 1921, as modified by the law of 9 July 1975, allows for leniency in
two conditions:
a) Disclosure prior to any investigation:
If the perpetrator reveals to the authorities the identities of the offenders or, if the names are not
known, the existence of an offence, he/she may benefit exemption from or reduction in sentence,
depending on whether it is a minor offence or an offence which has to be judged in the criminal court.
b) A reduction of imprisonment sentences may be granted for the guilty party who reveals the names
of associates whose names were not known.
A new law  (17/11/1998) extends the possibility to close bars and other places where infringements
(use, traffic) where committed. Previously the sentence was restricted to a person: consequently, after
the simple change of the name of the manager of the bar, actually its activities could restart. Indeed it
was opposite to the spirit of the law that aimed the place (bar,…) and not the person.
The law was published in the Moniteur belge/Belgisch Staatsblad on 23/12/1998 (the full text of the
law can be found on the website of the ministry of Justice (Moniteur belge/Belgisch Staatsblad) at:
http://www.just.fgov.be/html/fd2_w3.htm (box:1998022758).
MONEY LAUNDERING
By virtue of the law of 17 January 1990, the following may be seized, regardless of the nature or the
seriousness of the offence:
- assets derived directly from committing an offence (whatever the nature of the assets);
- any goods or valuables substituting these assets;
- any income derived from investing these assets;
- equivalent assets when the judge determines that the assets were obtained by committing an
offence, even though there is no longer any trace of them in the assets belonging to the perpetrator of
the offence.
Participation in money laundering is punishable by imprisonment for 15 days to 5 years and by a fine
of 5,200 to 200,000,000 BEF (130 to 5,000,000 EURO), or one of these sentences alone.
1.2.2.2 Alternative measures : diversion to treatment and alternatives to prison
Aims of alternative judicial measures
The objectives of judicial alternative measures are as follows 4 :
- To improve the offenders' awareness of the direct and indirect damages to the quality of life
caused by their behaviour and to fight against the way in which these behaviours have become a
feature of everyday life;
- To reduce the number and the duration of imprisonment in the framework of the law over
detention on suspicion;
- To avoid the feeling of impunity caused by a measure of filing and disposing definitely of a case
(although unsolved) when the case actually requires an organised social reaction, but without
having to go to the sentence and the enforcement of a short term imprisonment;
- To provide to these people education and training possibilities by means of practicing an activity
in an occupational context;
- To make the rehabilitation of delinquents having committed offences of a lesser seriousness
easier;
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- To associate local administrative authorities to credible initiatives aiming at reducing criminality;
- To repair in a significant way the material and moral damage, at individual as well as at
community levels, and to ensure the victim' rights;
- To reduce repetition of an offence.
Legal framework of alternative judicial measures
The alternative measures are as follows :
· At police level :  the therapeutical advice
· At public prosecutor’s department level
- Praetorian probation (probation prétorienne / pretoriaanse probatie)
- Penal mediation (mediation pénale / strafbemiddeling)
· Alternative measures at the juvenile court level (mesures de diversion / diversiemaatregelen)
· Alternative to detention on suspicion
· At the level of the judgement (Court)
- Suspension, reprieve and 'probation'
- Works for the benefit of the community and trainings in the framework of the law on 'probation'
· The level of the enforcement of the penalty
- Release on licence (libération conditionnelle/voorwaardelijke invrijheidstelling)
- Confinement
The Figure 1 is a flow chart of the judicial process and mentions the existing alternative measures
through the different levels of the judicial system.  These measures are general ones and are not
specific to drug related offences (however their usefulness is particularly relevant in these cases).
Clear information, intended for the general public, on the alternative measures ('To Penalise without
Imprisoning') is available on the web site of the ministry of Justice f .
FIGURE 1 :  Existing alternative measures through the different levels of the Belgian judicial process
                                                                                                Prison
Offence    Police services      Public          Examining             Judge       Commissions
Prosecutor magistrate
                 
                 
                 
Compulsory non-penal Penal mediation Alternative to Suspension Probation
confinement/treatment detention on suspicion Respite Release on licence
- Work penalty Confinement
- Training penalty
(Alternative (Alternative         (Alternative penalty) (Alternative measure
 measure)   measure) or penalty)
1.2.3    Law enforcement regarding diversion to treatment and alternatives to prison
In 1998, collaboration between the treatment demand network and the judicial system increased.
Specifically for young first time offenders, a practice of 'therapeutical advice'  was further installed and
developed in a number of judicial districts.  In general the widening of the treatment network with more
attention to low-threshold services and differentiated treatment goals (abstinence, reduction,
substitution, maintenance) continued.
                                                
f http://www.just.fgov.be/html/ni2.htm -Dutch language- or  http://www.just.fgov.be/html/fi2.htm -French
language.
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In Flanders, the number of Centres for Mental Health Care that offer ‘therapeutical advice’ is
increasing.  One observes growing variation in applying this method in the different judicial entities.
Therefore co-ordination of the method is needed.  An ad hoc work group started with collaborators of
these Centres for Mental Health Care to create a blue print of the method in 1998.  Its aim is to create
more uniformity and to offer a comprehensive manual for those Centres for Mental Health Care that
intend to start with the method.
1.2.3.1 Data from treatment centres on referrals from the justice/penal system
The treatment demand indicator provides information on the source of referral g.  Despite some initial
differences between categories reported by the CCAD, CTB/ODB and VAD registration systems, the
pooling of the data was made possible tanks the running harmonisation process.  Table 1 shows that
comparable proportions of treatment demands (respectively 18 and 19% in 1997 and 1998) were
referred by Court/probation/justice services.  According to the type of treatment (ambulatory/outpatient
or residential/inpatient care), one observes that a fourth of patients undergoing ambulatory treatment
are referred by Court/probation/justice services, what is higher than patients treated in residential
centres.
TABLE 1. Source of referral (%) of patients asking for or starting treatment in 1997
and 1998, CCAD/CTB-ODB/VAD, Belgium
1997*  1998 1998 Outpatient ** 1998 Inpatient **
M F T M F T M F T M F T
Number of cases 4,154 1,434 5,785 4,910 1,637 6,649 3,148 1,060 4,232 1,762 637 2,417
% % % % % % % % % % % %
Self referred, family, friends 40 41 41 43 40 43 38 35 37 54 49 53
Other drug treatment centre 13 15 13 16 17 17 14 13 14 20 24 21
GP,hospital,oth.med.sources 13 20 16 12 16 13 12 14 12 14 20 16
Social service 5 5 5 3 3 3 3 4 4 1 0 1
Court,probation,justice 21 9 18 20 17 19 25 26 25 9 4 7
Other 7 11 8 6 6 6 7 8 8 2 3 3
* : Data from CCAD and CTB/ODB are actually 1997 treatment demands when VAD data are 1996 demands.
** : Outpatient : data from centres offering ambulatory care / Inpatient : residential centres
1.2.3.2 Survey on collaboration between treatment services and justice/penal system
In September 1999, a questionnaire survey was conducted among 140 drug treatment services in the
Flemish Community (low and high threshold services, in and out patient services, drug specialised and
not drug specialised).  The subject of this survey is to estimate the extent and the nature of the
collaboration between the sector of drug care and the sector of justice in 1998 and 1999.  VAD
published an interim report at the end of 1999 5.  84% of centres received less than 25 referrals most
of these centres are the psychiatric hospitals and psychiatric annexes of general hospitals (PZ and
PAAZ) on one side and the centres for mental health (CGG) on the other side.  On the other hand,
more than half the day-care centres (DC), crisis intervention centres (CIC) and therapeutic
communities (TC) got between 51 and 100 referrals per year.  The distribution was similar in 1999
compared to 1998.
Among the institutions that refer the most, especially the police and the gendarmerie are mentioned
(although the difference with the court and the public prosecutor is very slight).  Probation, conditional
release and provisional release, therapeutical advice and mediation are judicial measures who lead to
most of the referrals.
Most centres reported that the number of referral increases or that at least is equal in 1998 compared
with the referrals before 1998.  The reasons most often mentioned when an increase is observed are:
                                                
g For a description of the various registration systems, see Part II : Epidemiology.
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training and better knowledge, collaboration and the drugs circular.  Most centres said the profile of
the referred persons stayed the same : nevertheless, an increase of the number of minors and a
change in the kind of drugs that are used (e.g. speed) was observed.
1.2.4 Any other important project of law or other initiative with political relevance to
drug related issues
1.2.4.1 Law proposals about drug
24/02/2000 : proposal (of members of parliament – not the federal government) modifying the law on
drug of 24/02/1921 in order to partially decriminalize the possession of cannabis and its derivates
The authors proposed that the positive right should be clarified. The prohibition policy against
cannabis should be given up because a.o. its ineffectiveness. Nevertheless, the prosecutions against
dealers should be continued and the drug use prevention efforts emphasized.
1.3.  Developments in public attitudes and debates
1.3.1 Public perception of the drug issues and public debates carried out by civil
society, national Parliament, organisations, NGO’s
On a political level, ambiguous signals are launched towards the general public : on the one hand a
new directive/circular 'softening' the prosecution policy for cannabis users and on the other hand an
official political statement of 'just say no'.  This leads to a great deal of confusion among youngsters
and parents.  Most of the youngsters think now that cannabis has been legalised.
A recent development in Flanders is the public admission via T.V. and press by well known
personalities of their usage of soft drugs. More and more items appear in newspapers on drug issues
and debates on drug use are not infrequent on television.
1.4.  Budgets and funding arrangements
1.4.1 Funding (figures) at national level - Federal Government
v Law enforcement (criminal system, police forces, etc.)
The ministry for Foreign Affairs funds matters related to international relationships.  Meanwhile
relationships to some organisations (UNDCP for example) were delegated to the ministry of Justice
(the ministry of Justice presides a co-operation between the competent departments of federal and
federate levels (Communities) and among the police departments, regarding the reduction of supply
and repression in the framework of international relations).
Additionally to its charge directly related to general justice affairs (a.o. the 'Police
Judiciaire/Gerechtelijke Politie, the Courts,…'), the ministry of Justice funds training projects for prison
personnel.  Health service in prison (prevention and treatment activities including their funding) is the
competence of the prison/justice administration (health policies of the ministry of Health are not in
force)..
In so far as keeping law and order, and crime prevention are concerned, the 'Gendarmerie/Rijkswacht'
acts under the supervision of the Minister of Internal Affairs.  With regards to repression, the
'Gendarmerie/Rijkswacht' reports to the judicial authorities and the Minister of Justice.  The
'Gendarmerie/Rijkswacht' set up a specific Drug Programme in the framework of its Bureau Central de
Recherches / Centraal Bureau voor Opsporing (Central Office for Investigation).  This programme
covers the following domains: prevention, drug and road traffic, local traffic and drug tourism,
international traffic organisations, drug production (laboratories), international co-operation (Europol,
Pompidou groups).
The ministry of Finance through the custom services is charged to control all imports including illicit
ones (actually a large part of seizures are performed by customs).
The 589 Belgian municipalities all have and support their own police force under the authority of the
municipality mayor, and under the orders of a chief of police (a new legal framework (police law) is
under preparation that should lead to a uniform police).
A complete reform of the police structure is in progress, organizing an integrated police service (law of
7/12/1998).
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v Epidemiology, research, evaluation, quality
The ministry of Health funded in 1999 and 2000 a feasibility study for the transformation of the National
Focal Point in a multidisciplinary monitoring centre.  The Prime Minister, through the SSTC/DWTC, funds
various investigations : treatment facilities (an evaluation of low threshold centres –MSOC/MASS- is in
progress), criminological, and epidemiological researches.
In addition the FRS/FWO funds several research projects (as example a study on consumption of
cannabis among youngsters).
v Prevention, treatments, trainings
The ministry of Social Affairs, through the INAMI/RIZIV, funds treatment charges and treatment
centres.   The ministry of Health supports the administration charged with the control of licit trade
through the Department of Narcotic Drug of the General Pharmaceutical Inspectorate h (ministry of
Public Health).  The Belgian Focal Point of the EMCDDA is located at the IPH (the scientific research
institute of the ministry of Public Health) and is funded and managed in collaboration with the
Communities and the federal ministries.
The ministry of Internal Affairs co-ordinates and funds (via the VSPP) projects in the framework of
crime prevention.  The VSSP also supports the education of prevention professionals and assists
them in their work.  It also fund the employment of local prevention workers in the field of crime
prevention.  A transit centre and the MASS/MSOC (low threshold centres) were created thanks to
funds from the ministry and from the INAMI/RIZIV.
The ministry of Justice funds training projects for prison personnel.  Health services in prison
(prevention and treatment activities including their funding) is the competence of the prison/justice
administration (health policies of the ministry of Health are not in force).
1.4.2 Community and Regional governments
LAW ENFORCEMENT (CRIMINAL SYSTEM , POLICE FORCES, ETC.)
Nothing specific for these levels.
1.4.2.1 Flemish Community
Funding (figures) at the level of the Flemish Community in the field of epidemiology, research, co-
ordination of prevention and treatment, evaluation, quality and training :
- at a Flemish level : subsidy of VAD for 8 areas of work (77.6 million BEF)
- at provincial level : subsidy of 6 provincial coordinators ( 15 million BEF)
- at a regional level (12 regional networking projects for centres of mental health (20 million
BEF)
EPIDEMIOLOGY, RESEARCH
The Flemish ministry of Health Policy funds :
·  Registration
- project to develop uniform registration programme in treatment sector
- registration project for prevention activities
- Flemish participation in Sub-Focal Point of European Monitoring Centre for Drugs and
Drug Addiction (VAD).
The other Flemish Ministers have no specific budget for drug problems, except the Flemish ministry of
Scientific Research, in which budgets are available for drug research. Private funding is also available.
PREVENTION AND TREATMENTS
                                                
h Ministère de la Santé publique, Service des stupéfiants de l’Inspection générale de la pharmacie / Ministerie
voor Volksgezondheid, Dienst verdovende middelen van de Algemene farmaceutische inspectie.
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The Flemish ministry of Health Policy funds :
· Prevention
- 10 prevention workers in centres for mental health
the funding is integrated in the global budget of the centres
- local prevention workers,
funded by local governments, welfare budgets, ministry of Interiors, …
·  Treatment
- centres for mental health funded by the Flemish government for dealing with mental health
problems, among which alcohol and drug problems
- psychiatric hospitals, and psychiatric wards of general hospitals
funded by the federal government in a global funding of hospitals
- therapeutic communities, crisis centres, day centres, medico-social care centres (MSOC-
MASS)
funded by the federal government on an individual basis
- within the welfare sector, different projects and organizations also offer care (and sometimes
treatment) for people with drug problems.
- Within the health sector, treatment is also done by general practitioners and non-drug specific
health organizations (f.i. school health service).
1.4.2.2 French Community
EPIDEMIOLOGY, RESEARCH
The ministry of Health of the French Community funds:
· Registration
- since 1992, permanent registration system on "treatment demand" indicator by the Sub-
Focal Point among out-patient- and inpatient centres as well as among general services
in the French Community (in co-operation with the ministries of Health and Social Affairs
of the French Community and the Walloon Region)
- data collection and publication of results by the Sub-Focal Point.
- Through its Sub-Focal Point the French Community participates in the Belgian
information Reitox Network of EMCDDA.
· Research
- Both the Walloon region and French Community fund or co-fund several research
projects on vulnerability and drug consumption. such as on new synthetic drugs, on
cannabis or on social vulnerability.
PREVENTION AND TREATMENTS
Within the framework of the1997 – 2001  health promotion decree,  the ministry of Health of the
French Community funds :
· Prevention on a basic and specific level
- field projects : focusing on children - adolescents or adults
- training and education programmes for key persons
- prevention material : folders, videos, theatre plays, pedagogic suitcase for teachers, etc.
- harm reduction projects: needles exchange programmes, peer AIDS and hepatitis
prevention programmes, harm reduction material.
· Prevention on an unspecific level
- positive discrimination projects in schools: a network of +/- 45 mediators and operators
are working in the schools in the Brussels and Walloon Regions to promote "school
catching up" actions
- an agreement between the Minister of Internal Affairs and the Minister-President of the
French Community helped to develop and to integrate specific primary drug prevention
programmes in urban secondary schools in co-operation with agreed prevention
services.  A federal budget is attributed to these prevention activities.
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EVALUATION, QUALITY, TRAINING
The Ministry of Health of the Walloon Region funds since October 2000 a harm reduction training
programme for specialised professionals.
1.4.2.3 Brussels Region
EPIDEMIOLOGY, RESEARCH
The Brussels Region  funds :
·  Registration
- project to develop uniform registration programme in treatment sector
- collection of available data from various registration systems
- Flemish participation in Sub-Focal Point of European Monitoring Centre for Drugs and
Drug Addiction (VAD)
- publication of results by the CTB-ODB.
PREVENTION AND TREATMENTS
The Brussels Region funds :
· Prevention - co-ordination
- harm reduction programmes and other projects
- training programmes for prevention workers and key persons.
·  Treatment
centres for mental health care and most of specialised treatment centres are funded within the global
subsidies of health care provision.
The financing of the programmes is set by agreement.
In addition to this source of finance, the agents in the field of course obtain financial support notably
from federal (social security health funds).
EVALUATION, QUALITY, TRAINING
Training tasks are also included in regional agreements with specialised centres.
1.4.2.4 German-speaking Community
EPIDEMIOLOGY, RESEARCH, PREVENTION AND TREATMENTS, EVALUATION, QUALITY, TRAINING
The government of the German-speaking Community subsidises the Centre for mental health as much
as the ASL.  The Centre for mental health is co financed by the CPAS of the 9 municipalities.
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PART II.  EPIDEMIOLOGICAL SITUATION
Chapter 2. Prevalence, Patterns and Developments in drug use
2.1.  Main developments and emerging trends
The trends observed in the last year have been the same trends for several years : growing popularity
of cannabis and XTC use among youngsters.  Focusing on the recent evolution by comparing 1998-99
with 1994-96 data, the life-time prevalence and the last-month prevalence increase, both for boys and
for girls in all age groups.  This is the case for cannabis/hashish and speed/XTC use.  The most
commonly used product is cannabis.  The use of LSD which was popular in the mid 80’s but decreased
gradually after, regaining some popularity these last years (since 93).  For half of youngsters, the use of
illicit drugs is limited to experimenting, which then goes no further.
As studies in general adult population were conducted in different part of the country (French
Community from 1996 to 1999 and Flemish Community in 1994), it is difficult to generalise their results
to the whole country and to perform a trend analysis from 1994 to 1999.  Meanwhile regarding
cannabis use one observes that the Flemish prevalence of 1994 (6%) does not conflict from a trends
point of view with the prevalence of the further periods observed in the French Community in 1996-97
and 1998-99, possibly indicating a global increasing trend during the nineties (as observed in other EC
countries).  Information on use of other drugs by adults is still lacking.
Illicit drugs problematic users are typically younger than 25.  Boys use drugs more frequently than girls
and use increases with age.  The most common reasons for the request of treatment are problems
related to the use of heroin and cocaine.  The ‘typical user’ starts at a young age (younger than 18,
even younger than 15 years old).  These people are confined to a psychiatric ward and/or have had
previous treatments. Poly-addiction has become very common.
Corresponding to the increase of the use of cannabis by youngsters, one observes an increase of
demands for treatment of problematic cannabis use.  This trend is particularly striking from the data of
the VAD monitoring systems because it is covering a.o. centres of mental health care.  Indeed, most
cannabis problematic users have easier access to advice and treatment in these centres than in
‘specialised’ addiction centres classically more oriented to opiates users.  Nevertheless, in some of the
latter centres, the situation is moving making more accessible the support to cannabis problematic
users.
Unlike to an apparent trend towards less intravenous use that could be caused by the fear of HIV and
HIV-prevention campaigns, prevalence of intravenous use of heroin seems not decreasing and some
sources suggest an increase of cocaine intravenous use.  The apparent decrease is in fact due to the
relative increasing proportion of ‘non-injected’ drug among drug whose the use is problematic enough
to involve in a treatment demand.
In 1999, HIV-seroprevalence among drug users remains low in Belgium.  In contrast, studies show
high prevalences of hepatitis B and C, which are not decreasing with years.  Given its evolution to
chronicity and cancer, hepatitis seems to become the main public health consequence of intravenous
drug use.  Nevertheless, keeping watch over HIV among drug users is essential as there are a very
susceptible group.
The set-up of low threshold centres offers an additional possibility to access to treatment including
methadone substitution and to enlarge risk reduction interventions
Tables 2, 3 ,4 and 5 give a summary of the available data and indicate trends when possible.
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TABLE 2. Synthesis table of epidemiological indicators on drug use : trends of drug
use in the population in Belgium for the period 1993-1999 (Figures are
percentages except when specified)
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
ADULT POPULATION
Cannabis Vlaamse G. 6 5.8
Lifetime prevalence ULB/Promes 7 12.8 20.8 
Last year preval. Vlaamse G. 6 1.5 ?
SCHOOL POPULATION
Cannabis RUG/Publ.Hlth 9 14.9 19.6 23.7 
Lifetime prevalence VAD 11 24.1
ULB/Promes 10 27.9
Last month preval. RUG/Publ.Hlth 9 7.6 10.8 14.6 
XTC RUG/Publ.Hlth 9 4.1 5.6 6.2 
Lifetime prevalence VAD 11 4.0
ULB/Promes 10 6.3
Last month preval. RUG/Publ.Hlth 9 1.4 2.0 2.8 
USE IN PRISON Free Clinic 25 42.0
Last month preval. Modus Vivendi 62 38.0 ?
FC / MV 23 42.0
Legend : = : stable /  : increase /  : decrease / ~~ : fluctuating /  : increase followed by a decrease /  ? : data not available or not interpretable
TABLE 3. Synthesis table of epidemiological indicators on drug use : trends of
problematic drug use, Belgium, period 1993-1999 (Figures are percentages
except when specified)
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
PROBLEMATIC USE
IVDU prevalence (‰) IPH 29 3.6 ?
Heroin use prevalence
(‰)
CCAD 31 6.3 ?
Poly-drug use
Modus Vivendi 32 32.0 45.0 36.0 36.0
Injecting use (current)
Main drug CCAD 34 30.2 34.3 28.7 24.0 24.0 19.9 
Heroin CCAD 34 35.9 40.9 39.9 37.0 37.3 35.3 =
Coord.Drog.Charl. 37 17.1 =
VAD 33 26.6
Cocaine CCAD 34 22.2 25.9 34.6 22.9 34.8 29.5 ~~
Coord.Drog.Charl. 37 10.8
VAD 33 8.9
Legend : = : stable /  : increase /  : decrease / ~~ : fluctuating /  : increase followed by a decrease /  ? : data not available or not interpretable
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TABLE 4. Synthesis table of epidemiological indicators on drug use : trends of health
consequences of use, Belgium, period 1993-1999 (Figures are percentages
except when specified)
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
MORTALITY
Drug related deaths (n) NIS-IPH 346 376 346 =
DRD involving opiates NIS-IPH 47.0 48.0 53.0 =
MORBIDITY
IVDU / new HIV IPH 63 5.5 7.2 3.4 3.8 4.5 2.9 3.4 
HIV / drug treatments GEMT 66 0.9
                 IVDUs ALTO 68 2.2
CCAD 34 4.9 5.7 3.0 1.4 2.6 1.6 
GIG 67 2.2
De Sleutel 38 0.8 5.4 0.5 ?
VAD 33 1.9
HBV / drug treatments GEMT 66 36.0
                 IVDUs CCAD 34 22.4 23.6 =
De Sleutel 38 20.5 24.1 23.9 =
HCV / drug treatments GEMT 66 78.0
                 IVDUs ALTO 68 56.0
CCAD 34 46.7 51.9 =
De Sleutel 38 39.5 46.4 37.9 =
Legend : = : stable /  : increase /  : decrease / ~~ : fluctuating /  : increase followed by a decrease /  ? : data not available or not interpretable
TABLE 5. Synthesis table of epidemiological indicators on drug use :offences,
availability and drug market data, Belgium, period 1993-1999
INDICATORS ORGANISATION (ref) 1993 1994 1995 1996 1997 1998 1999 Trend
People taken in            
for questioning (N)
SGAP 46 19,482 19,467 18,376 21,184 17,129 
Cannabis (% involv.) 72.7 65.0 65.7 68.6 =
XTC/amphet. (%) 3.5 16.0 0.9 15.6 ~~
Opiates (%) 16.5 7.0 25.6 5.9 ~~
Cocaine (%) 5.9 5.0 4.6 4.3 =
Seizures (N) SGAP 47
Cannabis 6,380 8,628 13,379 13,020 7,362 
XTC/amphetamines 684 978 1,002 2,672 2,163 
Opiates/heroin 3,082 3,024 3,158 1,112 720 
Cocaine 897 927 1,046 799 547 
Retail prices (euro) SGAP 47
Cannabis / g 8 7 9 6 6 =
XTC/amphet. /tab. 28 12 8 9 
Heroin / g 83 38 35 35 35 
Cocaine / g 55 49 40 50 55 =
AVAILABILITY (adults) ULB-Promes 7
Cannabis 59.2 70.4 62.9 64.5 
Cocaine 45.6 50.8 41.1 40.0 =
Legend : = : stable /  : increase /  : decrease / ~~ : fluctuating /  : increase followed by a decrease /  ? : data not available or not interpretable
2.2.  Drug use in the population
Since 1990 up to recently most population surveys carried out in Belgium have concentrated their
efforts on clearly specified demographic sets, often defined as various populations of young school
aged people.  Although partial, investigations have been conducted (or are being conducted) in the
general population.
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2.2.1 Main results
2.2.2 General adult population
In 1994, a telephone interview study was conducted among the Flemish general population (2,259
adults between 18 and 65 years) 6.  The study showed a low level of drug experience among the
general population : the prevalence of 'at least once use' of any illegal drug was globally 6.4% and
about 5.8% experienced cannabis. (Table 6).  It was higher among younger adults (<=35 years old):
11% used an illicit drug at least once, 9% cannabis, 2% amphetamine or speed and a little bit more
than 1% XTC as well as cocaine.   Prevalence was higher among males than females.
Sixteen % of young males aged 35 years or less had tried an illegal drug at least once and 7% during
last 12 months.   Cannabis represented the main substance used by more than 90% of consumers.
Since 1996 a continuous health behaviour monitoring has been conducted in four areas,
representative of the French Community households 7.  The survey is using a computer assisted
telephone interview method with random dialling of the household and random selection of one adult.
Every three months around 300 adults are interviewed (each people being interviewed once).  During
the 1996-1999 period the monitoring covered 3,311 adults of 18-69 years of age (the drug questions
were asked to adults of 18 to 49 years; n = 2,112).  The global participation rate is 69%.
TABLE 6. Lifetime prevalence (%) of drug use and last 12 months prevalence
(between brackets) among the adult population (18-65 years old), Flemish
Community, 1994 6
Drugs
 All
adults
18-65 y.
N=2,259
Young
adults
18-34 y.
N=924
Older
adults
35-65 y.
N=1,332
Total M F Total M F Total
Any illegal drugs 6.4  (1.8) 16.5  (6.9) 6.8  (1.9) 11.0 5.8  (0.4) 1.2  (0.0) 3.2
Cannabis 5.8  (1.5) 14.8  (5.7) 6.6  (1.5) 9.2 5.1  (0.4) 1.2  (0.0) 2.9
Amphetamine-speedi 0.9  (0.3) 2.0 0.1
XTC 0.5  (0.1) 1.3 0.0
Cocaine 0.5  (0.2) 1.2 0.0
Heroin 0.04    (-) 0.1 0.0
The access to cannabis and to cocaine as well as the consumption of cannabis (at least once and
during the last 7 days) was investigated.  Regarding the use prevalences, 21% (95%CI 13.2-28.6) of
adults interviewed in 1998-99 stated to have used at least once cannabis.  The prevalence decreases
with age from 34% among 18-24 to 13% among 45-49 years of age.  Males (29%) stated cannabis
experience more than females (13%).  Thirty-five % of young males aged 35 years or less
experienced cannabis at least once.  These differences remain significant after standardization
respectively for sex, education and area, and for age, education and area.
Twenty-nine persons out of 231 having experienced cannabis (12.5%) smoked cannabis during the
last 7 days, representing 2.6% of interviewed people.
As these studies were conducted in different parts of the country (Flemish Community in 1994 and
French Community from 1996 onwards), it is difficult to generalise their results to the whole country
and to perform a trend analysis from 1994 to 1999.  However the results of the continuous monitoring
                                                
i Amphetamines and speed were grouped in this analysis. Unfortunatelly grouping varies between studies.  This
remark is also valid when considering other types of grouping (age group, etc.).  Harmonisation in reporting of
results is progressively improving, e.a. thanks to the REITOX-EMCDDA guidelines.
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of the French Community adults can be compared.  Figures were standardized for age, sex (except
when stratified by sex), education and area : around 1,000 people were interviewed for each period
1996-97 and 1998-99 (Table 7).
The survey shows a significant increasing trend in the lifetime prevalence from 13% in 1996-97 to 21%
in 1998-99.  Taking into account the remark mentioned here above, one observe that the Flemish
prevalence of 1994 (6%) does not conflict from a trends point of view with the prevalence of the
following periods, possibly indicating a global increasing trend during the nineties (as observed in
other EC countries 8).
TABLE 7. Lifetime prevalence (standardized % and 95%CI) of cannabis use among
the adult population (18-49 years old), French Community, 1996-97 and
1998-99 7
Period N
 All
adults
18-49 y.
Young
adults
18-34 y.
Older
adults
35-44 y.
Total M F Total M F Total
1996-97 976 12.8
(10.8-14.8)
24.9 11.0 17.8
(14.6-21.1)
12.7 8.7 10.5
(7.3-13.8)
1998-99 1106 20.8
(18.3-22.8)
35.3 17.0 26.1
(22.5-29.7)
23.4 10.1 16.3
(13.0-19.6)
Adjusted rates for age, sex (for the total figure), education and area.
For the beginning of the 90ties, the only prevalence estimates are based on conscripts (see 2.2.d) and
are not comparable with the figures mentioned above.
2.2.3 School and youth population
2.2.3.1 Drug use from secondary school surveys
Several regional surveys were carried out in recent years, representative for secondary school
children of the Flemish 9 and French 10 Communities.  Two repetitive surveys in the Flemish and
French Communities used the standardized protocol validated at international level in the framework
of the WHO Health Behaviour School-aged Children (HBSC).  In1999 VAD conducted a very large
study in the Flemish Community schools using a different protocol 11 : this study will be repeated every
year and cover representatively all types of schools.
Even if one should be prudent in interpreting the quantitative elements of drug consumption by young
people, based on the data obtained by means of self-administered questionnaires, the results of these
studies globally indicate that in 1998-99 :
- around 25% of students of 15-16 years of age has tried an illegal substance at least once (Table 8);
- around 20% of students aged 15-16 years  experienced at least one cannabis during the last year ;
- around 15% of students aged 15-16 years  experienced at least one cannabis during the last month ;
- the frequency of use increases with age : more than 40, 30 and 20% of 17-18 years of age has tried
cannabis  respectively at least once, during the last year and during the last month (Table 9);
- the proportion of users of illicit substances is higher among boys than among girls;
- from 15-16 years of age onwards, cannabis derivatives are the products most used; ecstasy is the
second product most used ; among younger students, solvents or hypnotics or sedatives are the
products most used;
- an increasing trend in the use of illegal drugs, especially cannabis, XTC and amphetamines.
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TABLE 8. Prevalence of drug use among the school population aged 15-16 years,
Flemish Community 9 (1994-96-98-99) and French Community10 (1998)
Drugs Fl C 94 Fl C 96 Fl C 98 Fr C 98 Fl C 99
Period N=5,247 N=2,391 N=9,211 N=12,987 N=47,657
Lifetime 14.9 19.6 23.7 27.9 24.1
(Boys-girls) (20-10) (25-15) (28-20) (31-25) (29-19)
Last year - - - - 19.5
Cannabis
Last month 7.6 10.8 14.6 - -
Lifetime 4.1 5.6 6.2 6.3 4.0
(Boys-girls) (5-3) (8-3) (8-4) (7-5) (5-3)
Last year - - - - 2.9
XTC
Last month 1.4 2.0 2.8 - -
Lifetime 5.1 3.8 5.0 5.1 11.2
(Boys-girls) (4-6) (3-5) (5-6) (5-5) (10-13)
Last year - - - - 5.8
Hypnotics- sedatives or
Benzodiazepines
Last month 2.0 1.1 2.1 - -
Lifetime 2.6 3.2 3.8 7.0 6.5
(Boys-girls) (3-2) (4-2) (5-2) (8-6) (8-5)
Last year - - - - 4.5
Amphetamines
Last month 0.8 0.8 1.5 - -
Lifetime 3.3 2.9 4.4 5.8 4.2
(Boys-girls) (4-2) (4-1) (6-3) (7-5) (5-4)
Last year - - - - 2.4
Solvents
Last month 1.3 0.8 1.8 - -
In terms of trends, the prevalences are increasing in all age groups.  When we compare youngsters
aged 15-16 for years for 1994, 1996 and 1998-99 (Table 8):
- the lifetime prevalences of use of cannabis are regularly increasing from 15 to 25 % j;
- respectively 20-25-30 % in boys k and 10-15-20 % in girls experienced cannabis at least once ;
- the proportion of last month users among ‘lifetime’ users of cannabis increases: respectively 51-55-
62 %;
- the lifetime prevalences of use of XTC are respectively 3-3-6 %;
- respectively 5-8-7 % in boys and 3-3-4 % in girls;
- the proportion of XTC ‘regular’ users among users increases : respectively 34-36-45 %.
- the lifetime prevalence of use of hypnotics/sedatives are respectively 5-4-5 % l;
- respectively 4-3-5 % in boys and 6-5-6 % in girls;
- the proportion of ‘regular’ users of hypnotics among users are respectively 39-29-42 %.
- the lifetime prevalence of use of amphetamines are respectively 3-3-6 %;
- respectively 3-4-8 % in boys and 2-2-5 % in girls;
- the proportion of amphetamines ‘regular’ users among users are respectively 31-25-39 %.
                                                
j The 1998 French Community HBSC survey reports a higher prevalence : 28 % of youngsters stated to have
used cannabis at least once : the difference is more am ong girls  : 25% compared to 20% in Flemish
Community surveys.
k 1994 : Boys : 18% (French Com.) and 22% (Brussels) / Girls : 14% (French Com.) and 13% (Brussels).
l The 1999 VAD Flemish survey reports a higher prevalence : only considering benzodiazepine use, 11 % of
youngsters stated to have used at least once (10 % among boys and 13 % among girls).
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TABLE 9. Lifetime prevalence of drug use among the school population aged 17-18
years, Flemish Community9(1994-96-98-99) and French Community10 (1998)
Drugs Fl C 94 Fl C 96 Fl C 98 Fr C 98 Fl C 99
Gender N=5,247 N=2,391 N=9,211 N=12,987 N=47,657
Males 32.1 42.7 45.9 50.6 48.1
Females 14.2 23.0 32.6 39.0 27.5
Cannabis
Total 23.1 32.7 39.3 43.9 39.0
Males 8.9 13.9 14.8 14.4 11.0
Females 3.7 4.9 10.1 8.9 4.7
XTC
Total 6.3 9.3 12.2 11.2 8.1
Males 6.5 7.0 8.5 13.1 14.5
Females 2.1 3.1 5.6 7.3 7.5
Amphetamines
Total 4.3 5.0 6.8 9.8 11.4
Males 5.9 6.1 7.0 7.0 13.3
Females 4.9 5.5 8.7 5.6 15.9
Hypnotics- sedatives or
Benzodiazepines
Total 5.4 5.8 7.8 6.2 14.4
Males 8.0 12.4 11.0 7.4 5.0
Females 2.1 3.7 6.8 3.6 2.7
Solvents
Total 5.5 8.0 8.9 5.3 3.9
We present here below various surveys carried out in different regions of the country and give some
results as example.
- HBSC : Youngsters and health in Flanders, 1994-1996-1998 9
- HBSC : Health behaviour and life-styles of youngsters in the French Community, 1994-1998 10
- Interview of youngsters of Flemish Schools, 1999 11
- School survey on drugs in Charleroi (Wallonia), 1999 12
- Social diagnosis in 3 secondary schools in Verviers (Wallonia), 1999 13
- School-aged youngsters in Beveren (Flanders): a study in 1997-1998 14
- School-aged youngsters in Bruges (Flanders): a study in 1996-1997 15
- Study of youth behaviour in the city of Ninove (Flanders), 1995 16
- Mental health of youngsters in Brussels, 1994 17
- HBSC survey : Youngsters and health in Flanders, 1990-94-96-98  9
The purpose is to present an evolution about health-related attitudes and behaviours of youngsters.
The study is repeated on regularly basis (1990, 1994, 1996, 1998).  The sampling of the schools is
based on a stratification according to educational networks (local community schools, provincial
schools, official schools and government schools).  The respective samples for the study of 1994,
1996 and 1998 consisted of 10,414, 4,771 and 12,088 Flemish teenagers aged 11-18.  Before 1998,
the question about drug use was only asked to the students aged 15-18.
The number of drug users aged 15-16 and 17-18 is presented per groups of substance (Table 10).  In
general more boys than girls use illegal drugs.
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TABLE 10. Students having used a drug at least once (lifetime), for girls and boys
according to age, Flemish Community schools, 1998 9
15-16 y. 17-18 y.
Drug
Boys
N = 1 432
Girls
N = 1 355
Total
N = 2 787
Boys
N = 1 296
Girls
N = 1 286
Total
N = 2 582
% % % % % %
Cannabis 27.7 19.6 23.7 46.0 32.7 39.3
XTC/speed 8.0 4.1 6.2 15.4 10.2 12.8
Sniff, volatile inhalants 5.8 2.9 4.4 11.0 6.8 8.9
Tranquillizers 4.6 5.5 5.0 7.1 8.7 7.9
Amphetamines, stimulants 5.0 2.5 3.8 8.5 5.1 6.8
LSD 2.6 1.7 2.1 6.8 4.1 5.4
Cocaine 1.9 0.7 1.3 4.3 4.4 4.3
Heroin 1.2 0.3 0.7 2.2 0.4 1.3
FIGURE 2 :  Proportion of youngsters (15-16 years of age) having used at least once cannabis or
ecstasy, Flemish Community schools, 1994, 1996 and 1998 9
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Cannabis is most popular among boys : 28% of 15-16 year old boys and 46% of 17-18 year old boys
had used at least once, followed by XTC/speed and then volatile inhalants.  Among girls cannabis is
also the most popular, followed by XTC/speed, tranquillizers are third.
Figure 2 shows an increasing 1994-1996-1998 trends for cannabis use among 15-16 year old as well
in boys as in girls.  For XTC, such a trend is observed among boys during the period 1994-1996
whereas among girls the increase is delayed during the period 1996-1998.
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TABLE 11. Students having used a drug during the last month, for girls and boys
according to their age, Flemish Community schools, 1998 9
15-16 y. 17-18 y.
Drug
Boys
N = 1 286
Girls
N = 1 355
Total
N =  2 641
Boys
N = 1 296
Girls
N = 1 432
Total
N = 2 728
% % % % % %
Cannabis 18.0 10.9 14.6 27.9 15.0 21.5
XTC/speed 3.5 2.1 2.8 5.8 4.3 5.0
Sniff, volatile inhalants 2.2 1.4 1.8 3.4 2.5 2.9
Tranquillizers 1.8 2.6 2.1 2.5 3.0 2.8
Amphetamines, stimulants 1.9 0.9 1.5 3.3 1.9 2.5
LSD 0.9 0.7 0.8 2.6 0.9 1.7
Cocaine 0.3 0.3 0.3 1.4 0.9 1.1
Heroin 0.3 0.0 0.2 0.5 0.1 0.3
More boys than girls have used cannabis during the last month. This is both the case for youngsters
from 15-16 as those from 17-18.  In 1998 compared to 1996, the last month prevalence of cannabis
use has increased both among boys and girls in both age groups. The increase is the biggest amongst
the oldest girls  (17-18 years).
FIGURE 3 :  Proportion of youngsters (15-16 years of age) having used cannabis and ecstasy during
the last month, Flemish Community secondary schools, 1994, 1996 and 1998 9
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Comparing 1994, 1996 and 1998, an increasing proportion of cannabis users (ever used) are ‘regular’
ones (defined as last month use): 50%, 55% and 62 % respectively.  It is particularly striking among
youngsters of 15-16 and also among 14 year-old students (42%, 53% and 58% respectively).  For
XTC, a third of users were ‘regular’ in 1994 and 1996, whereas this proportion increases up to 43% in
1998.
Pattern of use
About 50% of boys who ever used cannabis, stopped. For the other products this percentage is
higher.  The proportion of ‘last month’ users of cannabis increased regularly from 1994 to 1998, as
well for boys as for girls (Table 12).  More boys than girls used several times speed or XTC during the
last month.  In 1998 the proportion of boys of 17-18 year of age who took it 1 to 2 times per month
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TABLE 12. Last month use of cannabis among youngsters of 17-18 year of age, by sex
and frequency of use, in 1994, 96 and 98, Flemish Community schools 9
Last month use of cannabis (%)
1994 1996 1998
1-2x 3x and
more
1-2x 3x and
more
1-2x 3x and
more
Boys 9.3 8.3 9.4 11.2 11.4 14.3
Girls 3.5 2.2 5.2 3.7 6.9 7.0
 (2.7%) decreased compared with 1996 (4.2%).  On the contrary for girls, the proportion who used it 1
to 2 times per month increased from about 0.8% to 2.1% in 1998.
The age of first use for the age group 15-18 was quite similar over the 3 consecutive studies : from
15.1 year old in 1994 and 1996 to 14.8 in 1998.
- HBSC Health behaviour and life-styles of youngsters in the French Community, 1994-98 10
'Health Behaviour in School-aged Children' studies were conducted in 1986 (n=3,593), 1988
(n=2,482), 1990 (n=4,649), 1992 (n=3,869), 1994 (n=15,347) and 1998 (n=12,987).  The aim is to
better know and understand the health behaviour and life style of teenagers of the French Community
in order to define and evaluate the health promotion activities for youngsters.  The sampling of the
schools are representative for the different provinces, educational networks (public and catholic) and
type of educational cursus.  Results presented are standardised for age, sex and type of education.
FIGURE 4 :  Proportion of youngsters aged 13-17 years) having used a drug at least once and during
the last month, French Community secondary schools, 1988, 1990, 1992 and 1994 10
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The products that young people consume most are alcohol, tobacco and medicines (especially among
girls) as well as derivatives of cannabis.  In 1994, 19% of youngsters aged 13-17 used a drug at least
once and 10% are ‘regular’ users (defined as last month use ; Figure 4).  For comparison, these
figures were 8%, 8%, 13% (at least once) and 1%, 3%, 7% (last month use) respectively in 1988, 90
and 92. An increasing proportion is using cannabis, reaching 84% of users in 1994.
Experimenting with drugs leads to ‘regular’ use (last month use) in 50% of cases.  This proportion is
stable from 1988 to 1994.
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- Interview of Flemish students for drug policy in schools  (Flanders), 1999 11
From January to June 1999, a very large survey was conducted in 104 secondary schools of Flanders
interviewing 47,657 representative students aged 11 to 22 years (boys 55% and girls 45%) : the study
covered representatively all types of schools and will be repeated every year.  The students are
respectively 26% in first and second year of secondary school, 36% in third and fourth year and 38%
in fifth and sixth year.  The lifetime prevalence of illicit drug use increase with age from 10% in the first
grade to 42% in the third grade.  Some results are presented in Table 13.
TABLE 13. Lifetime prevalence and last year prevalence (between brackets) of drug
use according to the drug, secondary Flemish schools, 1999 11
Drug N responses Having ever used Last year use
N % N %
Any illicit drug 41,256 12,430 30.1 9,333 22.6
Cannabis 43,678 10,717 24.5 8,218 18.8
Amphetamines 43,220 3,216 7.5 2,111 4.9
Hallucinogens 43,188 2,722 6.3 1,909 4.4
XTC 43,563 2,238 5.1 1,527 3.5
Cocaine 43,176 1,225 2.8 772 1.8
Heroin 43,048 388 0.9 208 0.5
- School survey on drugs in Charleroi (Wallonia), 1999 12
From March to June 1999, a survey was conducted in 12 secondary schools of Charleroi (among 23
invited schools) interviewing 2,005 students aged 14 to 23 years (mean age : 16.1) including 49% of
boys and 51% of girls.  They are respectively 1,066 in third year and 934 in fifth year.  The lifetime
prevalences of the drug use increase with age (Table 14.  Boys used more than girls.  Taking into
account tobacco and alcohol for which use is more frequent (respectively 61 and 88%), poly-use is
stated by 41% of students.
TABLE 14. Students having ever used a drug according to their secondary school year,
Charleroi, French Community, 1999 12
Drug N responses Having ever used Third year Fifth year
N % % %
Cannabis 1985 725 36.5 29.7 44.3
XTC 1976 148 7.5 6.2 8.9
Heroin 1971 36 1.9 1.9 5.6
- Social diagnosis in three secondary schools in Verviers (Wallonia), 1999 13
In November and December 1999, a survey was conducted in three secondary schools of Verviers
interviewing 929 students aged 11 to 20 years (boys 54% and girls 46%).  They are respectively 265
in first year class, 388 in third year and 274 in fifth year.  The lifetime prevalences of the use of
cannabis and XTC increase with age (Table 15) without any significant difference of the cannabis
prevalence between gender.
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TABLE 15. Students having ever used a drug according to their secondary schools
year, Verviers, French Community, 1999 13
Drug N responses Having ever used First year Third year Fifth year
N % % % %
Cannabis 830 151 18.2 6.1 15.5 31.7
XTC 818 41 5.0 1.8 5.4 7.1
Cocaine 814 23 2.8 2.8 2.6 3.2
LSD 813 19 2.5 1.9 1.4 3.9
Heroin 817 15 1.8 1.9 1.7 1.9
- School-aged youngsters in Beveren (Flanders): a study in 1997-1998 14
“De Sleutel”, an organisation active in the field of drug prevention and research, conducted this school
survey in Beveren.  1238 students of 3 secondary schools participated in this study : 59% were boys
and 41% were girls. The mean age was 15.6 years of age (13-19 years).  This school population filled
in a questionnaire about the following topics: school, leisure time, the use of drugs like alcohol,
tobacco, illicit drugs and medication.
Results (prevalence of use,…) are not yet available but should be probably interesting as the study
was conducted in an area more rural than, for example, the study in Bruges (here below).
- School-aged youngsters in Bruges (Flanders): a study in 1996-1997 15
“De Sleutel” conducted this school survey in Bruges. 3,534 students of 18 secondary schools in
Bruges participated in this study : 48% were boys and 52% were girls. This study includes only the
students aged 16 year or more. This school population filled in the same questionnaire as mentioned
here above in the Beveren study.
36% of students ever used cannabis, 8% ever used LSD, and 7.5% having ever used XTC (Table 16).
TABLE 16. Proportion of students aged 16 year or more, ever having used illicit drug
(N= 3,534), Bruges, 1996-97 15
Drug %
Cannabis  35.8
LSD    8.3
XTC    7.5
Amphetamine    6.8
Cocaine    3.9
Heroin    0.8
Patterns of use
Table 17 shows how many times the ‘ever-users’ used illicit drugs. ‘Regular’ users were defined as
using illicit drugs at least 1 time/month during the last 6 months. Of the total group who ever used
cannabis (N = 1,266), 15% used cannabis only once (‘experimental use’) and 39% used it ‘regularly’;
in total 50% of users (experimental, intermediate, ‘regular’) stopped using cannabis.  Experimental use
was proportionally high for cocaine and heroin.  The proportion of ‘regular’ users is high for cannabis
but also for cocaine.  The absolute number of ‘regular’ users, defined as use at least 1x/month during
the last six months, was similar for cocaine and amphetamine and close to the number of XTC
‘regular’ users.
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TABLE 17. Pattern of use of illicit drugs among users having consumed at least once,
according to the type of drug, Bruges secondary schools, 1996-97 15
Users Only once Intermediate ‘Regular’ use (see text)
N (%) (%) (%) (N)
Cannabis 1,266 14.7 46.0 39.3 498
LSD 292 33.3 52.3 14.4 42
XTC 266 27.2 45.7 27.1 72
Amphetamine 239 29.3 47.3 23.4 56
Cocaine 138 45.2 15.7 39.1 54
Heroin 28 50.0 38.6 21.4 6
- Mental health of youngsters in Brussels, 1994 17
A study of the mental health of youngsters in secondary schools was carried out in 1994. The purpose
was to assess the mental health and the subjective feeling about the health of adolescents and the
use of illegal drugs. 2,209 students (aged 14-19 and over) (boys: 57% / girls: 43%) of 20 secondary
schools of Brussels (17 French-speaking and 3 Dutch-speaking schools) completed a questionnaire
about their socio-demografic situation (age, sex,..), their subjective health status, the relationships in
school, the family, their behaviour and the consumption of illegal drugs, and the use of services which
help with drug problems.
The use increased with age and boys more than girls.  The differences between boys and girls are
observed both in the aspect of trying and for the drug use during the month prior to the study : 34% of
boys and 27% of girls aged 17-18 years stated that they had tried an illegal drug and, for the same
age group, 21% of boys and 14% of girls have used drugs during the month before the study.
2.2.3.2 Drug use from a primary school survey
- Study of youth behaviour in the city of Ninove (Flanders), 1995 16
The specificity of this study was to involve also younger teenagers aged less than 12 years and
attending primary school.
2,824 pupils of 8 schools in Ninove, aged 10 year or more, filled in a questionnaire at the end of 1995:
47% were boys and 53% were girls; 838 of these children are 10 to 12 years old among which 550
pupils attend primary school.
Among the 550 pupils of the primary school, 0.8% had ever used drugs (boys and girls comparable).
The consumption of illegal drugs increases up to the age of 18 and older (Table 18).  Meanwhile only
7% of the Ninove school population stated to have use drugs at least once (boys: 10% / girls: 4%),
which seems low compared to the 'Flanders HBSC' study of 1994 9 (globally 17% of 14-18 years used
at least once cannabis).
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TABLE 18. Pupils having used at least once an illicit drug according to age, Ninove,
1995 16
10-12 m 13-15 16-18 >18 Total
N % N % N % N % N %
Yes 11 1.3 54 5.3 94 12.1 37 22.6 196 7.1
No 801 98.7 968 94.7 680 87.9 127 77.4 2,576 92.9
Total 812 1,022 774 164 2,772
2.2.4 Specific groups : Conscripts
In 1991, from March 1 to November 30,  2 743 military male conscripts were picked at random from
the daily list at the CRS (Selection and Recruitment Centre) 18.  The objective was to get a picture of
the phenomenon, even though the sample could not be considered as representative of the young
male Belgian population as a whole.  Medicines and/or illegal drugs were searched in urine (2 513
tests), 155 (6.2%) were positive for at least one type of drugs: 89 for cannabis (3.5%), 66 for opium
based drugs (2.6%), 10 for amphetamines (0.4%), 7 for benzodiazepines (0.3%) and 3 for cocaine
(0.1%).  The high level of opiates should be linked to with the taking of legal medications (antitussives;
n=30).  On the other hand, it should be mentioned that cannabis in urine is diagnosed for several
weeks after use.
2.2.5 Specific groups : Prisoners
On 31 December 1996 the total number of imprisoned people in the 33 Belgian prisons was 8,296 19.
Available figures of drug use in prison are estimates based on specific inquiries or on judicial
sentences.  In 1994 the proportion of people imprisoned for breaking the drug law (possession and
trafficking) was estimated as 50% 20.  As this number continuously increased since 1970, it is
suspected that consequently the proportion of drug users among prisoners increased as well as drug
trafficking in prison.  People imprisoned for breaking the drug law are only a part of drug users in
prison as many of them are imprisoned because of other offences (theft,..).
Most imprisoned drug users are relatively young.  In 1993, 51% of them was 25 years or less and 9%
less than 20 years of age 21.
TABLE 19. Drug use among prisoners, 1999 22
Drug
Prior to imprisonment
Last month use
During imprisonment
(previous and current  imprisonments incl.)
N Use
%
IV use
%
Use % IV use %
Any illicit drug 246 50.0 9.4 42.0 2.4
Cannabis 246 40.7 1.2 36.6
Cocaine 246 21.5 5.3 8.9 N=2
Heroin 246 14.5 3.7 12.6 N=2
XTC 246 8.9 0.8 4.9
Amphetamines 246 7.7 2.0 8.1 N=2
LSD 246 6.1 0.8 2.0
                                                
m This figure includes pupils aged 10-12 year attending primary or secondary school .
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In 1999, a self-administrated questionnaire was proposed to prisoners of 2 prisons : a men prison
(Brussels) and a women section in another prison (Flanders).  Participation was voluntary :  230 men
participated (approx. 38% of the total population) and 16 women (61%) making a total sample of 246.
The questionnaire is part of an epidemiological research tool for drug use, risk behaviour and health in
prisons.
Use before and during the imprisonment were investigated based on self-reports of prisoners.  Half of
the prisoners stated use during the last month before the imprisonment.  A nearly similar proportion
(42%) reported to use during current (or having used during previous) imprisonment(s) : current and
previous imprisonment were investigated together in order to minimize refusals, although of course the
anonymity was guaranteed.
In 1997, a self-administrated questionnaire was proposed to prisoners of 1 prison in Wallonia.
Participation was voluntary :  115 men participated.  The questionnaire is part of an epidemiological
research of the European Network for AIDS Prevention in Prison 23.
The period of drug use before imprisonment is different as the above presented study : last year use.
Nearly half of the prisoners reported cannabis use and one out of four cocaine before the
imprisonment, and respectively 38 and 15% during the current or previous imprisonment.
In 1993, a study conducted in the Antwerp prison 24 among 1,627 prisoners (17-71 years, mean : 29
years) shows that 42% used an illegal drug at least once (lifetime prevalence).
On the other hand, studies (1989 25 and 1994 26) reported that respectively 54% and 50% of drug
users had at least once been imprisoned.  It appears that a lot of drug users are imprisoned several
times.
TABLE 20. Drug use among prisoners, 1997 23
Drug N
responses
Prior to imprisonment
Last year use
During imprisonment
(previous and current  imprisonments incl.)
Last year use
Use
%
Ever IV
use %
Use % IV use %
Any illicit drug 115 n.a. 22
(n=25)
n.a. 1.7 (n=2)
Cannabis 115 45 38
Cocaine 115 23 15
Heroin 115 n.a. n.a.
XTC 115 21 8
Amphetamines 115 17 4
LSD 115 11 9
2.3.  Problematic drug use
Beside the information on treatment demands obtained from registration of demands in treatment
centres and in hospitals (see 3.1), it still remains quite difficult to estimate the problematic drug use at
the moment in Belgium.
Some estimates were made but with very large confidence intervals, making them unreliable.  In the
framework of the European Reitox project on prevalence, the feasibility of various methods was
evaluated for Belgium 27.   Two estimates of drug use prevalence (one national and one regional) are
presented here.
Risk behaviours (injection, sharing, polydrug use) are documented from the various monitoring
systems of treatment demands and from surveys of patients (GPs) or users (snowball surveys).
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2.3.1 National and local estimates
2.3.1.1 National prevalence estimate of intravenous drug users
A national prevalence estimate of problem drug use in Belgium was performed in 1999 28 .  In this
exercise, the studied prevalence is that of intravenous drug users (IVDUs) n.  The estimation is based
on the 1995 data from the Belgian HIV/AIDS combined with the 1995 data from the drug treatment
demand database of the French Community of Belgium (CCAD).
The number of IVDUs has been inferred from the number of alive HIV persons, the prevalence rate of
IVDUs among HIV patients and the prevalence rate of HIV seropositivity among IVDUs.
The Belgian HIV/AIDS registry gives information on the risk factors associated with the HIV-
seropositivity of patients diagnosed in 1995 (IVDUs among all known HIV positives registered by
clinical laboratories).  The treatment demand database of the French Community of Belgium (CCAD)
provides information of the HIV-seropositivity self-reported by patients starting treatment and having at
least once used a drug intravenously.
The number of intravenous drug users aged 15-54 years in Belgium is estimated as 20,200
corresponding to a prevalence rate of 3.6 per mille among 5 602 499 people aged 15-54 years.  In
most European countries, the number of HIV patients being also IVDUs is not directly available and
must be estimated using the back calculation methodology 29.  The prevalence rate of IVDU using this
approach was 0.34% in Denmark (1195), 0.38-0.48% in France (1995) and 0.42% in Ireland (1993).
In Norway, the prevalence rate of IVDU was estimated to be in the range 0.29-0.42% using the
multiplier method with mortality data (1997).  The Belgian estimate of the prevalence rate of IVDU
(0.36%) is therefore consistent with values found in other European countries with other methods.
2.3.1.2 Regional prevalence estimate of opiate users
Local prevalence of problem drug use in French Community of Belgium was estimated 30.  The
method used is capture - recapture on the basis of the 1993 and 1994 data of the drug treatment
demand database of the French Community of Belgium (CCAD).  In this analysis, a problematic drug
user is defined as an opiate user demanding for treatment.
The number of opiate users was estimated for the French Community and various sub-entities
(Brussels and Walloon Region).  The prevalence rates were calculated for the 15-54 years group.
Table 21 presents the estimates where the results for the French Community are the addition of the
figures of Brussels and Wallonia.  Analysis were also performed for provinces.  The prevalence
estimate is the higher in the province of Liège : 7.9 / 1 000.
                                                
n If IDU
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where HIV
n
 is the number of HIV positive patients in the population and HIV)|p(IDU  is the prevalence rate
of injecting drug use among HIV patients.
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TABLE 21. Number and prevalence of opiate users in the French Community of
Belgium, 1993-1994 30
Area 15-54 years population
(01/01/1995)
Number of opiate users Prevalence rate / 1000
Brussels 523,664 6,769 10.9
Wallonia 1,811,515 7,841 4.3
French
Community
2,335,179 14,610 6.3
These results have however to be interpreted with caution because the underlying assumptions
required to apply the method are obviously not met (lack of mutual independence of the two samples,
and probability of selection into a sample/list for each individual probably not equal).
2.3.2 Risk behaviour and trends
The use of multiple drugs and the sharing of needles and/or syringes for intravenous administration
are recognised risk behaviours.  Information on these behaviours comes from treatment centres and
from various studies.  It should be considered as an indication of the prevalence of these behaviours
among some selected groups of drug users.   More than absolute figures, trends are probably more
reliable.
2.3.2.1 Poly-drug use
- Rock Festival (French Community), 1996-1999
A survey on drug use is repeatedly conducted during a Rock Festival in the camp where 50,000
spectators live during the festival 31.
In 1999, 686 spectators were interviewed :  88% stated to use at least one illicit drug, 33% of
respondents used exclusively one drug.
TABLE 22. Proportion of poly-drug use, Rock festival, French Community of Belgium,
1996-1999 31
1996 1997 1998 1999
N interviews 123 167 157 686
Only 1 drug (%) 47 40 25 33
3 drugs or more(%) 32 45 36 36
Total : at least 1 illicit drug (%) 87 93 88 88
In 1999, the survey was performed in the whole site of the festival and not around the stand (as for
previous surveys).   There is no major difference in the pattern of consumption observed in 1999
compared to the three other years : thus these figures are probably representative of the whole
population of the festival.
2.3.2.2 Injecting and sharing
Determinants and consequences
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Chapter 3.  Health Consequences
3.1.  Drug treatment demand
3.1.1 Number and characteristics of clients of treatment centres
For the first time, 'Belgian' figures are provided, based on the experience gained through the 2000
EMCDDA Treatment Demand Indicator exercise 32.  The figures have been obtained by pooling the
data from the 3 regional systems.  Despite some initial differences between categories reported by the
CCAD, CTB/ODB and VAD registration systems, the pooling of the 1998 data was made possible
thanks the running harmonisation process.  The relevant institutions and regional monitoring systems
in charge of data collection, processing and reporting as well as the currently harmonisation process
for the development of a national information system are described in annex C.
In the three systems, around one third of treatment demands are located in specialised residential
centres.  Most of patients (68%) registered by VAD in 1996 demanded for treatment in units based in
general services (mental health care centres) whereas 50% and 74% of patients registered
respectively by CCAD (1998) and CTB/ODB (1997) are treated in specialised non-residential centres.
The system of the Flemish Community (co-ordinated by VAD) registered 4,855 cases.  One
characteristic of the VAD database is its coverage of Centres of Mental Health Care where ambulatory
treatments are offered and that attract a different population of drug users.  In the CCAD and CTB-
ODB systems, such centres are not covered at the moment.  It explains why some Belgian figures
(age distribution, main drug) differ compared to the previous results of CCAD (French Community) and
CTB-ODB (Brussels Region) systems (for example, the proportion of opiate users is respectively 67%
and 73% in the CCAD and CTB-ODB databases in 1998 when it is 25% in VAD : consequently, the
1998 global Belgian table reports 43%).
Considering that these regional variations are due to a methodological difference (coverage of
different types of centre) and that there are no reasons to believe that the situation should be strongly
different in Brussels and in the French Community in the mental health care centres that they do not
cover, the Belgian TDI partners agreed that these pooled figures could be used as Belgian ones.
FIGURE 5 :  Age distribution of patients in Belgian treatment centres, CCAD, VAD, CTB-ODB, 1998
In 1998, 7,958 patients from ambulatory and residential treatment centres undergoing treatment for
problematic drug use (alcohol as first substance excluded) were recorded : 5,897 males and 1,937
females.  4,855 treatments were registered in the ambulatory and residential centres located in the
Flemish Community33, 1,466 in the French Community34 and 1,836 treatments by centres of
Brussels35.  Table 23 shows the two-fold increase of the number of registered cases in the VAD
system in 1998.
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Figure 5 shows the age distribution of males and females patients for all treatments.  Patients treated
for the first time, as expected, are younger.
Almost 70% of applicants for care registered in 1998 CCAD database had already been taken care of
on previous occasions and for 30% it was the first treatment.  This figure is higher in the VAD
database but the definition of first treatment is different : CCAD rules define first treatment as the first
treatment for drug problem in any centre when for VAD it means the first treatment in the same centre.
TABLE 23. Number, mean age and sex ratio of people undergoing treatment and
proportion of first demands, French Community, 1993-99, Flemish
Community, 1996 and 98, Brussels Region, 1997-98
CCAD 34 VAD 33 CTB / ODB35
1993 1994 1995 1996 1997 1998 1996 1998 1997 1998
Nr of ALL treatments 1,618 1,212 1,176 1,570 1,681 1,466 2,374 4,855 1,810 1,836
Mean
age
26.8 26.1 27.3 26.9 27.4 31.5 26.6 26,2 30.0 30.5
Male/female sex
ratio
3.3 3.4 3.3 2.9 2.8 3.2 3.0 3.0 3.6 3.2
Nr of FIRST
treatment demands
513 390 352 497 547 447 - 2,568 - -
% first demands / all
demands
31.7 32.2 29.9 31.7 32.5 30.5 - (52.9) o - -
In 1998, the mean age of ‘VAD’ patients is younger (26.2 years) compared to CCAD (31.5 years) and
CTB-ODB (30.5 years) systems.  Mean age is slightly increasing over time in CCAD database.  There
are 3 times more demands from males than females while this ratio is stable over years and similar in
the three systems.  Table 23 does not show any other particular trend within each system from 1993
to 1998, but that should be investigated in relation to the coverage of the respective monitoring
systems.
Figure 6 and Table 24 show the difference in the age distribution of the population covered by both
CCAD and CTB-ODB (older population) and VAD (younger) registration systems.
For 1998 in the CCAD and CTB/ODB data, the 15-24 years old represent respectively 29%
(decreasing from 42% in 1993) and 19 % and the 25-34 years old are respectively 49% and 56%.  The
proportion are at the opposite for the VAD 1998 data :  57% of the sample are aged less than 25 years
(30% less than 20 years and 26% 20-24 years aged) and 27% are 25-34 years of age.
FIGURE 6 :  Age distribution of patients starting treatment: comparison between CCAD, VAD, CTB-
ODB treatment databases, 1998
                                                
o The definition of first treatment is different : CCAD : first treatment for drug problem in any centre; VAD : first
treatment in the same centre.
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These differences in the age of the population covered should be taken into account when comparing
the stated type of drug used by the patients from the different systems.
TABLE 24. Number and age distribution of people undergoing treatment in centres of
the French Community, 1993-98, Flemish Community,1996 and 98, and
Brussels Region, 1997-98
CCAD 34 VAD 33 CTB / ODB35
1993 1994 1995 1996 1997 1998 1996 1998 1997 1998
Nr of ALL treatment
demands
1,618 1,212 1,176 1,570 1,681 1,466 2,374 4,855 1,810 1,836
Mean
age
26.8 26.1 27.3 26.9 27.4 31.5 26.6 26.2 30.0 30.5
Age <15 0.3 0.7 0.4 1.1 1.4 1.0 2.0 2.0 0.0
Distrib. 15-24 42.5 41.9 39.6 40.0 36.0 29.3 50.0 54.7 21.0* 19.1
25-34 46.6 50.2 46.3 47.4 48.4 48.6 29.3 27.0 62.0 56.2
35-44 8.2 6.6 9.9 8.1 11.3 13.6 12.5 11.3 17.0** 21.9
45-54 2.0 0.5 2.5 2.8 1.7 2.0 4.5 3.6 2.4
>=55 0.7 0.2 1.2 0.7 1.1 0.5 1.5 2.3 0.5
* : <25 years; ** : > 34years
3.1.2 Hospital discharges: RCM/MKG and RPM/MPG
RCM/MKG (Résumé Clinique Minimum / Minimale Klinische Gegevens) and RPM/MPG (Résumé
Psychiatrique Minimum / Minimale Psychiatrische Gegevens) are registration systems operating
respectively in general hospitals and in psychiatric hospital and psychiatric units of general hospitals.
The aim of these systems are to provide information on the number of patients admitted in hospitals
and on various characteristics related to the diagnoses and the treatment.  The data of RCM/MKG of
1995 and RPM/MPG of 1996 (second mid)-1997 (first mid) were analysed.  We present some results
extracted from the first issue of the RCM/RPM Flash 36.  Further analyses have not been performed.
The hospital stays where the diagnoses (main or associated) are related to the use of illicit drugs,
amphetamines or solvents were selected.  This figure represents an over-estimate of the number of
patients as one patient can stay several times in hospital during one year.  When several diagnoses
TABLE 25. Annual number of stays related to drug use in medicine/surgery (1995) and
psychiatric units (1996-97) of Belgian hospitals
Medicine and surgery units Psychiatric units     Total
Opiates 1,945 1,742 3,687
Cocaine 129 246 375
Cannabis 145 779 924
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Hallucinogen/amphetamine 343 483 826
Poly-addiction 46 1,707 1,753
Unclassified 1,570 1,866 3,436
Not specified 2,903 429 3,332
Total 7,081 7,252 14,333
were mentioned, a hierarchical ordering was used as follows : poly-addictions, opiates, cocaine,
hallucinogens, amphetamines, cannabis, induced troubles, intoxications, non-specified.  As medical
use of opiates was excluded for the analysis, opiates consumption means in fact heroin consumption.
All poly-addiction diagnoses included the use of heroin.
More than 14,000 stays per year are connected to a problematic drug use: around half of the stays are
hospitalisation in medical or surgery units.  Opiates (heroin) is the main reason when the reason is
specified : 75% of cases in medicine/surgery units and 35% in psychiatric units.
The proportion of poly-addiction is high in psychiatric units : 24% of all cases (34% when not taking
into account unclassified and not specified diagnoses).  From the RPM/MPG, 68% of stays are
associated with a psychiatric co-morbidity and 20% a somatic co-morbidity.
Records where the drug is 'unclassified' or 'not specified' are frequent especially in medicine/surgery
units (63%).  Several reasons are possible.  When one code of ICD9 or DSM IV cover different
substances, it is consequently not possible to specify the involved drug.   On the other hand, it seem
that some clinicians prefer not reporting or specifying the use of illicit substance in any
administrative/official report in order to ensure privacy or for medico-legal reasons (but it is clear that
the information is processed in an anonymous way).
Overdoses can not be estimated as most of them are treated in emergency units, not yet covered by
the RCM/MKG nor RPM/PMG systems.
3.1.3 Substitution treatment and methadone
Some data are available from treatment centres (French Community) and from the Ministry of Public
Health (Inspection Générale de la Pharmacie-Service des Stupéfiants / Dienst Verdovende Middelen
van de Algemene Farmaceutische Inspectie).
3.1.3.1 Treatment centres
Up to 1998, this information could only be obtained for the French Community.  Since 1999, this
information is also registered in the Flemish Community system (although some institutions could
already provide figures). Nevertheless this information is very partial: indeed in Belgium, most
treatments are offered by general practitioners and are not yet covered by the treatment demand
indicator information system.  This situation is fully true for the French Community whereas a
distinction should be made for the Flemish Community, where the involvement of GPs started very
recently (before that, specialised centres were practically the only ones to offer methadone treatment
in Flanders).
Among patients demanding treatment in the centres of the French Community 34, 13% (222/1,681) in
1997 as well as in 1998 (194/1,466) were undergoing a substitution treatment with methadone.  Mean
age was respectively 27.1 and 29.3 years (to be compared with the mean age of all treated patients
respectively 27.4 and 31.5 year in 1997 and 1998).  As expected, patients substituted for the first time
are younger : in 1998, their mean age was 27.8 compared to 29.3 for all substituted patients and 31.5
for all patients.
TABLE 26. Number and characteristics of people undergoing methadone substitution
treatment, French Community, CCAD, 1998 34
All substitution treatments First substitution treatments
Males Females Total Males Females Total
N people 139 55 194 27 13 40
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Mean age 29.0 30.0 29.3 28.2 27.1 27.8
Age distribution (%)
<25 38.8 23.6 34.5 33.3 30.8 32.5
25-39 53.9 67.3 57.7 59.3 69.1 62.5
40 and over 7.2 9.0 7.7 7.5 0.0 5.0
IVDU when starting treatment (%)
     Currently injecting any drug 31.1 36.0 32.6 - - -
     Ever injecting any drug 49.6 50.0 49.7 - - -
The mean age at starting methadone substitution in centres of the region of Charleroi 37 is stable
(respectively 24.2, 23.3, 23.6, 13.9 and 24.1 years from 1995 to 1999) and started 4 years after the
first use of methadone (4.1 to 4.8).  Twelve percents of substituted patients got at least once
methadone which was not prescribed : this proportion was stable over years.
In 1999, in the treatment centres van De Sleutel, 23% of patients among 852 for which medical data
are recorded started a methadone substitution treatment 38.
3.1.3.2 Estimate of the number of people undergoing methadone substitution
Figure 7 presents the quantities of methadone sold in Belgium 39 based on data centralised by the
Ministry of Public Health - General Pharmaceutical Inspectorate (Inspection Générale de la
Pharmacie-Service des Stupéfiants / Dienst Verdovende Middelen van de Algemene Farmaceutische
Inspectie).
FIGURE 7 :  Trend of release of methadone in Belgium from 1975 to 1996*
0
20000
40000
60000
80000
100000
120000
19
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96
Grams
METHADONE-Total
* : The 1996 figure is probably underestimated
The increase  of global quantities of methadone is striking since 1990.  Before 1990, the small peak
observed in 1982 corresponds to a period when the mediatisation of the use of methadone was very
large.  The increase started before the 'Conférence de Consensus sur la méthadone /
Consensusconferentie over methadon' (October 1994).  Nevertheless the impact of the 'Conférence /
Conferentie'  made easier the prescription of methadone.  The increase in methadone use since the
end of 1994 is observed on Figure 7.  The increasing trend is continuing in 1997 (preliminary data to
be confirmed).
These data will allow to determine an estimate of the number of patients undergoing a substitution
treatment with methadone (calculation based on the quantities of methadone sold by wholesalers to
pharmacies divided by a mean daily used quantity per patient) but there are some methodological
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problems to obtain a reliable figure of the quantities sold in Belgium as well as for the determination of
the mean daily dose (differences between the regions, the cities regarding the daily dose, the
compliance,...).
3.1.4 Patterns of use
- Treatment centres (French Community), 1995 34
The average age when a subject takes heroin for the first time (978 individuals) is 19.3 years and the
addiction lasts on average for 6 years.  The requests from people of Belgian nationality represent 88%
of the total number of requests.  The courts constitute the source of referral for 8% of drug users, an
individual request of subject 38%, general practitioner 10%, hospital 9%, parent or family 9%, friends
9% and another centre 8% (unknown 9%).
- Treatment centres (Charleroi), 1995-1999 37
Figures are comparable in Charleroi centres:  the average age when a subject takes heroin for the first
time is 19.5 years (stable from 1995 to 1999) and the addiction lasted on average 6.6 years (1997
data).
First use of cannabis of patients undergoing treatment decreases regularly from 16.4 years in 1995 to
15.6 years in 1999 (Table 27).  The methadone first use age (it means the start of the substitution
treatment) is stable : 24.1 years in 1999.
TABLE 27. Age at first use of substances, Charleroi, 1995-1999 37
Substance N cases with information Mean age at first use of the substance
1995 1996 1997 1998 1999 1995 1996 1997 1998 1999
Cannabis 481 509 510 606 674 16.4 16.1 16.1 16.0 15.6
LSD 138 153 164 220 244 19.0 18.6 19.4 19.0 18.8
Heroin 564 490 542 597 709 19.8 19.3 19.5 19.4 19.5
XTC 149 174 195 268 287 20.7 19.8 20.2 20.6 20.0
Cocaine 342 346 366 482 589 20.4 19.9 20.0 20.0 20.2
Medicines 195 251 258 308 330 20.6 20.4 21.0 20.0 21.5
Methadone 349 350 379 466 546 24.2 23.3 23.6 23.8 24.1
3.2.  Drug-related mortality
3.2.1 General population mortality register
Aiming at the identification of mortality due to drug use in the Population mortality register, the
following codes of the International Classification of Diseases version 9th were selected (alcohol was
excluded when possible) :
304 Drug  dependence
305 Nondependent abuse of drugs
E850-E858 Accidental poisoning by drugs, medicaments and biologicals: opiates and related
narcotics, barbiturates, other sedatives, hypnotics, tranquillisers, antidepressants,
psycholeptics (hallucinogens), psychostimulants (amphetamine), central nervous system
stimulants
E950 Suicide and self-inflicted poisoning: analgesics, antipyretics, antirheumatics,
barbiturates, other sedatives, hypnotics, tranquillisers, psychotropic agents, other specified
and unspecified drugs and medicaments
E980.0-E980.5 Injury undetermined whether accidentally or purposely inflicted by analgesics, antipyretics
and antirheumatics, barbiturates, other sedatives and hypnotics, tranquillisers and other
Belgian National Report on Drugs 2000 - Belgian Information Reitox Network 58
psychotropic agents, other specified drugs and medicament, unspecified drugs  and
medicaments
According the EMCDDA DRD standard p, the definition of the groups are as follows : 304 = 304.0-
304.9; 305 = 305.2-305.9; E850-E858 = E850.0, E850.8, E850.9, E851, E852, E853.2, E854.1,
E854.2, E855.2 ; E855.9, E858.8 + N codes according to DRD standard ; E950 = E950.1 - E950.5 + N
codes according to DRD standard; E980 = E980.1- E980.5 + N codes according to DRD standard.
Changes have been made to the selection to adapt to the specific Belgian situation (over- and
underinclusivity occur because it is impossible to make combinations with more than one N code).
Only underlying causes stated on the death certificates are used.  The data cover Belgium completely.
The number of deaths (identified on the basis of the selected codes above described) is quite stable
over years In 1995, there were 207 male and 139 female deaths.
TABLE 28. Number of drug related deaths according to the cause, Belgium, 1986-1995
Gender / Code 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995
Males 186 187 195 208 207
Females 128 138 151 168 139
304 20 23 13 12 11
305 12 4 21 13 13
E850-E858 31 24 89 94 97
E950 191 209 200 223 204
E980.0-E980.5 60 65 23 34 21
Total 350 na 365 292 296 314 325 346 376 346
The registration covers all deaths but it is possible that the notification of the cause can vary (work in
progress).  There could have been variations in the coding throughout time due to different institutions
responsible in different Regions for coding.  In 1993, the responsibility of the processing of the forms
moved from the federal level (NIS) to the Community levels.  It could probably explain the increased
number of  ‘accidental poisoning’ (E850-E858) and the corresponding decrease of ‘undetermined
injuries’ (E980.0-E980.5) due to a methodological variation in coding.  For Brussels, there was another
change when the Flemish Community started coding the certificates for them as well.
There might be an underreporting due to other causes of death used by physicians who fill out the
death certificates. There is no clear view on this yet and no other reference available to estimate the
extent of the underreporting. An assessment of the quality of these data is currently in progress.
Table 29 shows the relative part of opiates as toxicological cause associated to the death.  Based on
the most recent data (1995) where toxicological information is specified in the death certificate (60%),
opiates are associated in half of cases, showing a slight increase compared to 1991 and 1992.
TABLE 29. Proportion of drug related deaths according to the toxicological cause,
Belgium, 1991-1995
 Toxicology
 
 
1991
1992 
1993 
1994 
1995 
% of cases with known toxicology
 
                                                
p DRD-Standard Field Trial definitions were used : there are codes that are possibly overinclusive or over- and
underinclusive because of the non-availability of specifications required by the DRD-standard.
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3.2.2 Overdoses registered by police services
There is a register of overdoses, that is however not held in a systematic way.  The figures do not
cover the total amount of fatal overdoses, but only these actually recognised as such and recorded by
the police services.  Although Table 30 shows a decreasing trend of the annual number of recorded
deaths by overdoses, it should be interpreted with caution as it is reasonable to think that the
coverage could vary for the presented period.
TABLE 30. Number of overdoses recorded by police services, Belgium, 1991-1995 40
1991 1992 1993 1994 1995
Overdoses 90 75 80 46 48
Boys 73 60 67 43 na
Girls 17 15 13 3 na
Minors 9 1 0 1 na
Mean age 28 27 28 28 na
Mean age boys 28 27 27 28 na
Mean age girls 27 27 27 28 na
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3.2.3 Mortality and causes of death in drug-users
As far as we know the only follow-up survey of patients was started in 1996 at the Solbosch
therapeutic community (average follow-up two and a half years). It revealed a mortality rate of 9%
among patients in the group studied, i.e. an annual mortality rate of 3.6% in this population of former
patients 41,42.  However, this study involved a small sample of 80 patients among which there were 7
deaths and 18 patients were lost of follow-up.  The generalisation of these results is difficult.
3.3.  Drug-related infectious diseases
Epidemiological situation regarding drug-related infectious diseases is presented as special key issue
(Part IV Chapter 15).
3.4.  Other drug-related morbidity
3.4.1 Non-fatal drug emergencies
No information gathered.
3.4.2 Psychiatric co-morbidity
No information gathered.
3.4.3 Other important health consequences : Drugs and driving : the BTTS study
In 1995 and mid-1996, a prospective multi-centre study was conducted in hospital emergency
departments in order to determine the prevalence of consumption of alcohol, medications and illicit
drugs in victims of road traffic accidents, and to describe related characteristics and associations 43.
All drivers, aged at least 14, of bicycles or motor vehicles involved in a traffic accident on a public road
and admitted in emergency units of 4 university hospitals (Gent, Leuven, Brussels, Liège) and 1
regional hospital (Namur) were included.  Toxicological analyses were performed on blood and urine
samples.
Among the 2,053 cases (males: 74%, females: 26%) of whom one third aged 14-24 years, 28%
presented an analytical alcohol blood concentration exceeding the Belgian tolerance limit (0.5 pro
mille) and 19% were positive for one or more substances.  Table 31 shows that the highest score was
noticed for benzodiazepines (8.5%), opiates (7.5%) and cannabis (6%).  Age related differences were
observed: the prevalence of use of benzodiazepines, barbiturates, medical opiates increases with age
and amphetamines, cannabis and cocaine were more frequently observed in younger drivers.
TABLE 31. Prevalence of detection of alcohol, medications or illicit drugs in victims of
traffic road accidents, Belgium, 1995-1996 43
Substance (sample) N analysed N positive q Prevalence (%)
Alcohol (blood) 1,871 529 28.3
Benzodiazepines (blood) 1,871 160 8.5
Opiates (urine) 1,879 141 7.5
Medical use 103
Non-medical use 38
Cannabis (urine) 1,879 113 6.0
Amphetamines (urine) 1,879 56 3.0
Barbiturates (urine) 1,879 25 1.3
Cocaine (urine) 1,879 14 0.7
Methadone (urine) 1,879 5 0.4
Considering age groups, 17% of 45-54 years and 12% of 55-64 were benzodiazepine-positive; 8.5%
of 14-17 were cannabis-positive and 12% of 18-24 years old r.
                                                
q Limits as follows : 5 pro mille for alcohol , presence for other substances.
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Chapter 4. Social and Legal Correlates and Consequences
4.1.  Social problems
4.1.1 Social exclusion (housing, unemployment)
We present information based on data collected by treatment centres and the regional monitoring
systems of the different parts of the country (CCAD – French Community, VAD - Flemish Community,
CTB-ODB - Brussels-Capital).  Through the treatment demand indicator, information on social
characteristics of the patients is available.
Sixty percents of patients undergoing ambulatory treatment are living with members of their family
(parents and/or partners and/or children).  Among residential patients, one out of three is living alone
(Figure 8).  Women life more often with members of the family.
FIGURE 8 :  Distribution of the living status (alone or not) of patients undergoing residential or
ambulatory treatment, CCAD, VAD and CTB-ODB monitoring systems, 1998, Belgium
FIGURE 9 :  Distribution of the living status (stable or unstable) of patients undergoing residential or
ambulatory treatment, CCAD and CTB-ODB monitoring systems, 1998, Belgium
                                                                                                                                                        
r As traces of cannabis may still be detected in the urine after several weeks of abstinence, it does not mean that
cannabis was used when driving.
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Around 22-24% of patients are living in unstable accommodations or in an institution (respectively 14 and
10% of ‘residential’ patients and 9 and 13% of outpatients ; Figure 9 ; VAD data not available).  Women
are less often living in an institution and benefit more often a stable accommodation.
FIGURE 10 :  Distribution of the labour status of patients undergoing residential or ambulatory
treatment, CCAD and VAD monitoring systems, 1998, Belgium
Around one third of patients are economically inactive or unemployed.  Comparing in- and outpatients,
one observes that 60% of inpatients has a regular employment compared to 30% only among
‘ambulatory’ patients and that 30% of outpatients are pupils or students (only 10% of inpatients) (Figure
10 ; CTB-ODB data not available).  There are no difference between males and females.
Depression and unemployment were associated to the use of heroin in a study carried out in 1994 on
a group of drug addicts admitted to the emergency unit of Saint-Pierre university hospital in Brussels44.
The average age of the patients was 27.2 years (range: 15-41 years of age). The man/woman ratio
was almost two to one ; women attended to emergency unit several times more often than men.  More
than 90% were unemployed; 43% were on CPAS/OCMW (public centre for social assistance) benefit;
20% had no official source of income.  75% had a fixed residence; 41% lived alone and 22% lived with
their parents.
In 82% of cases, heroin was the drug causing the problem (combined with other psychotropic
substances in 85% of cases).  The most frequent problem among heroin addicts admitted to the
emergency department was depressive behaviour (in 40% of cases, this was indicated either by a
suicide attempt or by a request for hospitalisation).  32% came to the department requesting
hospitalisation for a drying-out session.  These requests, which were then referred for a consultation,
were seldom satisfied because of excessively long waiting lists and because more than 50% of these
requests were not prompted by a well thought out desire for a drying-out session, but rather were
really a request for temporary shelter from the difficulties of life.
4.1.2 Public nuisance, community problems,
No information available.
4.2.  Drug offences and drug-related crime
These figures have been collected by the police services and grouped for the United Nations Drug
Control Programme by the Belgian General Police Support Service (SGAP/APSD).  This service is the
Belgian contact for Interpol, Europol and the SIS of Schengen.  It collects data from all police services
in Belgium, specifically the municipality polices (mainly oriented to the local trafficking), the  judicial
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police and the gendarmerie/rijkswacht (local, national and international trafficking) and the customs
(national and international trafficking).
Two sources are used.  Police's reports sent by units of Judicial Police,  'Gendarmerie/Rijkswacht s'
and municipality polices to the Court are the first one.  From 1994 to 1997, six variables were
available: identification number of the report, identification of the involved unit, type of infringement,
tentative or not, location and time of the infringement.  From 1998 onwards, the covered variables will
be expanded (e.a. the type of drug will be available).
The second source is the 'unique form' (formulaire uniforme/eenvormig formulier) that are also
transmitted by Customs and Accises (Taxes) when a seizure is performed.  The aim of this form was
initially to stimulate the exchange of operational information between the different police units.
Although it is estimated that these forms are not systematically used (used for around 50% of
infringements), interesting information is included as type and quantity of seized drugs.
A large re-organisation of the forces of police was initiated in 1998: a unique police force resulting
from the merging of the Judicial Police, the 'Gendarmerie/Rijkswacht' and the municipality polices will
be constituted.  Simultaneously the development and improvement of a unique database used directly
by all services of police for the registration of their repressive activities is in progress.
The interpretation of the national criminal statistics on the seizure of narcotics calls for some
explanation. The statistical data on the seizure of narcotics is based exclusively on the positive results
of searches or investigations but by no means reflects the number of infringements committed in this
field.  On the other hand, these figures do not provide any information on the severity of the
infringement, nor on the importance of the seizure.
In the 1993 statistics, a distinction was made for the first time between the use and the trafficking of
narcotics.  The term use is applied to narcotics seized from a person who had them in his possession
but only for personal consumption.  The term trafficking is applied to all seizures of narcotics where it
appears that they were not only intended for personal use.  Meanwhile, it is recognized that
categorizing of infringements vary largely between police units.
To distinguish between police and custom reports is not possible at the moment in Belgium.
4.2.1  ‘Arrests’ for use/possession/traffic and trends
The evolution of the number of 'arrests' related to illicit drugs registered by police can be an indicator
of the activity of the illicit drug market, although it can also be considered as the result of the effort of
the police to better control it.
The definition of an arrest is varying between countries.  In Belgium, the first contact with the police is
reported in a police' report  (several infringements can be mentioned for a person taken in for
questioning).  These reports are transmitted to the prosecutor's room.  The judge will then prosecute
or not the person, who will be actually arrested or not.  Consequently we call the figures presented
here as 'number of people involved in affairs connected to narcotics' corresponding to the number of
persons mentioned in police reports.  The information on (definite) arrests (consequent to an order
from the judge) is not available.
                                                
s The reports of the Gendarmerie/Rijkswacht units are also centralised at BCR/CBO (Bureau Central de
Recherche - Programme Drogue / Centraal Bureau voor Opsporing – Programma Drugs / Central
investigation office – Drug programme).  Some units of the municipality police also report to this central
'Gendarmerie/Rijkswacht' office.  Data are kept in a database called POLIS.   Data are related to the
infringements (type, location, date).  Drugs classified according categories (cannabis, opiates, LSD,…) are
mentioned in most of cases.  For the identification of the substance, the Becton-Dickinson test as well as the
experience of the policeman are used.  Following information is available: involved person, vehicle used,
modus operandi, tools used.  There is no information on the seizure or not of substances neither on their
weight.
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Figure 11 is based on data supplied by the police and shows the number of people involved in affairs
connected to narcotics, bringing together users, as well as dealers and (international) traders.
The number of police arrests for drug law offences increased threefold over the last 10 years.  Since
1992 there is a big increase in the total number of persons concerned in case of illicit drugs : in 1992
this number doubled almost involving 18,179 persons.  The following years about 19,000 persons
have been yearly concerned in a case of illicit drugs.  In 1998 there were 23,184 persons taken in for
questioning and 17,219  in 1999.   Comparable data are not available for 1996 and 1997 : the figures
on the numbers of persons involved is not available but well the number of infringements : 1, 2 or 3
infringements can be reported in a police's report concerning one person.
FIGURE 11 :  Number of people involved in narcotics affairs, Belgium, 1985-1999 45
As in most EU countries, ‘arrests’ for drug possession for personal use are predominant in Belgium
(respectively 73, 71 and 73% in 1996, 97 and 98 / Table 32).
Cannabis is the main drug involved in the ‘arrests’ for drug offences : respectively 72, 65, 66 and 69%
in 1995, 97, 98 and 99  (Table 33).
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TABLE 32. Number and proportion of infringements related to narcotics according to
the type of infringement, Belgium, 1996-1998 46
Possession/ Use Trafficking Other Total
N % N % N N
1996 27,158 73.2 8,391 22.6 1,575 37,124
1997 32,381 70.5 11,153 24.3 2,424 45,958
1998 31,586 72.6 10,158 23.3 1,778 43,522
TABLE 33. Proportion (%) of infringements or people involved in narcotics affairs
(possession for abuse or trafficking) according to the type of drug, Belgium,
1995, 1997,1998 and 1999 47
1995 1997 1998 1999
Unit analysed N infringements N infringements N people N people
28,117 ? 23,184 17,604
Narcotics
Opiates 16.5 7.0 25.6 5.9
Cocaine, Crack 5.9 5.0 4.6 4.3
Cannabis 71.7 65.0 65.7 68.6
Psychotropic substances
Stimulants Speed
XTC
Amphetamines
2.4
0.5
0.6
8.0
8.0
0.9
(all
stimulants)
15.6
Depressants  (including
methaqualone)
0.9 0.9 2.0
LSD and other hallucinogenic agents 1.5 2.2 2.4
Other 7.0 2.0
TOTAL 100% 100% 100% 100%
Analysis based on the ‘Uniform forms’.
TABLE 34. Number and proportion of infringements related to narcotics affairs
according to the type of drug  and type of infringement, Belgium, 1995 47
Possession for abuse Trafficking Total
N
infringements
% N
infringements
% N
infringements
%
Narcotics
Opiates 4,534 16.5 94 14.4 4,628 16.5
Cocaine, CRACK 1,565 5.7 95 14.5 1,660 5.9
Cannabis 19,920 72.5 239 36.6 20,159 71.7
Psychotropic Substances
Stimulants Speed
XTC
Amphetamines
637
0
160
2.3
0.6
51
129
17
7.8
19.8
2.6
688
129
177
2.4
0.5
0.6
Depressants  (including
methaqualone)
243 0.9 0 243 0.9
LSD and other
hallucinogenic agents
405 1.5 28 4.3 433 1.5
Total 26,315 100% 516 100% 26,831 100%
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When taking into account the type of infringement, the data of the year 1995 indicates that cannabis
was many more involved when possession for abuse is the infringement (73%) than when trafficking is
concerned (37%) (Table 34).
4.2.2 Convictions and court sentences for drug offences and imprisonment for drug law
offences
Reports of sentences are centralised in the Ministry of Justice (Service de la Politique Criminelle /
Dienst voor het Strafrechtelijk Beleid).  The most recent available results is a specific analysis of 1994
data performed at request of the parliamentary working group on drugs.  The following years data will
be soon analysed as the required computerisation of this information system is nearly completed.
In 1994, 5,606 sentences were recorded with at least one qualification connected to “narcotics”.  Table
35 presents the 4,963 sentences where the information on consumption and/or trafficking is available.
Of the 2,016 judgements where consumption was the infringement, only 30% are joined with another
infringement, 70% being related to consumption alone.  Among these 2,016 judgements for
consumption, 635 main sentences are actually custodial sentences, i.e. 32% compared with 54%
suspended prison sentences and 15% fines.
For consumption/trafficking, we obtain the following distribution:  12% fines, 38% custodial sentences
and 50% suspended prison sentences.
Finally, for trafficking, we found 4% fines, 36% custodial sentences and 60% suspended prison
sentences.
TABLE 35. Main sentences handed down connected with narcotics, Belgium, 1994 48
Fines Custodial
sentence
Suspended
prison sentence
Total
N % N % N % N %
Consumption 299 15 635 32 1,082 54 2,016 41
Trafficking 12 4 101 36 167 60 280 6
Consumption and
trafficking
335 12 1,001 38 1,331 50 2,667 54
Total 646 13 1,737 35 2,580 52 4,963 100
Although it would appear that one out of two cases ends with a suspended prison sentence (but
information on the partial suspension of sentences is not available), in fact, in more than one third of
cases (35%), even among the category of consumers without trafficking activity,  a custodial sentence
is handed down.
4.2.3 Drug-related crime
4.2.4 Specific information on theft, violence and other drug related criminality was not
gathered.  Nevertheless, the treatment demand indicator provides information on
the source of referralt.
Table 36 shows that comparable proportions of treatment demands (respectively 18 and 19% in 1997
and 1998) were referred by Court/probation/justice services.  According to the type of treatment
(ambulatory/outpatient or residential/inpatient care), one observes that a fourth of patients undergoing
ambulatory treatment are referred by Court/probation/justice services, what is higher than patients
treated in residential centres (7%).
                                                
t  For a description of the various registration systems, please see Part II : Epidemiology.
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TABLE 36. Source of referral (%) of patients starting treatment in 1997 and 1998,
CCAD/CTB-ODB/VAD, Belgium
1997*  1998 1998 Outpatient ** 1998 Inpatient **
M F T M F T M F T M F T
Number of cases 4,154 1,434 5,785 4,910 1,637 6,649 3,148 1,060 4,232 1,762 637 2,417
% % % % % % % % % % % %
Self referred, family, friends 40 41 41 43 40 43 38 35 37 54 49 53
Other drug treatment centre 13 15 13 16 17 17 14 13 14 20 24 21
GP,hospital,oth.med.sources 13 20 16 12 16 13 12 14 12 14 20 16
Social service 5 5 5 3 3 3 3 4 4 1 0 1
Court,probation,justice 21 9 18 20 17 19 25 26 25 9 4 7
Other 7 11 8 6 6 6 7 8 8 2 3 3
* : Data from CCAD and CTB/ODB are actually 1997 treatment demands when VAD data are 1996 treatment demands.
** : Outpatient : data from centres offering ambulatory care / Inpatient : residential centres
4.3.  Social and economic costs of drug consumption
a) Studies and estimates of health care costs, other social costs
No information gathered.
b) Estimates of total consumption/demand/expenditure on drugs
No information gathered.
Chapter 5. Drug Markets
5.1.  Availability and supply
5.1.1 Sources of supply and trafficking patterns
Information on supply and trafficking patterns is largely developed in the Belgian Questionnaire sent
for the UNDCP annual report 45.
Based on several investigations and seizures, a new trend is observed in 1999 : the drug traffickers
are mingling various type of narcotics in a same transportation.  The final destination of a large part of
these ‘mixed’ seizures, involving residents in Belgium, should be UK.  It is not yet obvious to know to
what extent the most famous criminal organisation used this kind of operating way.
5.1.1.1 Heroin
80% of the total traffic of heroin comes from the golden croissant (Southeast-Asia) and the other 20%
comes from the golden triangle (Laos, Cambodia and Vietnam).
5.1.1.2 Cocaine
Cocaine comes mostly from Latin-American Andes-countries. The drugs come mostly via Colombia,
Brazil, and Venezuela or from Trinidad and Tobago to Belgium using boats and planes. The airport of
Brussels (Zaventem), the harbours of Antwerp and Zeebrugge are known for this. Most of the cocaine
is in transit and is meant for other countries like The Netherlands, France, Germany and United
Kingdom. Seizures of cocaine have constantly increased for the last ten years, with a record of about
3 tons in 1993.
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5.1.1.3 Cannabis
Cannabis is a popular drug in Belgium.  Cannabis comes mostly from Morocco, Colombia, Nigeria and
Cambodia by ship or transported via the road. The most important destination is The Netherlands,
United Kingdom and Eastern Europe.
Sixty two percent of the total hash traffic comes from Morocco, 28% from Pakistan and 8% from
Kenya.  The Netherlands and Eastern Europe are quite often the destination for this traffic.
5.1.1.4 XTC
XTC is imported especially from The Netherlands and Eastern Europe, but also Belgium is a
producing country.
5.1.2 Availability of different drugs, trends and possible reasons
Information on adults perceptions about the availability of cannabis and cocaine is investigated
continuously by the health behaviour monitoring carried out in the French Community.  Various
surveys investigated pupils about the actual availability of illicit drugs.
- Health behaviour monitoring (French Community), 1996-97 and 1998-99 49
The health behaviour monitoring reports that 2/3 of adults (18-49 years) believe possible to get
cannabis and 45% cocaine near to their house.
- Youngsters in Brussels, 1997 50
In this qualitative study, 22 teenagers of Brussels (14 boys, 8 girls / 13-18 year old) were interviewed
in July 1997.  They stated that cannabis is available everywhere: from friends, in The Netherlands,
during festivals, in youngster-house, at school.
- School-aged youngsters in Bruges (Flanders), 1996-97 15
3,475 pupils aged 16-18 from 18 schools of Bruges participated in 1996-1997 in a study about the
relation between the use of drugs and the environment of school-aged youngsters.  There was a
question about how they get their drugs.
More than one out of three (39%) of the users stated that he/she has asked himself/herself for the first
product ; 28% got it from friends, 4% got it from his boy- or her girlfriend and 2% got it from another
person.
- Mental health of youngsters in Brussels, 1994 17
Among 2,209 pupils of secondary schools in Brussels (17 French and 3 Flemish schools), 23% have
tried illegal drugs at least once: they stated that they can get hold of illegal drugs without too many
problems.
About 40% of boys said that they could get cannabis derivatives, 21% said the same for ecstasy and
16% could get opiates “without problems”.  Comparative percentages for girls are lower (23%, 12%
and 9% respectively).
5.2.  Seizures
The numbers of drug seizures are not available for 1996 and 1997 but now 1998 and 1999 being
available, it is possible to observe and discuss some trends.  Of course, all preliminary remarks
regarding the interpretation of these data remain valid and should be taken into account (see 4.2).
These figures have been collected by the police services.  The statistical data on the seizure of
narcotics is based exclusively on the positive results of searches or investigations but could not reflect
the number of infringements committed in this field.  We can only suspect some trends and have of
tentative discussion.
FIGURE 12 :  Number of seizures and quantity of drug seized per drug, Belgium, 1985-1999
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Globally the number of drug seizures have increased in the nineties, reaching a maximum around
1995 for most narcotics (as far as we know because data of 1996 and 1997 are missing).  After
increasing up to 1995, the number of cannabis seizures stabilised in 1998 and decreased in 1999
(Figure 12).  The number of heroin, cocaine and LSD seizures has increased up to 1992, than levelled
off to decrease in 1998 and 1999.
At the opposite, those for amphetamines and ecstasy showed a higher and continuous increase up to
1998 and a slight diminution in 1999.
TABLE 37. Number and quantity of seizures per drug, Belgium, 1996-1999 45
1996 1997 1998 1999
N Quantity
(kg)
N Quantity
(kg)
N Quantity
(kg)
N Quantity
(kg)
Cannabis na 106 690 na 48 705 13 020 9 609 7 362 5 847
Cocaine na 838 na 3329 799 2 088 547 1 761
Heroin na 133 na 55 1112 75 720 83
Amphetamines
/ XTC(pills)
na 184 413
pills
na 126 211
pills
2672 271 080
pills
2 163 489 566
pills
LSD (pills) na 13 704
pills
na 621
pills
75 2 050
pills
73 1 047
pills
All seizures are included (Police, Coast Guard and Customs) / na : non available
Over the past 10 years, cannabis quantities have increased up to 1996, but then decreased by half to
48 705 kg in 1997 and then to 9 609 kg in 1998 and 5 847 kg in 1999 (Table 37).
The quantities of other drugs seized have been fluctuating from one year to another, particularly in the
case of heroin, cocaine and LSD.
In 1999, 83 kg of heroin and 1 761 kg of cocaine were seized in Belgium.
After a peak in 1995 (320 441 pills), the quantities of amphetamines/XTC seized decreased in 1996-
1997, and then increased again to 271 080 and 489 566 pills respectively in 1998 and 1999.
Additionally to elements for discussion of the trends in term of number of seizures, one should mention
that the large variations between years in the quantities seized in Belgium could be the result of the
collaboration between countries in the fight against trafficants : the current policy/strategy when a
traffic is discovered, is to postpone the intervention (arrest of the trafficants and seizure of the drugs)
and to follow the travel  in order to be more efficient by discovering the organization of the distribution,
the partners in crime…  So such data on quantities will be better interpreted at larger (European) level.
At the moment in Belgium it is not possible to distinguish police and customs seizures and this limits again
strongly the relevancy of the discussion on the quantities seized.
Coming back to the numbers of seizures, following hypothesis could explain the trends :
- actual decrease in the availability of some narcotics on the Belgian market
- global reduction of  police resources dedicated to drug control
- specific reduction of police resources dedicated to the fight against cannabis consequently to the
directive of 1998.
5.3.  Price/purity of illicit drugs
TABLE 38. Wholesale- and retail prices (BEF) of drugs, Belgium, 1993,95,97,98,99 51
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Products Wholesale sale (BEF/g)
(from supplier to dealer)
Retail sale (BEF/g)
(from dealer to consumer)
1993 1995 1997 1998 1999 1993 1995 1997 1998 1999
Cannabis 65-80 30-175 60 - 100 35 - 70 35-70 200-500 150-400 100 – 600 250 250
Heroin 950 600-900 600 -
1,000
600 600-800 3,000-
4,000
800-2,250 1,500 1,500 1,500
Cocaine 950-1,650 460-900 800 -
1,200
700 600-
1,200
1,500-
3,000
1,200-
2,750
1,200-
2,000
2000 1,500-
3,000
Crack 1,000
Amphetamine 120-250 1,000
XTC (by tab) 150 120-250 20 – 100 40-50 800-1,500 500 250 – 400 300-400
LSD (per
dose)
80 100-350 300
TABLE 39. Wholesale- and retail prices (EURO) of drugs, Belgium, 1993,95,97,98,99 51
Products Wholesale sale (EURO/g)
(from supplier to dealer)
Retail sale (EURO/g)
(from dealer to consumer)
1993 1995 1997 1998 1999 1993 1995 1997 1998 1999
Cannabis 1.5-2 0.7-4.5 1.5-2.5 0.9-1.8 0.9-1.8 5-12 4-10 2.5-15 6 6
Heroin 24 15-22.5 15-25 15 15-20 74-92 20-56 35 35 35
Cocaine 24-41 12-22.5 20-30 17.5 15-30 35-75 30-68 30-50 50 35-75
Crack 25
Amphetamine 3-6 25
XTC (by tab) 4 3-6 0.5-2.5 1-1.2 20-37 12.4 6-10 7.5-10
LSD (per
dose)
2 2.5-9 7.5
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TABLE 40. Products seized: number of seizures and amounts (1985-1999), Belgium 45
1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Cannabis (N) 1,705 1,949 2,359 2,758 2,527 3,127 4,432 6,166 6,380 8,628 13,379 NA NA 13,020 7,362
Quantity   (kg) 10,429 3,791 6,562 13,008 9,844 7,918 6,021 9,504 35,217 59,903 70,686 106,690 48,705 9,609 5,847
Heroin (N) 321 423 507 869 887 1.045 1,732 3,316 3,082 3,024 3,158 NA NA 1,112 720
Quantity (kg) 92 78 141 116 89 291 186 107 76 137 129 133 55 75 83
Cocaine (N) 132 226 254 380 422 375 513 933 897 927 1,046 NA NA 799 547
Quantity (kg) 62 116 270 404 89 537 756 1,222 2,892 479 576 838 3,321 2,028 1,761
Amphet. (N) 38 54 92 151 81 66 85 92 124 106 102 see XTC see XTC see XTC see XTC
Quantity (kg) 3.5 2.4 9.0 47 4.2 15 77 96 19 23 68 see XTC see XTC see XTC see XTC
XTC/Ecstasy (N) 18 196 267 560 872 1002 NA NA 2,672 2,163
Quantity (pills/tablets) 1,654 75,742 15,240 98,215 55,637 320,441 184,413 126,211 271,080 489,566
LSD (N) 38 7 32 22 22 36 88 233 254 301 281 NA NA 75 73
Quantity
(doses)
1,346 639 6,497 877 2,186 16,841 2,417 13,603 5,659 5,237 5,458 13,704 621 2,050 1,047
NA : not available / see XTC : Amphetamines and XTC have been pooled from 1996 onwards
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Chapter 6. Trends per drug : overview
This sixth Chapter includes information mostly mentioned above but here presenting simultaneously
different indicators for each drug.  The methods of the mentioned studies as well as their limitations
are not described again in this section : we invite the reader to go back to Part II Epidemiology.
6.1.  Cannabis
TABLE 41. Synthesis table of epidemiological indicators on CANNABIS : use in adult
and school-aged population, offences, seizures, price and accessibility,
Belgium, 1993-1999 (Figures are percentages except when specified)
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
ADULT POPULATION
Lifetime prevalence Vlaamse G. 6 5.8
ULB/Promes 7 12.8 20.8  ?
Last year preval. Vlaamse G. 6 1.5 ?
SCHOOL POPULATION (15--16 y.)
Lifetime prevalence RUG/Publ.Hlth 9 14.9 19.6 23.7 
VAD 11 24.1
ULB/Promes 10 27.9
Last month preval. RUG/Publ.Hlth 9 7.6 10.8 14.6 
PROBLEMATIC USE
Treatment demands CCAD 34 3.8 5.7 6.2 11.9 13.2 14.0
(% cannabis= main drug) VAD 33 22.0 30.3 
CTB 35 6.6 7.6
PEOPLE TAKEN IN  for
questioning
(% cannabis / all offence)
SGAP 46 72.7 65.0 65.7 68.6 =
SEIZURES (N) SGAP 47 6,380 8,628 13,379 13,020 7,362 
RETAIL PRICES (euro) SGAP 47 8 7 9 6 6 =
ACCESSIBILITY (adults) ULB/Promes 7 59.2 70.4 62.9 64.5 =
It is uneasy to generalise these figures to the whole country, to compare between data and to find out
trends, nevertheless one observes that :
- the use of cannabis in adult and secondary school population is increasing over the 1990’s;
- 1 in five adults (French Community) experienced cannabis at least once (corresponding to the
European mean figure);
- at the age of 15-16 years, 1 in 4 already experienced (equal to the European mean figure),
among which the half used cannabis during the last month.  The lifetime prevalences of use of
cannabis are regularly increasing from 1994 to 1998 from 15 to 25 %; respectively 20-25-30 %
in boys and 10-15-20 % in girls experienced cannabis at least once.  The proportion of last
month users among ‘lifetime’ users of cannabis increases: respectively 51-55-62 %;
- the proportion of patients (starting treatment) stating cannabis is their main problematic drug is
increasing;
- cannabis is the cause of 70% of the cases in which people are taken in for questioning
(stable);
- the number of seizures increased during recent years but decreased in 1999;
- the retail price is relatively stable;
- most of adults stated that they could get cannabis quite easily near to their home.
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- HBSC survey : Youngsters and health in Flanders, 1990-94-96-98 9
Cannabis is the most used illicit drug : 24% of 15-16 year old boys and 46% of 17-18 year old boys
had ever used.  Figures show an increasing 1994-1996-1998 trends for cannabis use among 15-16
year old as well in boys as in girls.  Although about 50% of boys who ever used cannabis stopped, for
the other products this percentage is higher.  Globally and as well for boys as for girls, an increasing
proportion of cannabis users (ever used) are ‘regular’ ones (defined as last month use): 50%, 55%
and 62 % respectively in 1994, 96 and 98.  It is particularly striking among youngsters of 15-16
(presented here) and also among 14 years old students (42%, 53% and 58% respectively).  The age
of first use for the age group 15-18 was quite similar over the 3 consecutive studies : from 15.1 year
old in 1994 and 1996 to 14.8 in 1998.
FIGURE 13 :  Proportion of students aged 15-16 years having used cannabis, XTC at least once
(left) and during the last month (right), Flemish schools, 1994, 96 and 98 3
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- HBSC survey : Health behaviour and life-styles of youngsters in the French Community, 1988-199810
Cannabis represents an increasing proportion of the drug used (respectively 35, 40, 40, 84% in 1988,
1990, 1992 and 1994).  In 1998, 28% of 15-16 years (boys : 31% - girls : 25%) experienced cannabis.
The use increases with age : from 5% among 11-12 years and 12% among 13-14 years reaching 44%
in 17-18 years (boys : 51% - girls : 39%).
FIGURE 14 :  Proportion of youngsters having used a drug at least once and during the last month,
French Community secondary schools, 1988, 1990, 1992 and 1994
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- Qualitative research on cannabis,1998 52
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A qualitative exploratory survey was conducted in Brussels in July 1997.  Twenty-two youngsters
(8 girls and 14 boys aged 13 to 18 years) participated using semi-structured interviews.  This
preliminary study revealed interesting results on the multiple information sources, the ‘friendly’ way of
starting, the decisive role of parents and peers, the role of the school, the reason of the use, the
consequences of the legalisation, etc.
- Survey in Flemish Schools, 1999 11
In 1999, the lifetime prevalence of cannabis use is 24.1% of 15 to 16- year-olds (boys : 29% - girls :
19%) experienced cannabis.  The use increases with age : from 1% among 11-12 years and 6%
among 13-14 years reaching 39% in 17-18 years (boys : 48% - girls : 28%).
- Social diagnosis in 3 secondary school in Verviers (Wallonia), 1999 13
The lifetime prevalences of the use of cannabis and XTC increase with age without any significant
difference of the cannabis prevalence between gender.  Lifetime prevalence rates are 6% in first year
of secondary school (corresponding to 12 years of age), 16% in third year (around 14 years) and 32%
in fifth year (16 years).
- School survey on drugs in Charleroi (Wallonia), 1999 14
The lifetime prevalences of the drug use increase with age.  Boys used more than girls.  Lifetime
prevalence rates are 30% in third year of secondary school (corresponding to 14 years of age) and
44% in fifth year (16 years).
 - School-aged youngsters in Bruges (Flanders), 1996-97 15
The most consumed products by young people are alcohol, tobacco and medicines (especially among
girls) as well as derivatives of cannabis.  Among the population who ever used illicit drugs, 98% used
cannabis : 15% used cannabis only once (‘experimental use’) and 39% used it ‘regularly’.  The
proportion of ‘regular’ user is the highest for cannabis.  In total 50% of users (experimental,
intermediate, ‘regular’) stopped using cannabis.
- Mental health of youngsters in Brussels, 1994 17
Out of 2209 pupils of the Brussels secondary schools, cannabis is the product most mentioned by
young people: 19% have experienced using these products and 11% had used them during the month
preceding the study.
- Rock Festival, 1998 31
The surveys repeatedly conducted during “the Rock Festival" showed extensive use of cannabis
among spectators (lifetime prevalence 88% in 1998) and among drug users (98% in 1998).
- Treatment centres, 1993-1998
The most recent data from the treatment demand registration systems of the French Community
(CCAD, 1993 to 1998), the Flemish Community (VAD, 1996 and 1998) and Brussels (CTB-ODB,
1997-1998) are compared.  Of course, differences in the type of centres and in the age of the patient
population covered should be taken into account.
Cannabis as main drug shows an increasing trends and is reported in 1998 by 30% of clients in the
Flemish Community, by 14% of the French Community (4% in 1993) and only by about 8% in Brussels
(but cannabis is more and more often stated as ‘secondary’ substance).  Among first treatment
demands (French Community), cannabis represented 27% in 1998.
- Drug use among prisoners, 1993 24,1997 and 1999 22
In 1999, 41% of 246 prisoners stated to have used cannabis during the last month before their
imprisonment and 37% used it ‘regularly’ during the current or a previous imprisonment.
In 1997, nearly half of the prisoners (45%) reported cannabis use during the year before the
imprisonment and 38% during their current or a previous imprisonment.
In a 1993 study conducted in the Antwerp prison, the main drugs (42% of prisoners were drug user)
was cannabis (37% of users).
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- Drug telephone line  (French Community), 1997 53
In 1997, the French-speaking drug help line was contacted 4,945 times.  Most of the callers stated
they were not drug users and thus the reported substances are to be considered as substance of
concern and not as used substances.  Among 3,085 calls involving a substance, cannabis represents
the most frequently mentioned (40%).
6.2.  Synthetic drugs (amphetamine, ecstasy, LSD)
TABLE 42. Synthesis table of epidemiological indicators on XTC : use in adult and
school-aged population, offences, seizures, price and accessibility, Belgium,
1993-1999 (Figures are percentages except when specified)
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
ADULT POPULATION
Lifetime prevalence Vlaamse G. 6 0.5
Last year preval. Vlaamse G. 6 0.1 ?
SCHOOL POPULATION (15--16 y.)
Lifetime prevalence RUG/Publ.Hlth 9 4.1 5.6 6.2 
VAD 11 4.0
ULB/Promes 10 6.3
Last month preval. RUG/Publ.Hlth 9 1.4 2.0 2.8 
PROBLEMATIC USE
Treatment demands CCAD 34 0.6 2.0 2.7 2.8 3.2 1.5
(% XTC-stim. = main VAD 33 20.1 22.0  ?
drug) CTB 35 7.2 10.3
PEOPLE TAKEN IN  for
questioning
(% XTC-amph./all  offence) SGAP
46
3.5 16.0 0.9 15.6 ~~
SEIZURES (N) SGAP 47 684 978 1,002 2,672 2,163 
RETAIL PRICES (euro) SGAP 47 28 12 8 9 
AVAILABILITY (adults) - ?
More difficult than regarding cannabis use, it is uneasy to generalise these figures to the whole
country, to compare between data and to find out trends, nevertheless one observes that :
- the information on use of XTC use in adult is out-dated : it showed a very low (less than 1%)
lifetime prevalence in 1994 (Flemish Community);
- from 15-16 years of age onwards, XTC (and other club drugs) are the second product most
used (after cannabis);
- at the age of 15-16 years, a slightly increasing proportion of students (reaching 6% in HBSC
1998 surveys - respectively 7 % in boys and 4 % in girls -) experienced XTC;
- among XTC users less than half used XTC during the last month; however, the proportion of
XTC ‘regular’ users among users increases : respectively 34-36-45 % in 1994, 96 and 98;
- the proportion of patients starting treatment and stating XTC as their main problematic drug
seems increasing; in centres participating to the Flemish VAD monitoring system, XTC and
stimulants users (not including cocaine) represent 22% of clients in 1998 but only 10% in
Brussels CTB-ODB (including cocaine) and around 2% in CCAD system (these differences
seems to be explained by a coverage of different type of treatment centres);
- XTC is the cause of a varying proportion the cases in which people are taken in for
questioning;
- the number of seizures increased during recent years;
- the retail price is declining reaching 9 Euro (360 BEF) for a tablet in 1999;
- no information on accessibility in adults is available.
- HBSC survey :Youngsters and health in Flanders, 1994-96-98 9
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Globally more boys than girls used illegal drugs. Cannabis was most popular followed by speed/XTC
(Fig. 2 and 3).  Data show an increasing trend for XTC in boys during the period 1994-1996 whereas
among girls the increase is delayed during the period 1996-1998.  Interviewed in 1998, 6% of 15 to
16-year-olds (boys : 8% - girls : 5%) and 12% of 17 to 18-year-olds (boys : 15% - girls : 10%) had
experienced XTC (a least once).
For XTC, a third of 15-16 year users were ‘regular’ in 1994 and 1996, whereas this proportion
increases up to 43% in 1998 and 1999.
- HBSC survey :Health behaviour of youngsters in the French Community, 1988-98 10
In 1998, 6% of 15-16 years (boys : 7% - girls : 5%) experienced XTC.  The use increases with age :
from 2% among 11-12 years and 4% among 13-14 years reaching 11% in 17-18 years (boys : 14% -
girls : 9%).  The proportions are similar for amphetamines (10% among 17 to 18-year-olds).
- Survey in Flemish Schools, 1999 11
In 1999, the lifetime prevalence of XTC use is 4% of 15 to 16- year-olds (boys : 5% - girls : 3%).  Use
increases with age : from 0.3% among 11-12 years and 1% among 13-14 years reaching 8% in 17-18
years (boys : 11% - girls : 5%).
The lifetime prevalence of amphetamines is slightly higher : 6% of 15 to 16- year-olds (boys : 8% -
girls : 5%).  Use increases with age : from 0.6% among 11-12 years and 2% among 13-14 years
reaching 11% in 17-18 years (boys : 14% - girls : 8%).
- School-aged youngsters in Bruges (Flanders), 1996-97 15
Among the participating students who ever used illicit drugs, 20% ever used XTC, 18% amphetamines
and (more surprising) 22% LSD (98% ever used cannabis).  ‘Regular’ users were defined as using
illicit drugs at least 1 time/month during the last 6 months. Of the total group who ever used,
respectively 27, 29 and 33% used XTC, amphetamine and LSD only once (‘experimental use’) and
respectively 27, 23 and 15% used it ‘regularly’.
- Mental health of youngsters in Brussels, 1994 17
Out of 2209 pupils of the Brussels secondary schools, XTC has become the second most used
substance by young people after cannabis (6% had tried XTC and 2% had used it within the last 30
days).  For the 17-18 age group, 8% of boys had tried ecstasy, compared with 6% of girls.  Medicines
follows: 5% and 2% respectively.  Included among medications, are amphetamines : 3% had tried
amphetamines -excluding ecstasy- and 1% had used them within the last 30 days.  The respective
frequencies of use of LSD are 4% and 1%.
The percentages of youngsters trying and using the various drugs are higher for boys than for girls,
regardless of the age group : 8% of boys had tried ecstasy compared with 6% of girls; and 7% of boys
had had experience with LSD compared with 4% of girls in the same age group.  There is however an
exception which should be noted: the percentage of girls in the 15-18 age group who have tried
barbiturates is higher than for boys in the same age group.
- Rock Festival (French Community), 1998 31
In 1998, 88% of the 157 interviewed people stated to have used an illicit drug at least once (lifetime
prevalence).  Beside cannabis reported by 98% of respondents, LSD was used by 62%,
amphetamines and XTC by nearly half of respondents.  XTC, amphetamine and LSD use increased
compared to 1996 and 1997.  The main increase regards LSD use from 22% in 1996 to 62% in 1998.
One possible explanation of the increasing use of stimulants and hallucinogens could be the more and
more “techno music” orientation of the festival.
- Treatment centres
In 1998, stimulants including amphetamines and XTC are considered the main drug by 30% of
treatment patients of the VAD Flemish Community monitoring system, by 8% in CTB-ODB Brussels
centres (including cocaine) but only by a tiny fraction of the CCAD French Community system (2%).
Differences in the type of centres and in the age of the patient population covered should explain
these variations.  Among first treatment demands (French Community), stimulants represent 3% in
1998 (males 2%, females 5%); most of this ‘stimulants’ category are XTC users (males 2%, females
4%).
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Among patients undergoing treatment in a centre of the Charleroi 37, the mean age at first use of LSD
and XTC was respectively 19 and 20 years.  XTC and LSD are less frequently daily used among
patients undergoing treatment in these centres.
- Street snowball survey, 1998 54
In the framework of a European snowball survey conducted in 1998, 1,243 drug users were
interviewed in Brussels (n= 370), Charleroi (n=501), Liège (n=254) and Namur (n=118).  The snowball
methodology reaches different groups of drug users aiming particularly users who do not have any
contact with prevention and treatment facilities.  The main used substances were heroin (75%) and
cocaine (65%) when XTC was used by 25%.
- Drug consumption in prison, 1993 24
In 1999, respectively 8 and 9% of 246 prisoners stated to have used amphetamines and XTC during
the last month before the imprisonment and respectively 8 and 5% used ‘regularly’ during the current
or a previous imprisonment.
In 1997, respectively 17% and 21% reported amphetamines and XTC use during the year before the
imprisonment and respectively 4 and 8% during their current or a previous imprisonment.
In the study conducted in the Antwerp prison in 1993, 42% of prisoners were drug users.
Amphetamine was used by 10% of users.
- Drug telephone line  (French Community), 1997 53
In 1997, among 3,085 calls involving a substance, cannabis represents the most frequently mentioned
(40%); heroin is the second one (14%).  XTC, alcohol and cocaine represent each around 7%.
- Survey on Drug Use at mega house exhibition 55
In February 2000 a survey on drug use was conducted at an exhibition on techno and house music,
clothing, beverages and related aspects. This exhibition took place in Mechelen (Flanders).
People walking by the booth of a prevention organization were asked to fill out a one-page
questionnaire. This organization distributed leaflets with information on different types of drugs and
condoms promoting safe sex to reduce the risk of infectious diseases among injecting drug users.
The respondents were mainly male (54.5 %), 27.3 % was female and 18.2 % did not mention his/her
gender.  56 % stated not to have used any illicit drug in the 6 months, whereas 44 % stated to have
used something.  104 respondents (21%) stated to have used XTC or amphetamines in the last 6
months.   Of these 104, 64 % mentioned to use XTC, amphetamines or speed from time to time,
whereas 36 % reported to use one of those ‘regularly’ (this is respectively 13 % and 7 % of the total
number of respondents).
Among XTC users, 27 % has mentioned using XTC when being in a group on another occasion than
going out.  20 % mentioned taking XTC at school, 9 % has mentioned using XTC when being at home
alone and 6 % mentioned using XTC at work.  The fact that there is only 6 % of the people using XTC
at work whereas there is 20 % using it at school, could be related to the age distribution of this group.
On the basis of these data, we could group the users in users in recreative places and people that
also use XTC in other places. There are however no significant differences between the people on
frequency of partying (c² (1) = .98, p = ns) or frequency of using amphetamines (c² (1) = .01, p = ns).
XTC users go out more frequently than users of other substances or than non-users and they state to
go out more often to a dancing than users of other substances do.  Of the XTC users there is only one
who does not consume any other products (also includes legal products as alcohol and tobacco).
XTC users are most often also consumers of alcohol, tobacco, cannabis and magic mushrooms (in
that order of preference).  There are some differences between users who consume a whole range of
substances and the ones that consume a limited group of products.  The group that consumes more
different types of products, also consumes these products at a higher frequency than the other group
(except for tobacco, where there was no difference).
All XTC users have a rather positive attitude towards having their drugs tested (mean value of 3.0
which corresponds to ‘I probably would have my drugs tested’).  XTC users have a significantly more
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positive attitude than non-users towards having the possibility to have drugs tested (mean difference =
-.50, p < .01). There is no significant difference with other users towards having drugs tested.
6.3.  Heroin/opiates
TABLE 43. Synthesis table of epidemiological indicators on HEROIN/OPIATES: use in
adult and school-aged population, offences, seizures, price and
accessibility, Belgium, 1993-1999 (Figures are percentages except when specified)
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
ADULT POPULATION
Lifetime prevalence Vlaamse G. 6 0.04 ?
Last year preval. Vlaamse G. 6 0.00 ?
SCHOOL POPULATION (15--16 y.)
Lifetime prevalence RUG/Publ.Hlth 9 0.7 0.6 0.7 =
VAD 11 0.8
ULB/Promes 10 3.4
Last month preval. RUG/Publ.Hlth 9 0.1 0.1 0.2 =
PROBLEMATIC USE
Heroin use prevalence(‰) CCAD 31 6.3 ?
Treatment demands CCAD 34 86.0 85.1 77.3 74.3 67.7 69.4
(% opiates = main drug) VAD 33 39.5 22.1 
CTB 35 77.1 72.7
Injecting use (current) CCAD 34 35.9 40.9 39.9 37.0 37.3 35.3 =
Coor.Drog.Charl 37 17.1 =
VAD 33 26.6
MORTALITY
Drug related deaths (n) NIS-IPH 346 376 346 =
DRD involving opiates 47.0 48.0 53.0 =
PEOPLE TAKEN IN  for
questioning
(% opiates/all  offence)
SGAP 46 16.5 7.0 25.6 5.9 ~~
SEIZURES (N) SGAP 47 3,082 3,024 3,158 1,112 720 
RETAIL PRICES /g (euro) SGAP 47 83 38 35 35 35 
ACCESSIBILITY (adults) - ?
More difficult than regarding cannabis use, it is uneasy to generalise these figures to the whole
country, to compare between data and to find out trends, nevertheless one observes that :
- the information on use of opiates and heroin in adult general population is out-dated : it
showed a very low (less than 0.1%) lifetime prevalence in 1994 (Flemish Community);
- at the age of 15-16 years, a very limited proportion of students (less than 1% (stable) in
Flemish surveys but 3% in the French Community HBSC survey) experienced heroin;
- the proportion of patients starting treatment of heroin/opiates addiction as their main
problematic drug seems decreasing; in 1998, heroin/opiates users represent around 70% of
clients in centres participating to French Community CCAD and Brussels CTB-ODB systems
but only 22% in the Flemish VAD monitoring system (these differences seems to be explained
by a coverage of different type of treatment centres);
- injection behaviour among heroin users starting treatment is quite stable (in contrast to the
global trend in treatment centres due to the relative increase of people treated for non-
injectable drug) and varies between monitoring systems;
- heroin and opiates are the main cause of drug-related deaths (stable for 1993 to 1995);
- heroin/opiates are the cause of a varying proportion the cases in which people are taken in for
questioning;
- the number of seizures decreased during recent years;
- the retail price has been stable since 1995;
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- no information on accessibility in adults is available.
- HBSC survey :Youngsters and health in Flanders, 1994-96-98 9
As regarding other illicit drugs more boys than girls use opiates : respectively 1.2 and 2.2% of boys
aged 15-16 and 17-18 years used heroin at lest once for respectively 0.3 and 0.4 in girls of the same
age groups.  Respectively 0.3 and 0.5% of boys aged 15-16 and 17-18 years used during the last
month when nearly none girls did it.
- HBSC survey :Health behaviour of youngsters in the French Community, 1988-98 10
In 1998, 3% of 15-16 years (boys : 4% - girls : 2%) experienced heroin.  The use increases with age :
from 1.4% among 11-12 years and 3% among 13-14 years reaching 3% in 17-18 years (boys : 4% -
girls : 2%).  The proportions are similar for amphetamines (10% among 17 to 18-year-olds).
- Survey in Flemish Schools, 1999 11
In 1999, the lifetime prevalence of heroin use is 0.9% of 15 to 16- year-olds (boys : 1.1% - girls :
0.6%).  Use increases with age : from 0% among 11-12 years and 0.6% among 13-14 years reaching
1.1% in 17-18 years (boys : 1.4% - girls : 0.8%).
- School-aged youngsters in Bruges (Flanders), 1996-97 15
The most consumed products by young people are alcohol, tobacco, medicines and cannabis.  Among
the population who ever used illicit drugs, only 2% ever used heroin.  Use limited to a unique
experience was proportionally high for cocaine and heroin (50%) when 21% used ‘regularly’ (defined
as 1x/month for 6 months).
- Treatment centres
Opiates are reported as main drug by most people entering treatment in Brussels (77%) and in the
French Community (males 72%, females 66%, all 69%), and by 40% in the Flemish Community.  The
proportion of opiate shows a decreasing trend in the French Community centres.  Restricted to first
treatment demands, opiates represent 55% (males and females comparable) among the 447 first
demands registered in centres of the French Community 34.  Opiates are the only category where the
proportion of opiates as main drug is lower in ‘first treatment demand’ data than in ‘all treatment
demands’ suggesting either that opiates users restart more often a treatment or representing an actual
continuous decreasing trend of the proportion of opiate users starting treatment (previous first
treatment data should be considered).
Among 2,056 subjects (males : 72%, mean age : 29 years) having contact with French Community
treatment centres in 1996, heroin constitutes the drug mainly taken by 978 individuals out of 1,987, i.e.
49% of them.  The average age when a subject takes heroin for the first time (978 individuals) is 19.3
years and the addiction lasts on average for 6 years.
Figures are comparable in Charleroi centres 37  the average age when a subject takes heroin for the
first time is 19.5 years and the addiction lasts on average for 6.6 years (1997).  The proportion of daily
users among users for the years 1995-96-97 were respectively 77, 78 and 67% : other types of use
were probably residual use of heroin accompanying a substitution treatment.
The substitution treatments explain that the higher daily used drug is methadone, for which the
average first use age (it means the start of the substitution treatment) is 23.7 years.
- Rock Festival (French Community), 1998 31
In 1998, 88% of the 157 interviewed people stated to have used an illicit drug at least once (lifetime
prevalence) among which 16% heroin.
- Street snowball survey, 1998 54
In the framework of a European snowball survey conducted in 1998, 1,243 drug users were
interviewed in Brussels (n= 370), Charleroi (n=501), Liège (n=254) and Namur (n=118).  The snowball
methodology reaches different groups of drug users aiming particularly users who do not have any
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contact with prevention and treatment facilities.  The mean age was 28 years (14 - 55).  The main
used substances were heroin (75%) and cocaine (65%).
- Drug consumption in prison, 1993, 1999 24
In 1999, 15% of 246 prisoners stated to have used heroin/opiates during the last month before their
imprisonment and 13% used it ‘regularly’ during the current or a previous imprisonment.
In a study conducted in the Antwerp prison in 1993, 42% of prisoners are drug user.  The second main
drug was heroin (28% of users)(cannabis was used by 37% of users).
- Drug telephone line  (French Community), 1997 53
In 1997, among 3,085 calls involving a substance, cannabis represents the most frequently mentioned
(40%); heroin is the second one (14%).
6.4.  Cocaine/crack
For specific information on cocaine, go to Part IV Chapter 14.
6.5.  Multiple use (including alcohol, pharmaceutical products, solvents)
See Part II Chapter 2 – 3.3.2.a .   This issue will be largely  detailed in the next 2001 report.
Chapter 7. Conclusions
7.1.  Consistency between indicators
Progressively an overview of the epidemiological situation on drugs and related guidelines is being
developed.  The framework of the EMCDDA, the identification of priorities and related guidelines are a
real support.  Several surveys were conducted among pupils of secondary schools and their results
are comparable.  There are very few surveys involving adults and other subgroups, as prisoners, and
ethnic minorities.  There is consistency between trends of some indicators : for example, increasing
cannabis use among youngsters ands also in adults, consistency between the various school surveys,
high level of HCV among IVDUs reported by all studies.  Nevertheless  reliability of most data remain
relatively poor and should be improved in order to take decisions on solid basis.
7.2.  Implications for policy and interventions
a) Possible hypotheses and reasons for main trends and new developments in drug use
The trends observed in Belgium are very similar to those noticed in other countries of the European
Union 8. So it seems that hypotheses should be related to the European culture. For one reason or
another different sorts of drugs seem to fit in the youth culture and give an answer to specific needs of
(young) people.
Factors typical for a certain age, like the need to experiment, to provoke the establishment, the need
for kicks, fun, distraction are important elements, although their specific impact is difficult to assess.
In all cases the opinion of young people progressively evolved. They don’t think that using drugs
automatically leads to the old stepping-stone-theory and most of them think that people who use drugs
are not specifically different from anyone else.
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Also the fact that some synthetic drugs are so easy to produce leads to production (and use) of these
products in Belgium and in some of the neighbouring countries.
b) Relevance to policy issues or interventions for policy makers and professionals
Several researches and evaluations of policies, treatment facilities, etc are currently running.  Several
researches and evaluation of treatment or prevention programmes, on effectiveness of repressive
measures, studies of specific risk-groups (prisoners, youngsters out of school), ethnographic research,
research into the aetiology of drug use, cost of drug use, trend analysis have been conducted or are
currently running.  Unfortunately there are often not easily accessible because not officially published
or not disseminated (grey literature).
Recommendations for policy issues are generated from surveys : for example, the proposal of
Decorte56 to abandon the classical distinction between 'soft drugs' and 'hard drugs, and to introduce a
new distinction between 'soft use' and 'hard use' of any drug.  This approach allows to assess the
overall impact of any substance, without overreacting to the dangers it poses.  Every possible effort
should be made -legally, medically, and socially- to distinguish between the two basic types of drug
use: the experimental, recreational, and circumstantial, with minimal social costs; and the
dysfunctional, intensified, and compulsive, with high social costs.  In order to distinguish 'soft use' from
'hard use', greater attention will have to be paid to how drugs are used.
Some recommendations are directly to the current Belgian concern over legalisation.  Again from
Decorte 56  ‘ the drug policy should encourage the development and dissemination of information
control mechanisms among those who are already using drugs. Any abrupt shift in the present policy
would probably be inappropriate.  Informal social controls cannot be provided to users ready-made,
nor can formal policy create them ‘….‘ The sudden legalisation of cocaine, for instance, would leave in
limbo those who have not yet had the time to internalise information social controls ‘.
There is a growing demand of decision makers and also professionals them-selves for evaluation of
prevention and treatment.  At present, most attention is given to quantitative indicators, which are very
limited for evaluation (it mainly gives an indication of the number of activities; it concerns more
monitoring than evaluation) although qualitative indicators are also being identified and tools are being
developed to evaluate mainly in the field of prevention.
There is a growing demand for an evidence-based approach towards prevention and treatment.  More
research is needed into causal factors, trends in drug use, characteristics of groups of users, …
7.3.  Methodological limitations, data quality and information needs
Although some monitoring systems and epidemiological research have been carried out, the global
description of the situation and the alterations in drug consumption and drug related problems remain
incomplete.  The school population is the group where drug use is the best documented.  Regarding
adults, treated patients, judicial and police activities, reliable data are necessary in order to assess the
actual prevalence of drug use and particularly the problematic use.
In general the data quality of the school surveys is good.  Little by little we get comparable research
for specific age groups. Most of them are conducted by or in close co-operation with experienced
research institutions or universities, repeating regularly the survey using the same methodology and
the same tools.  In some cases the data have been validated by other research.  Both school surveys
in the Flemish and French Communities are conducted in the framework of the WHO HBSC cross
national survey.  So at present comparisons can be made on the level of the Flemish Community
between 1994 and 1998.  In the French Community, the trends of the behaviour of youngsters from
1986 to 1994 have been analysed and published 10.
Meanwhile more harmonisation between the other studies conducted in the different areas of the
country is necessary.  For example, the concept of ‘regular’ use is defined very differently in the
various studies.
On the other hand, we should stress on the competition of multiple geographically limited surveys
making uneasy to carry out the large standardised HBSC surveys : indeed more and more schools do
not agree to participate in the HBSC survey because of recent participation in a local school survey.
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In the field of epidemiological research the majority of studies conducted in schools are self-report
surveys, using a paper-based questionnaire to be filled in during school time.  Other methodologies
(Computer Assisted Telephone Interview, postal inquiry) have been applied in other surveys.  No
cohort research has been carried out.
Further efforts should be made to realise local and national estimates on the number of hard drug
(ab)users (or hard users).  Also insight and detection of new trends in drug (ab)use is important.  In
general more research is needed aimed at the social context of drug use, mechanisms of drug
(ab)use, …
Some results of official statistics become available (for example, RCM/MKG and RPM/MPG), but
analysis of most official statistics is not regularly carried out or not published (mortality data,
pharmacological data, judicial data,..).  The data on deaths related to drug use from the National
Institute of Statistics are old dated and the number of overdoses provided by police services is not fully
reliable.  Some information on infectious diseases (HIV, hepatitis B and C) is available but should be
improved and more specific and detailed.
Regarding demand reduction and treatment centres, a lot of interventions and actions were set up but
often without any evaluation.  There is a very important need to evaluate and monitor the practice of
(methadone) maintenance and substitution treatment.  Harmonised indicators for the evaluation of
demand reduction interventions should be implemented and a minimal harmonised data set should be
collected.  One observes a progressive harmonisation and at least an increasing compatibility
between registration systems for drug users used within traditional and even less traditional services
e.g. low threshold services for methadone distribution or street corner work.  Epidemiological data on
the treatment demands are progressively harmonised but the coverage of the registration systems is
not enough documented : this prevents us from obtaining reliable figures at national level.  Efforts
should be continued in order to make possible general utilisation studies.
An important effort is urgent in order to obtain reliable data.  Comparable data will permit comparison
between the different parts of the country and can also be pooled.  Such data will provide large and
necessary information in order to better define the priority interventions and to make the evaluation of
the numerous initiatives conducted all over the country possible.
There are many interventions as well in prevention as in care activities.  Regarding information and
data, the sources are also increasing.  Co-ordination is necessary for both issues : co-ordination of
interventions and co-ordination of data collection and surveys in order to prevent any counter-
productive competition.  A strategy for the data collection should be defined.
New developments such as Eco-drugs, alco-pops, smart drinks should be surveyed and investigated.
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PART III.  DEMAND REDUCTION INTERVENTIONS
Chapter 8.  Strategies in Demand reduction at National Level
There is no global national drug policy on demand reduction.  Most demand reduction interventions
are set up by the Communities and Regions.  In addition, there are some interventions set up by the
federal government, while several organisations participate in European programmes as well.  Several
organisations in the Flemish, French and German-speaking Communities are involved in European
programmes.  There are ‘Euregio’ and ‘Intereg’ projects involving the provinces of Limburg, Liège,
East- and West- Flanders and Hainaut.  The European Drug Prevention Week (EDPW) was
implemented in different parts of the country.  In Flanders, a co-operation was set up with the
Netherlands, to organise a conference and workshops on the intersectoral and local approach of drug
prevention.
National framework
At the federal level, the ministry of Internal Affairs has set up a number of demand reduction projects
from a crime prevention perspective.  The projects are given to local communes with higher than
average crime statistics.  The projects cover prevention, outreach and treatment objectives.  The local
authorities are responsible for the projects.  The VSPP of the ministry of Internal Affairs is evaluating
them.  Some projects have set up their own structure at the local level and try to fill a gap in prevention
or treatment facilities.  Other projects are integrated in existing health centres.  The projects operate
with annual contracts, which hinder them to develop a long term perspectiveu.
In every province, a medical social low threshold centre (MSOC-MASS) is set up to deal with
problematic drug users.  The centres are located in the major city of each province and provide
methadone, counselling, outreach,…  The centres are financed partly by the federal ministry of Health
and partly by the ministry of Internal Affairs.
The federal ministry of Health also provides support to a number of Therapeutic Communities, Crisis
Centres and Day Centres, which were set up in the seventies and have expanded their capacities
substantially in recent years.  They are recognised on an individual basis.  In the Flemish Community
they are organised into an umbrella organisation (VVBV – Vlaamse Vereniging voor
Behandelingscentra in de Verslaafdenzorg).
At the level of the Communities, the demand reduction structures vary.
Flemish Community
The Flemish government is funding the Vereniging voor Alcohol- en andere Drugproblemen (VAD) as
a co-ordinating agency for demand reduction at a Flemish level.  It is responsible for information,
training, data collection, consultancy and networking at the level of the Flemish community.
                                                
u At present numerous contracts exist with different cities and municipalities to fight against drug-abuse.
In Flanders :
Volets toxicomanie: 11 contracts with cities/municipalities
Plans drogues (prevention-contracts): 10 agreements with cities/municipalities
Plans drogues (outside prevention-contracts):  6 agreements with cities/municipalities
In Wallonia :
Volets toxicomanie: 5 contracts with cities/municipalities
Plans drogues (in form of prevention-contracts): 9 agreements with cities/municipalities
Plans drogues (outside prevention-contracts): 3 agreements with cities/municipalities
In Brussels :
Volets toxicomanie: 6 contracts with cities/municipalities
Plans drogues (in form of prevention-contracts): 1 agreement
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At provincial level, there is a network in every of the 5 Flemish provinces and in Brussels for the co-
ordination of prevention (Provinciale Preventieplatforms- PPP).  The Flemish ministry of Health is
financing a co-ordinator.  For treatment, there are networks in the field of mental health
(Overlegplatforms Geestelijke Gezondheid) in every province, financed by he federal ministry of
Health.
At a regional level, there is a structure of 10 prevention workers, based in centres for mental health.
They are working since 1988 and have created networks and contacts with different sectors in society
(education, youth work, workplace, adult education, welfare sector, leisure sector, …), to empower
them to develop a prevention policy in their setting.
The centres for mental health all provide outpatient treatment for drug users (some are more
specialised and offer more substantial treatment than others).  There are 84 centres in Flanders, yet
through a ‘fusie’ process, their number will be reduced to 24 in the course of the year 2000.  The
centres for mental health care are financed by the Flemish ministry of Health.
Inpatient treatment is offered by psychiatric hospitals and psychiatric wards of general hospitals.
Some of them have a drug specific unit.  The hospitals are financed by the federal government but
recognised by the Flemish Community.
At a local level, there are various projects that operate rather independently.  They deal mainly with
prevention and outreach, some deal with treatment.  These different local projects vary a lot.  Some
are financed by the Ministry of Internal Affairs, others are financed by the local authorities, others are
funded through welfare budgets (SIF), some projects are privately sponsored.  These various local
projects are co-ordinated through the provincial networks.
Organisational framework of PREVENTION in the Flemish community
General public
key persons:    education      youth work        workplace         adult ed.      leisure welfare
Local networks – local drug policy
prevention workers:      regional  local local projects
Provincial networks
Co-ordination level:     VAD VSPP
Government level:  Flemish government  Federal government
Organisational framework of TREATMENT in the Flemish community
 Local projects       MSOC        daycentres         CGG     CIC       TG          PZ/PAAZ
Provincial network for mental health
Co-ordination level: VAD VVBV
Government level:  Federal government   Flemish government
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8.1.  Major strategies and activities
As mentioned before, there are no major national strategies.
In the  Flemish Community, there is a global approach for prevention (see 9.1 for description) and to
a much lesser extend for treatment (as treatment is mainly financed by the federal government).  The
Flemish government has organised its policy through a ‘covenant’ that is signed between the
government and the co-ordinating agency VAD.   A policy plan was developed in which 8 areas of
work were defined to implement a Flemish drug policy 1999-2001.  The plan contains different actions
in each area of work, with indicators for measuring its realisation (evaluation).
The 8 areas of work are:
² Information
² Sensibilisation
² Co-ordination of prevention and treatment
² Representation
² Consultancy and support
² Training and education
² Development of concepts and methods
² Data collection and research
The provincial networks also have a ‘covenant’ with the Flemish government in which their areas of
work are defined to strengthen the Flemish drug policy (the areas are in the field of co-ordination,
implementation of concepts, data collection).
Sectors: the global prevention policy is implemented through the different sectors in society
(education, youth work, workplace, adult education, welfare sector, leisure sector, …).  Key persons in
these sectors are identified and training and consultancy is set up to empower them to develop a
prevention policy in their setting.
At a local level, drug networks are set up to develop a local drug policy with representatives of the
different sectors.
The treatment sector in the Flemish Community has started to organise themselves in the area of
crisis intervention.  Some regions have set up a ‘crisis network’ in which they are organising crisis
interventions.  The networks developed as a result of complaints mainly by police who could not find a
solution for drug users whom they come across during their activities (often during evening hours
when most centres are closed).  These voluntary networks are in an experimental phase in some
regions in Flanders.
Another recent trend in treatment is the setting up of case management and ‘zorgcircuits’ (treatment
networks).  The main aim of these networks is the provision and continuation of care for drug users.
The case manager follows the client during the care ‘traject’.  Different treatment centres in a region
define their treatment and care offer according to the specific needs of this ‘help seeking’ population.
This should result in a co-ordinated treatment network in every region.  This approach has started in
different regions in the Flemish Community, all on an experimental basis.
The Ministry of Health of the French Community has supported 34 drug prevention and research
programmes in 1996-97.  22 services were subsidised for local community approach programmes in
the French Community provinces.  These various programmes focus on drug primary prevention,
health education, leisure time and prevention, key-persons training, prevention by peer groups,
prevention tools construction, etc. Harm reduction activities are supported.  A specific budget for
primary drug prevention in secondary schools of urban areas was given by the federal Ministry of
Internal Affairs and co-managed by the VSPP and the French Community.
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The Ministry of Social Affairs of the Walloon Region supported 27 services involved in drug prevention
programmes, for their activities focusing on welcome, information and orientation of drug users, out-
patient treatment, key-persons training and research.
In Brussels, the support of these activities (22 services) came from the Ministry of the French
Community Commission of Brussels (Cocof).
The German-speaking Community funds a primary prevention project as well as a mental health
centre for secondary and tertiary prevention.  At this place should be mentioned that, for linguistic
reasons, (70,000 inhabitants live in the German-speaking part of Belgium) some people have to be
sent to neighbouring foreign countries, that's to say to Germany and Luxembourg to be treated in their
mother tongue. This is possible thanks to international treaties with this neighbouring countries.
8.2.  Approaches and new developments
8.2.1 New and innovative approaches
² Development of a ‘local drug policy’
² Crisis network
² Circuit of care/case management
² Provision of treatment for inmates: circulaire (2000)
8.2.2 Socio-cultural developments relevant to demand reduction
² Drug use among young people is still on the rise.  Drug use has become part of the youth culture
of different groups of young people.  They experiment with various (legal and illegal) drugs (poly-
drug use).
² Many sectors in society have come to realise that drug use among young people exists and there
is a growing motivation to deal with it.
Common key elements are more and more taken into account for prevention interventions. First,
young people experience real life problems during the critical adolescent period : relational and
psychological problems, such as the difficulty of getting along with their parents.  The quality of
relationships and the importance of dialogue between young people and adults is advocated by the
majority as an essential preventive measure.  It is crucial that young people get greater autonomy and
individual responsibility, which would allow them to deal with the very considerable role of peer
pressure in experience, learning and therefore in dealing with the risk factors due to exposure. No
moral approach is being used, yet each individual should be equipped to make responsible choices.
The co-ordinated initiatives use a broad framework of prevention in which person-focused and
structural interventions are combined.  Long term approaches in which a policy is developed with the
participation of all involved, forms the basis of prevention work.  In recent years, drug prevention is
often integrated as part of a local health policy.  As a matter of fact, the drug topic is often the starting
point to broaden a policy from a local drug policy to a global health policy.  The theoretical frameworks
are derived from international research literature.
With the emergence of HIV infection, AIDS and hepatitis, risk reduction new strategies have been
developed : needles exchange, treatment with substitution substances, distribution of condoms...  The
activities are a.o. undertaken within the security contracts of the Ministry of the Internal Affairs with
local authorities.
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8.2.3 Developments in public opinion
² Outing of ‘Famous People’ (BV- Bekende Vlaming) about their drug use in popular media
² Adults are still worried about drugs: they view drugs as the problem n°1 in national (Flemish)
surveys.
8.2.4 New research findings
² Cocaine research – Dr. Tom De Corte (see Part IV Chap 13 : Key issue Cocaine).
8.2.5 Specific events during the reporting year
² The set up of a federal working group (spring 2000) with representatives of different federal
cabinets (Health, Social Affairs, Interior, Justice) to evaluate the existing drug policy and to
prepare the set up of a ‘Central Drug Cel’ that will develop a national drug strategy.
² Conference : Drug Policy 2000 (Drugbeleid 2000/Gestion des Drogues en 2000) Brussels, 22-23
November 2000 : Annual national conference in which different topics are discussed and
presented from different perspectives (policy, prevention, treatment, repression, international
perspective,...).
² Study day “Ecstasy and harm reduction”.
EUROTOX (umbrella organisation composed of Infor-Drogues, Modus Vivendi and Prospective
Jeunesse) organised a study day (03.12.1999) concerning the new development of the knowledge
about the dangerosity of the ecstasy and the “new synthetic drugs”.  Prevention and harm
reduction (like the pills testing) strategies were also discussed.  Confrontation between the French
and the Dutch approaches were presented by Prof. B. Roques and Prof. P.J. Parquet for France,
and Dr E. Fromberg and Prof. P. Cohen for the Netherlands.
Around hundred professionals, scientists and representatives of Administration and Ministers
participated at this reflection day.
Paper of this event were published by Prospective Jeunesse : “De la prévention des risques aux
risques de la prévention : confrontation et débats sur les drogues de synthèse”, Les Cahiers de
Prospective Jeunesse, Numéro double 1-2, Volume 5, 2000.
8.2.6 Dissimination of information on demand reduction among professionals
(networks, Internet,..)
² In the Flemish Community an EWS-network was set up with partners, to collect information,
rumours about all kinds of illegal drug use (more than designer drugs) and to disseminate
information about new drugs or new ways to use them to the partners of this network.  The
‘DrugLijn’ (helpline) is the turning point of the information collection.
² Today’s multimedia world with many technical possibilities leads to an approach of Europe also to
the sector of fighting against drugs.  For the exchange of information inside and outside national
borders in the sphere of demand reduction, on the European level and under the management of
the EMCCDA, the EDDRA data bank had been developed.  All the projects are saved in a data
pool, so they help to run an efficient information policy and to develop co-ordinated measures
beyond national borders.
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Chapter 9. Intervention areas
9.1.  PREVENTION
9.1.1 Infancy and family
At the level of first childhood, ‘Kind en Gezin’ (Flemish Community) and the 'Office de la Naissance et
de l'Enfance’ – ONE (French Community) organise assistance to parents on healthy living.  A specific
parental training 'Elterntraining' was set up in the German-speaking Community.
Flemish Community
· Leaflets for parents.  Several services provide leaflets on drugprevention and adolescents
specially for parents
· Training programmes for parents
Ouders en drugspakket (three evenings): trainersmanual
Lindestraat 14 (one evening): trainersmanual and video
Both are aimed at parents of adolescents. Many regional and local prevention workers provide
these programmes. The sessions are mostly requested by schools, parent-teacher associations,
various socio-cultural organisations, …  For Lindestraat 14 there's also a train-the-trainer
programme.
· The DrugLine is a telephone information service for all questions or problems relating tot alcohol,
drugs or medicine. On working days from 12 a.m. until 9 p.m. and Saturdays from 3 p.m. until 9
p.m. on number 078/15.10.20.  The DrugLine is not exclusive for parents but a great deal of
parents consult the DrugLine.
French Community
The different organisations recognised by the French Community of Belgium in the field of Health
Promotion are regularly working with parents, mainly in the framework of students parent associations.
9.1.2 School programmes
9.1.2.1 Primary schools
Flemish Community
New programmes :
· ‘Drugpreventieproject’ (municipal police) : voluntary, general (life skills and drugeducation).
Teacher gives 4 lessons, the police gives 1 lesson, meeting with a former drug user in prison.
Parents get information about the project. Productevaluation.
· Schooladoptieproject ‘Doe eens normaal ’ : (=’Schooladoptionproject behave normal) (municipal
police) : voluntary, general (life skills and drugeducation, focus on prevention of criminality).  The
police gives the lessons, the teacher can elaborate some subjects.  Parents get information about
the project.  Productevaluation.
Following programmes are still performed  :
· DONNA / OSER (=’Drugeducation to just say no’) is a new programme for primary schools and
was introduced in 1998, initiated by the federal police (Rijkswacht/Gendarmerie). The programme
consists of lessons given by the teachers and some lessons given by the police in the classroom.
· ‘Gezondheid, je kan er zelf iets aan doen’ (=’Health, you can do something about it’) (VIG VZW
Vlaams Instituut voor Gezondheidspromotie) is a comprehensive health education programme,
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starting from kindergarten and including topics such as health risks, etc.  This programme, which
was initiated in 1985, was updated and revised and this new edition was again introduced to the
primary schools in 1998.
· ‘Contactsleutels’ (De Sleutel VZW) : lifeskills in primary school (8-12 years): manual for
teachers.
· project ‘Verbondenheid’ (=’Joint’) (Katholieke Universiteit Leuven)
· Principes voor drugpreventie in de basisschool (Principles for drugprevention in primary schools)
(VAD VZW).  To co-ordinate the different programmes, which are addressing primary school
teachers and their pupils, the VAD developed a series of general ‘Principles for drug education in
primary schools’.  These principles must form a framework for schools to choose one of the
programmes which are available and that fit best in their pedagogic approach of the school.
French Community
· Teachers' new package to help the primary prevention of drug addiction : in the scope of the
European Drug Prevention Week (November 98), the previous package made for the 94 E.D.P.W
was reactualised and completed by a few new tools.  Distribution of a new teachers' package for
the prevention of drug addiction in primary school intended for teachers in 1400 primary schools
which were not reached during the previous phase in the French Community.
· The new package encloses different documents: theoretical documents (for teachers) : 'Guide de
prévention primaire des toxicomanies à l'usage des enseignants' (Guide to primary prevention
of drug addiction, for teachers) (CCAD, May 1994)
· 'A l'école du risque' (Risks at school) (Prospective Jeunesse, 1992)
· 'Quelques données sur les comportements de consommation des jeunes' (Data on the
consumption patterns of young people) (Promes,1990).
German-speaking Community
· 'Bevor es zu spät ist' (Before it's too late) is addressing primary school teachers.  Various
materials were developed as exercise books: 'Gesünder und bewusster leben ' promotes a more
healthy and self-conscious life and tackles nutrition habits, smoking, life in group, self assurance…,
'Rauchfrei ' is a one-year programme specifically related to smoking.
9.1.2.2 Secondary schools
Flemish Community
New programmes :
· ‘Leefsleutels plus’  (12-15 years), ‘Leefsleutels in actie plus’ (15-18 jaar) en ‘Omgaan met risico’s
plus’ (interactive game for 12-15 years) : programmes for special education (Leefsleutels VZW) :
voluntary, general (life skills and drugeducation), teacher gives the lessons.
Various short programmes (1 day or less) performed by external organisations :
· Projectdagen (=projectdays) (De Sleutel VZW) : information, former drug users relate their
experience and life skills training.
· Forumtheater (De Kiem VZW) (Klap Klap VZW).
· Workshops on groupdynamics (Klap Klap VZW).
· CD-Rom en exhibition  (MJA VZW Jongerenbeweging van de Socialistische Mutualiteiten).
Following programmes are still performed :
· ‘Bevraging van leerlingen in het kader van een Drugbeleid Op School’ (=Questionnaire of
students in connexion with a drug policy in school) (VAD VZW).
In 1998 a new tool was developed for secondary schools, based on the materials that were
developed in the past (since 1994) in a global framework of ‘a drug policy at schools’.  ‘Bevraging
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van de Leerlingen in het kader van een Drugbeleid op school’ is a tool for schools to evaluate
their drug policy.  It consists of a questionnaire, which is addressing all the pupils of the school
and focuses on attitudes towards smoking, drinking and illegal drug use, their actual drug use, the
atmosphere in the school and what the pupils would like to change in the school, their knowledge
and opinions of the school policy towards drugs, etc.  The results are given back to the school
with recommendations towards their prevention activities for pupils, towards working with parents
and the adoption and optimisation of their drug policy.
· Europeers (=peerproject), CAD, Limburg VZW
Europeers is a new project, directed at pupils in their third year of secondary school.  The aims of
the project are to improve the skills of young people concerning conflict resolution, problem
solving, self esteem, to implement these skills in their social life and to transfer these skills to their
peers.  Every school selects two classes, in which the pupils elect two opinion leaders.  These
opinion leaders receive four training weekends about prevention, addiction and the above
mentioned skills.  The opinion leaders then transfer these skills to their classmates.  This project
was first implemented within the framework of the European Drug Prevention Week 1998.
· Groupwork with school attending young people (CAT-Preventiehuis Gent VZW)
The target group are young people who use drugs regularly in their leisure time and who do not
consider this drug use as a personal problem. As a result of their drug use, they have some
problems at school or in their home situation.  The young people are referred by the school health
service.  The group meetings are not therapeutic.  They aim at giving these young people some
tools to empower them to change their individual behaviour.
· ‘Lindestraat 14’ (=parents training programme) (VAD VZW)  manual for trainers and video.
Previous materials developed
· ‘Een drugbeleid op school’ (A drug policy at school): global framework for schools to develop
policy: manuals and training
· ‘Een beleid van tabakspreventie in de schoolomgeving’.  Manual on smoking policy in the schools
· ‘Leefsleutels voor jongeren’: Life skills programme for 12-14 years old, training programme for
teachers, manual, students’ materials
· ‘Als dat niet geweldig is’: video production and manual on alcohol prevention for 14-16 years old
· ‘De Uitdaging’: social skills programme for 16-18 years old: training programme for teachers and
manual
· ‘Sleuteltreinen’: programme for trips with school children: discussions
· ‘Motivational interviewing’: training programme for teachers, school health services to support
experimental drug users in school setting
· ‘Ouders and Drugs pakket’: parents training programme: manual for trainers and newspaper for
parents
· Various other programmes are being used.  An inventory is made to give an overview of all
available materials which can be used in a school setting57.
French Community
The different organisations recognised by the French Community of Belgium in the framework of the
Health Promotion Decree propose counselling, advice, support, information and trainings to the school
workers (teachers, direction, educators, etc.).  One of the mains aim is to engage schools in long term
prevention.  The “Programme quinquennal de la Promotion de la Santé de la Communauté française,
1998-2003” (five years programme) contains the strategies defined for the prevention of drug
addiction.
· The information brochure for students updated in 1998 was reprinted in 1999 because of its
success with youth and adults : “Un autre regard sur les drogues” (Infor-Drogues).
· The different other tools mentioned past years are for the most of them always used.
· New videotape 'La Bande à Simon' produced by the ‘CLAV’ and the related user's guide 'Sur la
Piste de Simon' realized by AVAT (Aide Vervietoise aux Alcooliques et Toxicomanes)
· 'Drôles de Nectars' (strange Nectar) (made by Fondation de France and included in the French
community school package in 1994)
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· 'Des grilles au pays des merveilles' (CCAD, August 1994)
· 'Fichier de jeux et activités' (Play and Activity Pack) (CCAD, August 1994)
· Evaluation - Needs and presentation of needs : video "recreation"
· These tools were created by the CERIS, Faculté des Sciences Psycho-Pédagogiques of the
University of Mons/Hainaut and are based on the "Needs Theory" of Prof. Pourtois.  The first tools
aim to draw a picture of the pupils of the class as a living entity.  The videotape, which is mostly
teacher-oriented aims at focusing on interactions that 'freetimebreaks' create at school and also at
making teachers be aware of their pupils behaviours
· 'Mes amis, mon jardin' (My friends, my garden) promoted by CAPA (Centre d'Actions de
Prévention des Assuétudes), this health promotion/education programme is based on a Canadian
programme which aims at developing good health, oriented behaviour in young people's mind
· 'Génération sans Tabac ' (generation without Tobacco) : realised by the ‘FARES’, is a health
promotion programme especially oriented against tobacco consumption
German-speaking Community
Audio- and videotapes, lessons and other materials were produced for teachers covering the domain
of primary prevention and self-control.  These tools were produced by ASL in collaboration with a
consultant office and  involving contributions from some programmes of Germany.
9.1.3 Youth programmes outside schools
Flemish Community
9.1.3.1 Types, settings of activities
· Support of youth work in working towards prevention of alcohol- and other drugproblems by
following working groups and by developing workshops in youth movements (VVKSM scouting,
KSA-KSJ-VKSJ), youth clubs, youth houses and young people’s services.
· Sensibilisation of sports clubs for alcohol and other drug problems by developing material and by
running a campaign on a provincial level. Within a global approach towards a local alcohol and
drug policy (a project introduced in the European drug prevention week 1998), a new publication
was developed which summarises the global philosophy of drug prevention in sports, the existing
materials and training opportunities and the support systems from within the sector and from
outside, which are available for local trainers. This publication forms part of a series of 9
publications towards 9 different sectors. Within the framework of the campaign posters and leaflets
are developed for sport clubs so that they can show their concern for this topic to the public. For
the trainers of the sports club we developed a manual.
9.1.3.2 Peer-to-peer approaches
· Europeers (CAD) and Jeugdadviseurs (In Petto): training programmes for peer education
approach.
9.1.3.3 Target groups
· Most activities, materials and interventions are developed for youth workers (youth leaders,…) and
trainers of sport clubs, but also for the policymakers in the youth work or the sports.
9.1.3.4 Specific research results, statistics and evaluation results : -.
9.1.3.5 Specific training
· The VAD organised different training weekends for coaches to develop a framework of coaches
in Flanders which is available for local youth workers to support them in the implementation of a
prevention policy and in the intervention phase at times when drug use is detected.
· The VAD is developing a training programme for trainers in the sports club to help them how to
go about with young people drinking alcohol, smoking or taking drugs. It also gives guidelines for
the implementation of a prevention policy.
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9.1.3.6 Existing materials and interventions
· ‘Drugbeleid in jeugdhuizen: hoe deal je ermee?’ drug policy in youth clubs: manual for key
persons in youth clubs to develop a drug policy, ‘Drugbeleid in jeugdbewegingen: hoe deal je
ermee?’  drug policy in youth movements: manual for leaders in youth movement to develop policy
· Training programmes for coaches in youth work, ‘Drugtoestandjes’ exhibition on drug use, ‘Drink
wijs’: exhibition on alcohol prevention, exhibition of the Druglijn (telephone help line),
‘Jeugdadviseurs’: training programme for peer education approach, ‘Drugs, een ramp op kamp’:
drugprevention on youthcamp: manual for monitors, ‘Europeers’: training programme for peer
education approach.
· ‘Hip zonder trip’: a game concerning drug. Active city game for 14-18 years, ‘Grenzen stellen’:
training programme how to handle aggressive behaviour from youngsters, ‘Drugs, maak er (g)een
spel van’: drug prevention on youthcamp: guide including different games, ‘Omgaan met
risico’s’ : prevention package for poorly educated. ‘Leefsleutels in het jeugdwerk’ Life skills
programma, ‘Een lokaal alcohol- en drugbeleid: op elk vlak de juiste aanpak. Het jeugdwerk’,
a publication summarising the philosophy of drug prevention in youth work.  .
· ‘Een lokaal alcohol- en drugbeleid: op elk vlak de juiste aanpak’, a publication summarising the
philosophy of drug prevention in sports, ‘Sport is genot zonder middelen, sport als preventie-
middel’, a manual for trainers.
French Community
· The Health Direction of the French Community produced an information brochure ‘Pour l’amour
du sport’ to increase public awareness about doping.  The target is the adults in charge of young
people practising a sport.  The brochure gives a synthesis of the knowledge about doping and
arguments to refuse it.  It’s a tool to help these adults to prevent the doping by discussing with
young people in a confident relation.  Ministère de la Communauté française, Direction générale de
la santé, “Pour l’amour du sport ” – Brochure d’information et de sensibilisation sur le dopage.  48
pages.  1999.
· 'Tele-Jeunes', a non-specific telephone help line for young people, 24/24 was locally (Liège) set up
between May and November 97.  The aim was to orient young people with drug problems to
specific facilities.  No evaluation has been done.
· The French Community also supported in 96-97 the realisation of a short film called 'No Problemo'
focus on daily life of teenagers.  This film will be useful in the future as prevention support activities
among 17-18 years old adolescents.
German-speaking Community
· Training of adolescents based on the peer-method (youth clubs, youth houses…), primary
prevention trainings for leaders of youth movement, one day-intervention during summer sport
trainings (with French and Flemish translations for participants from these communities).
· 'Zoff dem Stoff' is a free-alcohol intervention programme conducted in a big 'Mega-Disco' dancing
involving 1500-2000 young people in a drug prevention programme. Police and
'Gendarmerie/Rijkswacht'  collaborated.  A three-week exhibition and workshops were organised in
secondary schools before the event.
9.1.4 Community programmes
Flemish Community
· By the end of ’98, the project ‘A local alcohol and drug policy.  Join in!’ was launched.  In 1999
the project was implemented.  Therefore a permanent support system was worked out.  This
support system consists of:
a. people/structures where one can get answers
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The regional prevention workers based in a Centre for Mental Health and local prevention
workers were  available for further support and follow-up with a municipal working group,
made referrals to other agencies in the field of prevention, participated in informative and
educational seminars.
Consultation and co-ordination between these various prevention workers was organised on
the provincial level in the Provincial Prevention Platforms.
b. specific support programme
In each region, a specific support programme was developed, taking into account the local
needs for support.  In concrete terms: training, workshops, coaching, meeting days,… were
organised on a continuous basis.
c.  VAD (the Organisation for Alcohol and other Drug Problems)
VAD brought together the various regional and local prevention workers and the regional co-
ordinators who carry out the project to exchange experiences and to work out further
support.
· To keep the concept of a local alcohol and drug policy alive, the sector brochure ‘A local alcohol
and drug policy : the correct approach in every area’ for the national Police services was added
to the 8 original sector brochures (November 1999).  These brochures give an overview of the
possibilities to work within and between sectors concerning alcohol and drugs.  They also clarify
the role the sector can play in a local alcohol and drug policy.  An overview of the available support
is given as well as the training courses and the materials that are available in Flanders.
French Community
· Local 'drug prevention workshop ' in Tournai, was set up by the municipality in cooperation with
various prevention organisations.
German-speaking Community
· Each community organises staffs of voluntaries coached by community responsibles.  These staffs
carry out actions towards targeted-groups: the type of intervention depends on opportunities.
Indeed ASL was the initiator of a European action involving seven other European regions and
resulting in the set up of such voluntary groups.
9.1.5 Telephone help lines
Flemish Community
· There is one central Flemish helpline ‘De DrugLijn’ which was set up in 1994.  In 1999 the Druglijn
received 12,044 calls, which resulted in 5,814 effective communications. The line is open daily from
12 to 9 p.m., except on Saturday (open 15-21 pm). The telephone call is not charge free, but
people pay for a local call, wherever they call from in Flanders. People call anonymously, and will
not be judged. 25% of the callers are users (alcohol and/or (illicit) drugs), 50% are relatives (mostly
parents). For each DrugLijn-member there is a basic training (3 Saturdays, 5 evenings, a listen-
programme and an exercise-program, and further every 6 weeks a seminar about new trends,
products and telephone-communication.
French Community
· “Infor-Drogues” is the French drug helpline set up in 1971.  Since 1989 the line is open 24 hours a
day, all the year.
The telephone call is not free of charge but since November 2000 the cost of the call is the same
wherever it comes : local call cost.  Infor-Drogues is member of the FESAT (European
Foundation of Drug Helplines) and signed the charter : the service guarantee the anonymity of
the caller and make sure any information taken remains confidential.  Non judgement is a main
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principle.  In 1999, the service received 4.640 calls ; through these calls 8.836 demands were
registered (information 26 %; demands of prevention activity 4 %; advice demands 27 %;
demands of listening 5 %; help demands 30 %; demand of people for the counselling service 5
%; no explicit demand 3 %).  17% of the callers are users, 41 % are relatives (82 % are members
of the family), 13 % are professionals, 17 % “other” persons and 3 % unknown.
The products usually mentioned by the callers are cannabis (38,8 %), heroine (13,3 %), cocaine
(10 %), XTC (7,8 %), alcohol (7,3 %), methadone (6,2 %), medication (5,1 %).  The statistical
report 1999 contains a lot of other data.  The operators are all paid professionals (psychologist
and social workers) with sometimes a long experience of work in the drug field.  Weekly
supervision and intervision are part of the permanent training of the staff.
German-speaking Community
· Special messages were available for two weeks during the Tobacco-day period and during the
EDPW (but without free access).
9.1.6 Mass media campaigns
· No large media campaign were carried out in recent years.  There are interviews and debates in
the media at a regular interval.
Flemish Community
· The Flemish Government organised its second ‘Opkikker’.  This is a mass event for young people
in schools.  In preparation of the event, a call for projects/examples of good practice is being
launched in the schools, in which schools present their approach towards drug prevention.  A
committee studied the projects and selected some 120 schools from which 4000 pupils were
invited to a mass event.  Famous ‘cult figures’ were bringing music, quiz, show, which was highly
valued.  The general message is positive with the slogan: ‘drugfree is better’.  The 1998 edition
was the second version of this event.
· VAD published a new ‘Catalogus’ with an overview of the available materials (leaflets, posters,
gadgets, but also education packs, reports, etc.) at Flemish level.   The materials are targeted at a
general population as well as at specific groups.
· During the European Drug Prevention Week 1998, different initiatives were taken by local
communities (theatre, mass events, …) and by the Flemish government and VAD (press
conference) to get the message across about intersectorial co-operation and local action.  The
slogan :  « talking is the first step », was used by the various organisations to support their
activities.  The activities were concentrated during the week, but attention was given to continuity
and follow up after the week.
French Community
· In the field of health promotion a co-ordinated drug prevention action, between seven partners,
took place during the 3 days French song festival 'Francofolies 96 ' in the city of Spa.
· A great number of representations of the play 'La fleur dont on fait l'Hérov' by the Pocket Theatre
of Brussels took place in a theatre preventive approach.  Each representation was systematically
followed by a debate with the spectators, co-animated by prevention workers and the actors.
· In order to circulate information on the 'Opération Stérifix' (see 10.3.3), a press campaign was
organised in March 1998.  General public's newspapers (Le Matin, la Dernière Heure, la
Lanterne….) as well as specialised journals for pharmacists and GPs (Le Journal du Pharmacien,
Le journal du généraliste,…) agreed to participate and to include this type of information.
                                                
v Héro : based on a confusion between heroes (in French : héros) and heroin (called in French : héro)
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German-speaking Community
· Different campaigns were organised: a one-week campaign in newspapers for the 20th anniversary
of ASL and a press and radio campaign during the European Drug Prevention Week 1998.
9.1.7 Internet Website
Flemish Community
· Prevention
· The website contains the catalogue of VAD-publications. These publications are aimed at the
general public as well as at professional prevention workers (intermediairen?) working with
different target groups (schools, youthwork, labour, social-cultural work, local authorities, …).  An
important chapter of the website is dedicated to our library.
· Dissemination of prevention know-how among professionals:
Apart from the catalogue of publications mentioned above, the website offers an overview of the
training programmes VAD offers for professional prevention workers (going from a basic training
for new prevention workers, to follow-up trainings and master classes). The website also
mentions a page with links to other websites that can be relevant for prevention workers, as well
as a page where the VAD-newsletter can be downloaded.
· Statistics and evaluation results:
At this time, the website only provides statistics on the DrugLijn, the Flemish drug helpline.
However, we plan to extend our website with other statistics and evaluation results in the near
future.
French Community
· The first website of the French Community was opened by Prospective Jeunesse in 1997.  The site
will be updated in 2001.  The target are the users of the Internet and especially the professionals of
school, social helps and care, students and pupils.
The web site contains : information on drugs, the Belgian law, information about the training
activity, their publications, the presentation of the “Cahier de Prospective Jeunesse” (quarterly
publication) with abstracts of the articles and a questionnaire concerning a research about the
ecstasy.  Http://www.prospective-jeunesse.be.
· Infor-Drogues and Modus Vivendi will also open a website in 2000.
9.2.  Is not existing in EMCDDA Report structure
9.3.  Reduction of drug related harm
These issues are developed in Part IV Chapter 15 .3 (Key issue Infectious diseases).
9.3.1 Outreach work
9.3.2 Low threshold services
9.3.3 Prevention of infectious diseases
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9.4.  Treatments
There is an evolution going to:
- a broader offer of shorter treatment programmes
- more substitution programmes
- a broader offer of low threshold help
- more attention to parents (parent groups)
9.4.1 Treatments and Health care at national level
a) Services offered and their characteristics
DETOXIFICATION
· Most detox-programmes are carried out in clinics.  Some are specialised.  Detox is often condition
to enter therapeutic programmes in specialised centres.
INPATIENT TREATMENT
Crisis centres, therapeutic communities and drug centres in psychiatric hospitals are the main
providers of specialised inpatient treatment.
There’s only one specific therapeutical setting for only minors, RKJ-De Sleutel. In other settings
minors are hospitalised in mixed patient groups.
OUTPATIENT TREATMENT
Flemish Community
· Centres for mental health care, day-centres and MSOCs are the main specialised outpatient
treatment centres. In addition, certain non-specialised centres in the health and social welfare
sector are providing care and cure aspects of the treatment process.
French Community
· An assessment survey of the role of the Liège-based drugs reception centre as "an intelligent
signpost" was conducted regarding residential or outpatient orientation 58.  At a preventive level,
the results showed a correlation between the nature of the intervention and the subject of the
request: requests for survival assistance mainly led to interventions either of the outpatient type for
heroin users, or the residential type for people addicted to medical substances.  On the other hand,
requests from families or from the therapeutic sector mainly led to interventions of the
information/prevention type.
German-speaking Community
· Usually outpatient treatments are offered by specialised German centres (Rhenanie-Westphalie).
b) Objectives
Most of the inpatient settings require a drug-free condition starting and during the period of treatment.
The objective of treatment in cure-programmes is staying clean.
Outpatient settings with therapeutical objectives (cure) have less control on using drugs during the
treatment period. Some of them can work with the clients to controlled drinking or drug use.
c) Criteria of admission
There are no uniform criteria of admission. They depend from the setting itself and eventually
agreements with other centres forming part of a network (care-circuit).
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d) Involvement of public health services and GPs
· GENERAL HEALTH CARE
The GP is well placed to detect early  abuse  of psychoactive substances and to vigilance the
continuity of care.  But there are still many GPs who are reluctant to work with the target group
because of feelings of incompetence or the idea that only specialised people can help them. VAD
is working out training modules for this target group. The pilot presentations of 3 modules have
passed. For the module 'How to deal with drug clients in the practice of a general practitioner?' a
video production is being worked out. Collaboration with professionals of inpatient and outpatient
services is still on many aspects problematic. This was revealed in focus group research (Shared
care - VHI Brussels). which this year was followed by a Delphi-study. The results will serve for
creating an education map to increase the competence concerning early detection of alcohol
problems and good collaboration with specialists.
The role of GPs varies according to the regions:  their role in treatment and especially in
substitution treatment is more developed in the French Community.
Flemish Community
GPs have a role to play in drug treatment.  However, their role is not yet clearly defined and their is
no general approach within the primary care setting.
French Community
A network of GP's involved in treatment and assistance to drug users was set up. This GP's
network  called ALTO-SSMG (Société Scientifique de Médecine Générale) is one component of a
larger programme also called ALTO (Alternatives aux Toxicomanies) that is a global programme of
the French Community aiming at the diversification and  the co-ordination of resources of
prevention of damages related to drug addiction.  ALTO provides opportunities for exchanging of
GP's experience in the field of drug use.  The network is structured  and there are  groups in the
different part of the French Community.  An initial objective was to better define the role of GPs.
ALTO participated to the development of the Belgian protocol about substitution methadone
treatment.  ALTO GP's also participated in a study on drug and AIDS.
e) Co-ordination between public health services and other community drug services : -.
f) Special services : -.
g) Financing
Financing sources are diverse and the finance structure is complicated.
- The centres forming part of VVBV (daycentres, TG’s, MSOC’s) have a RIZIV-convention
(revalidation), except RKJ-De Sleutel (minors) who is financed by the sector special youth
care.
- The Centres for mental health (CGG) are financed by the Flemish community (department
of health)
- The psychiatric hospitals and the psychiatric wards of a general hospital (PAAZ) are
financed by the federal government.
Clients and patients have to be in order with their social security for getting help in private settings. For
people who are not, there exist a few of public hospitals (OCMW). They may also enter in Transit
Brussels where they get help and are stimulated to arrange their social security.
h) Statistics and evaluation results
i) Specific training
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For workers in the field of drug care and cure is extra education provided, realised by three
organisations for the Flemish part of the country. They have the choice between short courses on
specific topics or a three year course to ‘drug worker’.
9.4.2 Substitution and maintenance programmes
In Belgium, methadone programmes are still waiting for a legal basis to broader operate.
Flemish Community
· Many centres and GPs provide methadone to drug users.
French Community
· R.A.T. (Réseau d’Assistance des Toxicomanes - Assistance Network for Drug Addicts) :
methadone substitution therapy by a group of doctors in Brussels. A first evaluation survey of the
outcome of treated patients suggested a spectacular improvement in the index of severity during
the first six months, which was then stabilised 59.  Over a maximum period of two and a half years,
it would appear that nearly 50% of patients totally abstained from heroin.
German-speaking Community
· Methadone substitution is offered to some drug users under the control of SPZ (psycho-social
centre).
9.5.     AFTER-CARE AND RE-INTEGRATION
Flemish Community
· Therapeutic communities have their halfway houses. Aftercare is also organised in ‘Beschut of
begeleid wonen’ projects and taken up by outpatient health care provisions.
· Services offerd are: special assistance for finding a job or education and/or lodgement, advise to
older drug users and their families.
9.6.  Interventions in the Criminal Justice System
From 1998 to 1999, in the number of people questioned by police services for crimes linked to abuse
of cannabis has risen by 20%. The age of the offenders is constantly decreasing. Many of them are
between 12 and 15.
The central medical service of the penitentiary administration has just changed its name. It is called
now the " Penitentiary Health Service ".
Since 1998, medical services are undergoing major reorganisation : the authorities take into account
the advice of the Council of Europe.
In penitentiaries, the situation varies from one prison to another with the local management,
experience, investments in health care personnel and the way the health care services are organised.
A drug monitoring group was created in 1998 to develop an action programme. This became a
necessity after they had to state the use of drugs by 50 prisoners at the time they were actually jailed.
The programme has not yet been finalised.
a) Interventions
v Medical (detoxification, drug substitution)
· Most drug addicted prisoners are lodged in the psychiatric departments, which exist in eleven
prisons. Generally treatment consists of gradual detoxification with the help of methadone, except
for pregnant women and people jailed for short periods of time.
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· The interruption of substitution treatments in effect at the time of arrest is still an unresolved
problem.
· Gradually more and more specialised external services are intervening to offer and organise aid
(and subsequent follow-up) for drug addicted prisoners.
v Drug-free programmes
· So-called drug-free sections are in an experimental phase but their future is still uncertain.
· 
v Self-help groups
· Educational programmes for drug users are offered by drug helpers to experimenting and
advanced drug users who are referred from justice.
The current education programmes vary in aim, target group and duration. Increase the awareness
of their drug behaviour and other choices in life is a very common goal of these programmes.
These groups can be mixed with drug users referred from schools or mental health centres.
v Relapse prevention
· A note of the Ministry of Justice in the year 2000 specifies that drug addicted prisoners have the
right to the same care, guidance and, if necessary, the same therapy as free citizens. This note is
based on three main principles: no interruption in the treatment; in the case of treatment, continuity
should be ensured in the same way; similar care outside of penitentiaries and within them.  This
note opens the possibility to the temporary liberation of drug addicted prisoners in order to give
them adapted treatment and/or guidance. This liberation implies a series of conditions.
· 
v HIV/Hepatitis prevention (needles and syringe exchange)
· The Minister of Justice is the only competent authority regarding health in general, and prevention
and assistance of prisoners with AIDS or HIV infection in penitentiary system.  There is neither
prevention policy nor AIDS/HIV prevention programme.  Essentially thanks to the initiatives of
NGO's, and where there is good collaboration with prison authorities, local AIDS/HIV prevention
actions exist in prisons.
The Law of November 17th, 1998 allows the exchange of syringes and needles outside the
pharmaceutical sector. Today there are no distribution or exchange programmes for syringes within
the penitentiary institutions.
b) Drug testing : -.
c) Release: referral to treatment, aftercare, probation
See Part I  1 1.2.2.b.
‘Therapeutical advice’ is a method of early detection in which police services offer drug users, who
are arrested, the possibility to present themselves in a Centre for Mental Health Care for one or
more exploring conversations. In this way problems with drug use or other problematic life fields
can be detected earlier and can be followed by psychotherapeutical sessions. In this way the drug
user is stimulated to reflect about his drug use, and he has made acquaintance with a care service
so that he knows the way for asking help if it should be needed in the future.
Because the number of Centres for Mental Health Care who offers ‘Therapeutical advice’ was
increasing and there was growing a variation of different applications of this method, coordination
was needed. In 1998 started an ad hoc work group with helpers of these Centres for Mental Health
Care to create a blue print of the method in order to create more uniformisation and to offer a
comprehensive manual for those Centres for Mental Health Care who like to start with the method
too. This work group is still going on.
d) Statistics and evaluation results : -.
e) Specific training
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· Training programmes have been organised for penitentiary officials on the following topics: drug
addiction, drugs, hepatitis. It is nevertheless difficult to apply public health criteria in an
environment that remains dominated by the dogma of security, punishment and social control.
There are real problems in coordinating the various internal services of the prisons (on one hand,
the medical service, on the other, the psycho-social service); coordinating internal and external
services is also difficult, especially when the number of external services increases; this kind of a
situation leads to problems if you want to establish an efficient and consistent health policy, despite
the willingness of the participants.
The law of March 16th, 1999, organises the control of motor vehicle drivers under the influence of
drugs.  A training for police services has been organised for this purpose.
Flemish Community
· There are some pilot projects of drug free departments in prisons.  A training programme for
guards and prison personnel is realised.
 French Community
· In co-operation with the prison authorities of St-Gilles, a specialised prevention team has set up,
during the past year, a prison section 'Primary Day'.  The aims of this treatment programme were
to combat relapse offence behaviour among primary prisoners, drug addict or not, in fact people
who are for the first time in prison for a period longer than six months.  This programme works to
promote a better rehabilitation in co-operation with outside specialised workers and the prison'
personnel.  Psycho-social counselling is provided by a specialised social worker.
· TIMC (Toxicomanies et Interventions en Milieu Carcéral) is an EC collaborative network involving
participants from Belgium, France, Luxemburg and The Netherlands 60.  Its aim is to create
exchanges about drug use in prison and particularly focusing on the role of penitentiary workers
and other workers outside of the prisons.  Training of penitentiary workers is one main operational
achievement.   A drug use surveillance system started in 1997 in participating prisons.  Data are
monthly transmitted by fax to a co-ordination centre (Verviers/Nancy).
9.7.    SPECIFIC TARGETS AND SETTINGS
9.7.1 GENDER SPECIFIC ISSUES
Flemish Community
· There is one project in a therapeutic community (De Kiem) for pregnant women and women with
children.
9.7.2 PARENTHOOD AND DRUG USE - CHILDREN OF DRUG USERS
· Early interventions among children
At the level of first childhood, ‘Kind en Gezin’ (Flemish Community) and the 'Office de la
Naissance et de l'Enfance – ONE (French Community) organise assistance to parents on healthy
living.  A specific parental training 'Elterntraining' was set up in the German-speaking
Community.
Flemish Community
· Few centres are specialised in parental drug use.  There is one outpatient centre (Free Clinic) and
a new project in a therapeutic community (De Kiem): pregnant women and women with children.
· In two Centres of Mental Health Care a project for children of parents with psychological/psychiatric
problems (KOPP-project) is worked out to avoid or decrease psychological/social problems with
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the children. It is not a drug specific initiative but even children of drug or alcohol misusing parents
can be helped.
French Community
· Substitution programme for pregnant women : a young pregnant heroine addict women programme
was set up in Tournai besides the classic methadone program.  The acceptance in this programme
is subordinate to acceptance of criteria proposed by a 3 professionals team : a medical doctor, a
psychologist and a social worker.  Individual and family counselling help to take the decision.  This
programme is not yet evaluated.
· The previous programme "Treatment and rehabilitation for parents who are drug users" included :
counselling and methadone maintenance, parents groups, social, cultural and sporting activities.
To implement this program, a psychotherapist and a rehabilitation professional completes the team
to develop this programme inside of the prisons.  The intervention allowed specific actions on harm
reduction in women, pregnant and/or young mothers.
· A permanent workshop between several services and a GP's Network (ALTO-SSMG) oriented
their reflections on the methodology for tackling the consecutive problems about 'parenthood and
drug consumption'.  The aim is to try to keep children safe even if the parents are drug consumers.
9.7.3 PARENTS OF DRUG USERS
Flemish Community
· There are parents’ groups for parents of addicts and parents of experimental drug users. 'Ouders
& Drugspakket ' en ‘Lindestraat 14’ are prevention programmes for parents with adolescents (but
not problematic drug users) developed by VAD.
French Community
· A programme for provision of a help to parents of drug users has been initiated during the past
year.
9.7.4 DRUG USE AT THE WORKPLACE
Flemish Community
· There is a long tradition in developing prevention programmes in the workplace.  Alcohol problems
form the major problems.  Prevention programmes include the development of a policy and early
intervention programmes. There is a growing interest in other drug problems (illicit drugs and
medication).  More and more public enterprises are willing to develop such policies.
· A new publication was developed about legal issues concerning the use and abuse of alcohol and
other drugs at the workplace.
Within a global approach towards a local alcohol and drug policy (a project introduced in the
European drug prevention week 1998), a new publication was developed which summarises the
global philosophy of drug prevention in the workplace, the existing materials and training
opportunities and the support systems from within the sector and from outside, which are
available for this sector.  This publication forms part of a series of  8 publications towards 8
different sectors.
· Training programmes (for company doctors, nurses, social workers and supervisors) are available.
French Community
· There are programmes to prevent and manage alcohol abuse at the work place.  PAE (Prévention
Alcool Entreprise) is a pluri-disciplinaire team (university hospital and other specialists) offering
support for global and collaborative prevention and  management of alcohol problems at the work
place.
German-speaking Community
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· There are programmes to prevent and fight alcohol abuse at the work place.
9.7.5 ETHNIC MINORITIES
No information collected.
9.7.6 SELF-HELP GROUPS
Flemish Community
· There are many self help groups in Flanders.  Most are dealing with alcohol and medication
problems (AA-types). There are parents’ groups (for parents of addicts and parents of occasional
drug users), there is a junkie group (DEBED) and a Cannabis bond.
German-speaking Community
One group of parents of drug users exists as well as groups oriented to alcohol problems and
medicine addictions (AA approach).
9.7.7 GROUPS EXPERIMENTING WITH DRUGS
Flemish Community
· Educational group sessions can be organised for young experimental drug users to increase  the
awareness of their drug behaviour and other choices in their life. Participants are transferred by
schools, justice or mental health care centres. The trainer map ‘Working with a group of young
users’ including methods and exercises adapted for use in the Flemish community, VAD
developed for external workers in the field (1998), is in use. An evaluation questionnaire to gain
feedback from the trainers is made but results are not yet available.
French Community
· DELTA communities approach as low threshold programme is addressed to drug users, principally
who injected.  This programme is currently evaluated.
9.7.8 OTHER ACTIVITIES
Regular actions on alcohol and driving  are carried out at the national level especially during the
New Year period.  The 'Bob' system (at least one people identified before the feast who will not get
any alcohol-drink and who will drive when coming-back home) and free-alcohol drinks,… are
promoted through media campaigns.
Flemish Community
· Programmes for special youth care have been developed in recent years. A policy for the centres
for special youth care as well as training programmes for the personnel have been developed. A
training programme for trainers to provide continuous training in this sector and a manual were
developed.
· Courses on drinking and driving were provided.
German-speaking Community
· Special actions on alcohol and driving during the Carnival time including promotion of the 'Bob'
system, promotion of free-alcohol drinks,… and actions in secondary schools were organised.
Belgian National Report on Drugs 2000 - Belgian Information Reitox Network 106
Chapter 10. Quality Assurance
10.1.  Quality assurance procedures
a) Formal requirements for quality assurance : -.
b) Criteria and instruments applied in quality assurance : -.
10.2.  Treatment and prevention evaluation
10.2.1 Treatment and prevention evaluation
The following information is related to prevention evaluation only.
a) Evaluation policy
Prevention activities are rarely evaluated (mainly process evaluation) and yet there is a growing
demand for data that can prove the efficiency of prevention.  For many years, prevention workers have
been devoting great efforts to implement education and prevention programmes.  Of course, they aim
to make these as effective as possible.  Evaluations that have been carried out show that in general
the effects achieved by the prevention programmes appear rather insufficient and that in certain cases
their effects are even counter-productive.  Very often, however, the end result is a mixture of positive
and negative effects 61.
The limited budgetary resources allocated to the activities geared towards reducing demand, the
consequent lack of time of involved people, the lack of coherent long-term planning and the difficulty
involved in co-ordinating at the different levels (local, provincial, Community or federal) are certainly
not unconnected with this.
Nevertheless context evaluations, evaluations of implementation and process evaluations are
sometimes carried out. Unfortunately very little reporting of the results is being done.  Interviews with
key persons involved in the implementation of the programmes, questionnaires, pilot sessions, check
lists and group discussions are the most commonly used methods.
Initiatives should be stimulated to evaluate the functioning of various networks.  In this field, scientific
evaluation models often lack.
Some people stress that there is a dangerous pitfall in this general demand for evaluation results.
Since the nature of drug prevention is complex, it is very difficult to prove, whether and how, single or
a series of activities have affected non-use or non-problematic use of drugs.  While a multisectorial
approach for prevention is promoted, studies to evaluate the outcome of these strategies are hard to
conduct.
b) Requirements for evaluation (e.g. for funding) and d) Evaluation training
VAD has started the development of a series of instruments to evaluate the practice of training and
consultancy by fieldworkers themselves.  In a first phase, a limited instrument will be linked to the
registration programme for prevention activities.  More instruments will be developed and training will
be carried out to support field workers in using the instruments (2000-2001).
c) Use of evaluation results : -.
10.3.  Research
a) Demand reduction research projects: objectives, structure and organisation
Research on drug policy is available only on a limited scale. Economical research has not been
carried out.  At best, the subject has been dealt with as a minor part of research design.
Some results presented in this report have been extracted from various researches conducted in the
different part of the country and/or at a European collaborative level.  As example, public health
schools of French Community universities have participated in epidemiological researches focus on
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health behaviours among young people and in the multi-city study (Liège) of the Pompidou Group
(Council of Europe).
At national level, the research priorities are e.g. :
- to investigate why people take drugs
- to initiate evaluation research of treatments
- not  to limit research and policy only to illicit drugs.
b) Relations between research and drug services : -.
c) Funding of demand reduction research : -.
d) Training in demand reduction research : -.
10.4.  Training for professionals
a) Training in quality assurance and evaluation: type and structures : -.
Flemish Community
Training for teachers and guidance centres :
· New programmes :
- ‘Leefsleutels voor jongeren plus’ (life skills for adolescents in special education) (Leefsleutels
VZW) :
training for teachers
- ‘Aan de slag met de leerlingenbevraging’ (=’Get to work with the questionnaire of students in
connexion with a drug policy at school’) (VAD in co-operation with regional preventionworkers) :
training programme for principals and school personnel to use the results of the questionnaire to
optimise the drug policy in the school.
· Following programmes are still performed :
- ‘Contactsleutels’ (=life skills) (De Sleutel VZW)
- ‘Drug policy in schools’ (VAD in co-operation with regional preventionworkers)
- ‘Leefsleutels voor Jongeren’ en ‘Leefsleutels in actie’ (life skills) (Leefsleutels VZW)
- ‘Training for school health personnel’ (VAD in co-operation with regional preventionworkers)
- ‘Training programmes for parents’ (VAD in co-operation with regional preventionworkers)
French Community
Various awareness campaigns are organised by centres working in prevention or treatment for social
workers, physicians, psychiatrists, teachers, instructors.
· Training for Social Workers
This training was launched in the region of Liège in order to get in touch through them with the
target groups that are usually not readily accessible. This training tackles with the theme of Harm
Reduction by proposing a psychodynamic approach of the drug phenomenon.  An evaluation of the
results was performed.
· Antares
Antares is both a teaching and an support programme whose aim is the secondary prevention of
dependencies at school.  It is a voluntary Health Promotion programme especially oriented at drugs
and that started this year in the area of Charleroi.  It includes Teacher Training, drawing up some
guidelines to work out prevention policies within the education field, and supporting those actions
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taken. The project’s main aim is to allow and help secondary schools to deal with delicate
situations related to drug use.
The Antares programme objectives are as follows : to help the institution and its manpower to
define their values and limits, to enhance communication and encourage feelings expression, to set
up a consistency within the school and to arouse a collaboration with some drug field professionals,
to make up a shift team that will work as an intermediate with regard to the prevention actions that
will be performed.
This programme is also about giving the education team some help in making an accurate decision
in case of a consumer discovered in the school, and so avoiding as well to delegate the problem
systematically by handing it over to specialists only.  The two Antares responsible persons (one
has a degree in Law and the other one in Clinical Psychology) offer an analysis of both practice
and policy prevention that go on within the school. They help in clarifying the request or the
situation, in refining an existing prevention action or in working out a project, and they also give
some support in the implementation and the evaluation of it.
· Prison team training
In 1996-97, a programme of Quality Insurance was launched. It includes three training parts in the
drug field.  Firstly, the prison teams training of the prisons of St Gilles and Forest (Brussels).
Secondly, the prison’s psychologists and nurses’ training in the prisons of the French Community.
Thirdly, the prison’s teams training in the GERRMM’s frame.  It’s an exchange group of teams, like
scolarship trainee, between diverse prisons of the axe Rhin-Meuse-Moselle.  This programme
concerns the prisons of Verviers, Lantin, Tongres, Hasselt (for Belgium), Strasbourg, Metz, Nancy
(for France) and Maastricht (for The Netherlands).  The Brussels co-operation to this network has
extended in 1996-97 with the prison of St-Gilles.
German-speaking Community
ASL provide training aiming to get the skills and the necessary background to conduct in a good way
primary prevention actions: they are offered to community voluntaries and to teachers of the primary
and the secondary schools.
The training 'Ecole de prévention' was organised from January to April 1997:  "Comment gérer une
dépendance ?, Comment gérer la relation avec les dépendants ?" (how to manage an addiction? How
to manage addicts ?).  Five types of addiction were tackled.
b) University training, non-university vocational training, in-service training
French Community
Two universities are developing their post-graduate courses :
- Université de Liège (Ecole de santé publique) : Degree in public health science & drug addiction (3
years)
- Université de Mons (Faculté des sciences psychologiques) : Post-graduate in consciousness
modification & drug addiction (1 year).
c) Statistics and evaluation results : -.
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Chapter 11. Conclusions : future trends
In Belgium, prevention is becoming more and more organised.  Treatment and prevention activities
are being developed in various sectors mostly based on a local approach.  Initiatives are taken by the
sectors themselves, supported by prevention experts.  Participation and emancipation are central.
The organisation of demand reduction activities is improving.  Co-ordination at all levels is
developing.  Networks are set up to co-ordinate the different activities in the sectors.  For prevention :
development of local policy, set up of local networks with key persons of different sectors,
implementation of local actions.  For treatment: development of networks for crisis intervention and co-
ordination of care at local/regional level.  There are co-ordination structures that support the local level
with training, materials and registration.
The reduction in the demand for drugs, whether or not they are socially accepted, includes the various
approaches which range from general educational prevention to various specific modalities with
regard to information, counselling, guidance, care, treatment and after-treatment.
Parents, teachers, monitors of sport clubs or youth movements can work with young people towards
educational prevention which will encourage communication between adults and young people, and
which will give them the tools and the means to efficiently resolve the conflicts or problems
encountered in everyday life.  This education will also teach them how to manage anxiety and stress
and will help them to develop their critical faculties and their creativity.  It will help them learn to resist
peer pressure and the onslaught of advertising, the model of addiction par excellence.  These “primary
addiction prevention” activities must be part of an ongoing process.  It is a long-term process which
will develop social skills.
Psychosocial workers and health workers who work in the various health centres, psycho-medico-
social centres, school medical inspection centres, guidance centres or specialised mental health care
services contribute to the development of general or specific programmes.  Their interventions,
whether ad hoc or long-term, should preferably be geared towards the accompaniment and guidance
of natural intermediaries such as parents, teachers, etc.
A number of new concepts, based on the needs from the field workers, are under preparation :
children of alcoholics, drug users with young children, prevention and treatment for migrants,
gambling.
It is important to promote varied initiatives among populations at risk, other than among young people
as a whole.  All the initiatives undertaken to combat social exclusion, marginalisation and even crime
will reduce drug-related risks. The co-operation of social workers and of young people themselves will
be particularly beneficial in the context of this type of prevention through specific initiatives that are
gradually set up in the country.
There is a growing demand for evaluation of prevention and treatment.  At present, most attention
is given to quantitative indicators, which are very limited for evaluation (it mainly gives an indication of
the number of activities; it concerns more monitoring than evaluation) although qualitative indicators
are also being identified and tools are being developed to evaluate mainly in the field of prevention.
There is a growing demand for an evidence-based approach towards prevention and treatment.
More research is needed into causal factors, trends in drug use, characteristics of groups of users, …
A tailor made approach for specific target groups, based on research findings, is necessary for
different aspects of the drug problem.
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PART IV.  KEY ISSUES
Chapter 12. Drug Strategies in European Union Member States
12.1.  National policies and strategies
In 2000, an inter-ministerial working group was set up in order to re-design the drug policy in Belgium.
The group is coordinated by the federal Minister of Health and involves the federal Ministers of Justice
and of Internal Affairs : this group works in close collaboration with Community and Region Ministers.
The proposals for a new drug plan will be submitted by the federal government at the end of the year
2000.
Up to now, at federal level, more than a real global strategy, one should talk about a global philosophy
(see112c).
The current outline of the policy are based on the work of a federal parliamentary group that was set
up in 1996 to study the drug problem, in particular the situation of soft drugs.  Many experts from the
field of prevention, treatment and repression were heard.  The conclusions of this working group have
been adopted by the Parliament in June 1997.
Between an approach strictly repressive and a tolerance policy, a third way should exist, called
'normalisation' policy.  The three main tools of the drug policy are prevention, treatment and
repression.  The priorities are as follows :
7. to prevent and reduce drug use and particularly to reduce the number of new drug users
8. to offer a large panel of treatment methods and to guarantee to drug users a better quality of life
despite their drug use
9. to protect the community and its members who are facing the drug phenomenon and its
consequences
10. to consider the judicial approach, particularly imprisonment, as an 'ultimum remedium'.
Action plan in different fields
At political level
Given the federal structure of Belgium, the co-ordination of the different departments involved in the
drug issue required an interministerial conference (around 15 different cabinets).  There are a lot of
key actors on the one hand at  federal level : the ministry of Justice, the ministry of Foreign Affairs, the
ministry of Internal Affairs and the ministry of Social Affairs and Public Health, and on the other hand
at federate levels : the communities and regional governments (Flemish, French and German-
speaking Communities, Brussels-Capital Region).  Different departments have their own policy papers
and documents.
It is the objective of the interministerial current working group initiated by the Minister of Health in 2000
to re-design the drug policy and to co-ordinate the approaches of the various governments (federal,
Communities, Regions) and their ministers.
At justice level :
The aspects of repression and supply reduction are an exclusive federal competence. The
ministry of Foreign Affairs is the main responsible.  Regarding drug users, the approach is
avoiding that drug users who, apart from possessing drugs, committed no other infringement, get into
prison; the judicial approach, particularly imprisonment, should be the 'ultimum remedium' in order to
deal with problematic use of drug.
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In January 2000, the Belgian government and the Minister of Justice circulated a 'federal plan for
security and for penitentiary policy (the extended version of the text is available on the ministry of
Justice's web site w).  Some issues of the plan are dedicated to drug related matters.  The specific
objective is defined as 'to limit the public nuisances and the criminality related to the drug market and
traffic'.  More there is a obvious willingness to develop diversion to treatment and alternative measures
and to make easier the links between the judicial system and the health care system.
Demand reduction level
There is no global national drug policy on demand reduction.  Most prevention interventions are set up
by the Communities and Regions.  In addition, there are some interventions set up by the federal
government : demand reduction projects from a crime prevention perspective, medical social low
threshold centres (MSOC-MASS), support to a number of Therapeutic Communities, Crisis Centres
and Day Centres…
For information on the drug Policy of the Flemish Community Government  : see Part I 1.1.3.c.
12.2.  Application of national strategies
a) Organisational framework
FEDERAL GOVERNMENT
MINISTRY FOR FOREIGN AFFAIRS
The ministry for Foreign Affairs is in charge of international relationships.  Meanwhile relationships to
some organisations (UNDCP for example) were delegated to the ministry of Justice.
MINISTRY OF JUSTICE
By virtue of the mandate given in the context of national co-ordinators of the European Union and
Article 17 of the United Nations Convention of 1961, the Justice Department presides a co-operation
between the competent departments of federal and federate levels (Communities) and among the
police departments, regarding the reduction of supply and repression in the framework of international
relations.
The ministry of Justice funds training projects for prison personnel.  Health service in prison
(prevention and treatment activities including their funding) is the competence of the prison/justice
administration (health policies of the ministry of Health are not in force).
MINISTRY OF FINANCE
Customs is charged to control all imports including illicit ones (actually a large part of seizures are
performed by customs).
MINISTRY OF INTERNAL AFFAIRS
The ministry of Internal Affairs is co-ordinating (via the VSPP) projects in the framework of crime
prevention. The VSPP, which is a federal governmental administration created in 1993, is in charge of
the analysis and the follow-up of these projects.  In these projects, the municipalities decide upon
policies and strategies.
The VSSP also forms prevention professionals and assists them in their work. It mainly concerns the
prevention of criminality, using the most creative and efficient techniques.
A transit centre and the MASS/MSOC were created thanks to funds from the ministry and from the
INAMI/RIZIV.
The 'Gendarmerie/Rijkswacht' set up a specific Drug Programme in the framework of its Bureau
Central de Recherches / Centraal Bureau voor Opsporing (Central Office for Investigation).  This
                                                
w Ministry of Justice site : http://www.just.fgov.be/html/nb2.htm   in Dutch  or
http://www.just.fgov.be/html/fb2.htm   in French.
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programme covers the following domains: prevention, drug and road traffic, local traffic and drug
tourism, international traffic organisations, drug production (laboratories), international co-operation
(Europol, Pompidou groups).
COORDINATION BETWEEN POLICE DEPARTMENTS (ministry of Justice and ministry of Internal
Affairs)
A new legal framework (police law of 7/12/1998) lead to a uniform police on 01.01.2001.  The aim of
the reform is the improvement of the efficiency of-, collaboration and co-ordination between the police
services and particularly to ensure a better dissemination of and access to information.  Indeed
dissemination of information and access to the right information has been sometimes prevented by the
existence of different police services differently organised and controlled by different authorities.
Up to end 2000, the 'Police Judiciaire/Gerechtelijke Politie' was controlled by the judicial authorities
and the Minister of Justice;  The 'Gendarmerie/Rijkswacht' was under the authority of the Minister of
Internal Affairs. The “Police Judiciaire/Gerechtelijke Politie” and the 'Gendarmerie/Rijkswacht' were
competent on the whole territory.  In so far as keeping law and order, and crime prevention are
concerned, the 'Gendarmerie/Rijkswacht' acted under the supervision of the Minister of Internal
Affairs.  With regards to repression, the 'Gendarmerie/Rijkswacht' reported to the judicial authorities
and the Minister of Justice.  The 589 Belgian municipalities all had their own police force under the
authority of the municipality mayor, and under the orders of a chief of police. To a certain extent, the
SGAP/APSD (Service Général d’Appui Policier / Algemene PolitieSteunDienst) which run the central
offices of Interpol, Europol and Schengen in Belgium, centralised data and documents communicated
by all the local police forces, the 'Police Judiciaire/Gerechtelijke Politie', the 'Gendarmerie/Rijkswacht',
the Department of Economic Affairs and the customs.
MINISTRY FOR  SOCIAL AFFAIRS, PUBLIC HEALTH AND ENVIRONMENT
By the terms of the international conventions, the administration charged with the control of licit trade
is the Department of Narcotic Drug of the General Pharmaceutical Inspectorate x (ministry of Public
Health) (art. 18,1d of the Single Convention (1961) as such as modified by the protocol 72 (1972), art.
16,2 of the Convention on psychotropic substances (1971) and UN convention on illicit traffic in
narcotic drugs and psychotropic substances (precursors) (1988)).
In the context of the preparation of meetings for the Pompidou Group, co-ordination meetings are held
by the Permanent Correspondent from the ministry of Public Health.
The ministry of Social Affairs funds treatment centres. The Belgian Focal Point of the EMCDDA is
located at the IPH (the scientific research institute of the ministry of Public Health) and is funded and
managed in collaboration with the Communities and the federal ministries.
Flemish Community
Flemish Minister of Health
The Minister of Health of the Flemish Community has the competence in the field of drug prevention
policy.  At the end of 1995 a drug policy paper (Drugnota) within the general policy of health and
health promotion was presented.  The programme runs for three years (till October 1999) and consists
of seven actions: development of a uniform registration system in treatment and in prevention, training
of prevention workers, training of key persons in relevant sectors, provincial co-operation, regional
networking in treatment and a major event for secondary school children (de Opkikker).
The co-ordination of the prevention activities is given to VAD (operating within a broader framework of
the Flemish Institute of Health Promotion (VIG)).  The main task of VAD is to co-ordinate and support
the many structures, workers and projects at provincial, regional and local level.  VAD is the Sub-Focal
Point for the Flemish Community.
For all prevention activities taking place in education, a Commission is installed within the Flemish
Education Council (VLOR).  The Minister of Education and the Minister of Health are represented.
                                                
x Ministère de la Santé publique, Service des stupéfiants de l’Inspection générale de la pharmacie / Minister voor
Volksgezondheid, Departement verdovende middelen van de Algemene pharmaceutische inspectie.
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The Flemish Government decided in 1998 to implement a 'participatory risk-analysis' in education.
VAD developed a questionnaire for pupils aged 12-18 to evaluate existing drug policy in school.  After
a pilot phase, this questionnaire became a major project in secondary schools.
During the second half of 1998, the Flemish Government developed a policy plan with VAD, which
outlines the drug policy for the next 3 years.  At the end of 1998 a 'agreement' was signed between
the Minister of Health and VAD, which became the organisation responsible for the development of a
Flemish drug policy.
For the treatment sector, the role of the Flemish Minister of health depends on the agreements
between the federal government and the Communities.  The Flemish ministry subsidises the centres
for mental health, in which out-patient treatment is organised.  As for psychiatric hospitals, there is a
joint competence between the federal and community level.
At the provincial level, prevention platforms are set up by the provinces, with the financial support of
the Flemish ministry of Health.
In addition, these provincial prevention platforms and the platforms for mental health are stimulated to
formulate joint projects in which prevention and treatment at a provincial level are being linked.  Each
province can get a financial support for these projects.
At a regional level, 'LOGO's' were created in 1998 (per region of approx. 250,000 inhabitants) for the
implementation of Flemish health targets.  Drug problems are not among the five priority targets for
1999-2002.
At the local level, prevention initiatives are the responsibility of the municipalities and cities, with the
financial support of the federal ministry of Internal Affairs.
French Community
French Minister of Health
Since 1995, the French Community's health authorities are competent for health promotion policy.  A
new Decree, taken on the 14th of July 1997, reforms and reorganises the structure of health
promotion in the Community.  Drug prevention - sense largo - will be a part of the next five years
programme and the Community Plan. Its action focuses mainly on primary prevention.
The previous Decree - November 1988 - of the French Community recognised several structures as
"thematic service to the educators".  As umbrella organisation, CCAD is co-ordinating drug prevention
activities and carries out the collection of epidemiological data related to addictions and psychotropic
products consumption.
As "service to the educators", CCAD gives scientific and logistic support to the field workers and
services involved in primary prevention of alcohol and drug problems.
At the present time, negotiations are going on to adapt the missions of the CCAD in the terms of the
new Decree.  A temporary agreement was accorded to the CCAD till the end of August 1998.
The French Community delegated to the Walloon Region and to the French Community Commission
of Brussels its competencies regarding the levels of secondary and third prevention and regarding
outpatient treatment, rehabilitation, re-socialisation and harm reduction policies.
The Sub-Focal Point for the French Community was CCAD until August 2000 and EUROTOX since.
Brussels-Capital Region
Brussels-Capital Ministry of Health
The CTB/ODB "Brussels Drug Addiction Concertation" programme started on the initiative of the two
Ministers competent for questions of Public Health.  This initiative came shortly after the creation of
the Brussels-Capital regional government, as a result of the new breakdown of responsibilities in
Belgium.  The programme is supported by the entire "Collège Réuni/Verenigd College" of Brussels-
Capital which includes all the regional bi-community Ministers.  The programme is also co-ordinated
by two other Ministers, competent for health questions specifically concerning Dutch-speaking citizens
and French-speaking citizens.
A co-ordinator is appointed to implement the programme.  He regularly reports to a Supervising
Committee made up of two representatives of the association ‘Plate-forme de santé mentale pour
Bruxelles-Capitale/Overlegplatform voor geestelijke gezondheid voor Brussel-Hoofdstad’, one
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representative of each of the two competent Ministers, two representatives of the "Concertation and
Co-ordination Committee” (see below) and observers representing respectively the Minister-President
of the Region and the two Ministers competent for Assistance to persons.
The concertation and co-ordination committee of the CTB/ODB programme has met every month
since the programme was launched.  A ministerial Decree dated 15 September 1994 has officially set
its duties and membership.  This committee includes experts in the field (health and social aspects) as
well as lawyers, representatives of the Courts, the Prosecution, the national and local police.
As Sub-Focal Point of the Belgian REITOX network, CTB/ODB supervises the collection and
transmission of information to the Belgian Focal Point and EMCDDA and to the Brussels institutions
working directly in the field.
The Brussels programme covers the following eleven objectives:
- systematical collection of statistical data;
- drafting and distribution of a vademecum of existing services and persons;
- support and co-ordination of prevention;
- encouraging the reception of drug addicts by front-line, non-specialised institutions;
- development of support for reinsertion;
- establishment of an integrated co-ordination of interventions of the various governmental
authorities;
- collaboration with international co-ordination;
- improvement of specialised centres;
- taking action with the national Medical Association and the national Pharmaceutical
Association;
- creation of a concertation and co-ordination committee and appointing the head of the
"Brussels Drug Addiction Concertation" project;
- support to harm reduction activities.
German-speaking Community
The government of the German-speaking Community authorises the Centre for mental health ‘Sozial
Psychologisches Zentrum’ (SPZ) to give ambulatory therapy to individuals with addiction problems.
The German-speaking Community also subsidises the ASL for the co-ordination of the actions.
As Sub-Focal Point of the BIRN for the German-speaking Community, ASL has to co-ordinate drug
prevention activities and to collect epidemiological data related to drug use.
b) Main results achieved
12.3.  Evaluation of national strategies
a) Evaluation plan:
Description of criteria, activities, implementation
The conclusions of the parlementary working group adopted by the Parliament and approved by the
Council of Ministers in June 1997 mentioned the importance of the evaluation : ‘If we want to adapt the
drug policy to the context of the societal evolution, regular evaluations of the results of the applied
measures are needed’.
Several evaluations are currently in progress :
Evaluation of the Directive of 1998 modifying the action of the judicial authorities establishing a
distinction between possession of cannabis for personal use and other illegal drugs with non
acceptable risk for health.
Variable and heterogeneous enforcement of the directive in the different judicial districts
In principle, should place cannabis users outside off the judicial field…
Message not understood by youngsters that believe that cannabis was legalized..
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Evaluation asked for by the Minister of Justice. In progress.
- Evaluation of Mass/Msoc’s
In 1996, medico-social relief centres for illicit drug users (MASS/MSOC) were initiated by the federal
ministry of Internal Affairs.  An evaluation was asked for by the Scientific services of the prime Minister.
In progress.  Expected final report by April 2001.
b) Principal results: need of changes, new trend : -.
At Belgian level, more than actual results there are many expectations about pending issues
- results of the evaluation of the Mass/Msoc’s ?
- results of the evaluation of the directive ?
- new drug plan for Belgium ? co-ordination between levels ?
- effects of the police reform ?
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Chapter 13. Cocaine and base/crack cocaine
Regarding this issue we shall often refer to the recent thesis of Dr. Tom Decorte ‘Informal control
mechanisms among cocaine and crack users in the metropolitan area of Antwerp’56.  Indeed this study
made an original contribution to the field of drug epidemiology by describing a sample of 111 cocaine
users from within their culture rather than from outside, and to present their world as they see it (the
in-sider's view).  Decorte said ‘official statistics, population surveys, and utilisation studies, are useful
indicators of drug use, but they are often biased, partial, and focused on the best known, most visible,
accessible, and perhaps most marginalized subgroups of drug users.  Moreover, observing or
interviewing respondents with the intent of helping, controlling or treating them probably biases the
research findings as well ’.
As multiple references will be made to the thesis of Decorte, every sentence extracted from the thesis
will be mentioned between quotation marks and in italic.
‘ To make the sample comparable to the 1987 Amsterdam community sample of cocaine users
studied by Dr. Peter Cohen (Centre for Drug Research, University of Amsterdam), Dr. Tom Decorte
defined identical sample acceptability criteria: (1) cocaine as a main drug; (2) a minimum lifetime
experience of 25 instances of cocaine use; (3) a mini- mum age of 18 years; (4) not having been found
guilty of a felony; (5) not having participated in any drug treatment program.  Furthermore, some social
groups, such as Street junkies, prostitutes, professional criminals, secondary school pupils and youth
club members were explicitly eliminated as target populations, in order to obtain information about
'hidden' and 'non-captive' subpopulations of cocaine users’.
‘Using a snowball sampling procedures, 111 experienced cocaine users were recruited from the
metropolitan area of Antwerp.  They participated in a double interview : a semi-structured
questionnaire and a open biographical interview’.
‘ The cocaine users found in Antwerp differed markedly from drug users as they are depicted by the
non-using public, health care professionals, law enforcement officials, other research projects
(especially in utilisation studies), and the media. Drug users who do not confirm to the stereotype of
‘worst-case scenarios' are less likely to come to the attention of health practitioners or the police, and
ordinary citizens rarely identify them as drug users.  The study demonstrates that it is possible to
recruit a group of 'invisible' cocaine users who do not fit the stereotype of drug use as heavily
associated with deprivation, ill health and crime.  Indeed, in other research projects the main barrier to
finding such 'hidden populations' may consist in failing to seek them’.
13.1.  Different patterns and users groups
a) Administration and effects sought
From Decorte study : ‘Our data show that cocaine produces a wide range of positive effects on those
who use it in moderation: more energy, a certain intellectual focus, enhanced sensations, and
increased sociability and social intimacy.  Social, sexual, or recreational activities and work can be
enlivened, and many respondents use the drug not only in pleasurable but also in productive ways.
Typically, interviewees perceive the financial consequence of their cocaine use as a more important
disadvantage than whatever physical or psychological adverse effect they report. Most participants
were prepared to live with the unappealing aspects of cocaine, which were outweighed by its
appealing factors.
b) Prevalence, patterns and frequency of consumption
It is uneasy to generalise these figures to the whole country, to compare between data and to find out
trends, nevertheless one observes that :
- the information on use of cocaine in adult general population is out-dated : it showed a very
low (0.5%) lifetime prevalence in 1994 (Flemish Community);
- at the age of 15-16 years, a very limited proportion of students (less than 2% in Flemish
surveys and 3% in the French Community HBSC survey) experienced cocaine.
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TABLE 44. Prevalence of use (%) of cocaine in adult and school-aged population
Belgium,1994-1999
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
ADULT POPULATION
Lifetime prevalence Vlaamse G. 6 0.5 ?
Last year preval. Vlaamse G. 6 0.2 ?
SCHOOL POPULATION (15--16 y.)
Lifetime prevalence RUG/Publ.Hlth 9 0.9 0.6 1.3 ?
VAD 11 1.9
ULB/Promes 10 3.5
Last month preval. RUG/Publ.Hlth 9 0.1 0.3 0.3 ?
- HBSC survey :Youngsters and health in Flanders, 1994-96-98 9
Respectively 1% and 4% of students aged 15-16 and 17-18 years used cocaine at least once
(respectively 2% and 4% in boys and 0.7% and 4% in girls) ; only 0.3% and 1% of students  aged 15-
16 and 17-18 years used cocaine during the last month.
- HBSC survey :Health behaviour of youngsters in the French Community, 1988-98 10
In 1998, 4% of 15-16 years (boys : 5% - girls : 3%) experienced cocaine.  The use increases with age
: from 2% among 11-12 years and 3% among 13-14 years reaching 4% in 17-18 years (boys : 6% -
girls : 4%).
- Survey in Flemish Schools, 1999 11
In 1999, the lifetime prevalence of cocaine use is 2% of 15 to 16-year-olds (boys : 2% - girls : 1%).
Use increases with age : from 1% among 11-12 years and 13-14 years reaching 4% in 17-18 years
(boys : 5% - girls : 2%).
- School-aged youngsters in Bruges (Flanders), 1996-97 15
Among the students who ever used illicit drugs, 11% used cocaine : of course this is lower than
cannabis (98%) and XTC or amphetamines (20%) but higher than ‘ever-users’ of heroin (2%).
Although experimental use was proportionally high for cocaine (45% used only once), the proportion of
regular users is the higher for cannabis but also for cocaine : 39% of cocaine users used it regularly
(1x/month during the last 6 months) – what is two times more than heroin.
- Mental health of youngsters in Brussels, 1994 17
Out of 2209 pupils of the Brussels secondary schools, trying and using cocaine (as well as crack and
heroin) is limited.
- Rock Festival (French Community), 1996-98 31
During the 1998 festival, 88% of the 157 interviewed people stated to have used an illicit drug at least
once (lifetime prevalence) among which cocaine was used by nearly half of respondents (45%) and
crack by 3% (it should be specified that Belgian crack users do frequently call crack 'cocaine free-
base').  Cocaine use increased compared to 1996 (26%) and 1997 (31%).
1999 ??
- Street snowball survey, 1998 54
In the framework of a European snowball survey conducted in 1998, 1,243 drug users were
interviewed in Brussels (n= 370), Charleroi (n=501), Liège (n=254) and Namur (n=118).  The snowball
methodology reaches different groups of drug users aiming particularly users who do not have any
contact with prevention and treatment facilities.  The mean age was 28 years (14 - 55).  The main
used substances were heroin (75%) and cocaine (65%) when crack was used by 5%.
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- Drug consumption in prison, 1993 24, 1997-99 62
In 1999, 22% of 246 prisoners stated to have used cannabis during the last month before their
imprisonment and 9% used it regularly during the current or a previous imprisonment.
In 1997, 23% reported cocaine use during the year before the imprisonment and 15% during their
current or a previous imprisonment.
In the study conducted in the Antwerp prison in 1993, 42% of prisoners were drug user.  The main
drugs were cannabis (37% of users), heroin (28%) and cocaine (16% of users).
From Decorte study : ‘ Three in four respondents were 'snorters' at the time of the interview.  In all
three periods (initial period, period of heaviest use, and most recent period) snorting was practised by
an overwhelming majority of the respondents. The proportion of injecting respondents was relatively
small. Seventy-three respondents (65.8% of the Antwerp sample) kept a stable route of ingestion
(mostly snorting). Thus, the initial snorter (or chaser) is not merely a cocaine user who has not yet
injected but will inevitably do so. And the cocaine injector is not bound to continue as an injector for
the entire duration of his/her cocaine career ‘.
‘ The Antwerp cocaine users sample have a lot of experience with all kinds of drugs.  Only a minority
use cocaine by itself, whereas most combine the use of cocaine with the use of other drugs. Yet, it
would be wrong to conclude that our respondents are permanently taking 'drug cocktails' (i.e.
combining several types of drugs at the same occasion of use). They have clear ideas (and informal
rules) about which drugs can be combined, and which substances should not be combined ‘!
‘ Respondents experience their cocaine use career as a dynamic, often irregular, pattern, subject to
many changes. In all community samples, the proportion of respondents reporting a discontinuous
or irregular pattern of use (in the Antwerp sample almost 90%) is larger than the proportion of those
reporting a continuous one.  Moreover, most respondents report a preference for weekends, and more
than 70% report a low rate of use at a typical occasion (non-bingers) ‘.
‘ A very large proportion of the Antwerp respondents report having stopped for more than one month
(86.5%). Nearly 60% of the total sample report more than 5 abstinence periods of one month or
longer.  The average duration of the longest period of abstinence was 15 months. Seventy-one
respondents (64%) report having cut back on their cocaine use. About half of the respondents who
had temporarily abstained or cut back on their cocaine use, did not experience any problems with it.
Most others qualify these 'problems' as minor discomforts that manifest themselves initially and fade
away after a few days or weeks. Thirty-two respondents (29.7% of the total sample) report having quit
cocaine, 6 of whom did so without consciously reflecting on it ‘.
 ‘ More than three in four respondents (77.6%) perceive themselves as 'controlled' users.  The most
important indicators of 'controlled' use according to the Antwerp respondents were: periodical
abstinence, refusing cocaine when it is offered (in other words: resisting craving), small doses and/or
low frequency of use (and consequently, low level of use), fewer active efforts to obtain cocaine, other
activities taking priority over cocaine use, positive reasons for using cocaine. Most respondents report
a sense of increased mastery and control over the product. Many users have to go through a period of
loss of control over the substance, or to learn about the negative and dangerous aspects, but in the
end they are able to use the substance more consciously and to prevent cocaine from interfering with
relationships and activities that take priority (such as a job, family life, etc.) ‘.
‘ However, the user may reach a stage where he/she is no longer able to conform to the others'
expectations and starts to lie about his/her cocaine use. Almost half of the respondents who report
having lied state they concealed their illicit drug use from non-using friends to minimize the risk of
police attention, to avoid being labelled a 'drug user' or 'addict', or to avoid concern anxiety,
disappointment, shock, etc. in significant others. Almost one in three of the respondents who report
having lied state they lied about the quantity of cocaine they had with them to other users. These lies
are typically meant to avoid sharing the drug with others, because it is hard to obtain, or expansive, or
because these respondents simply want all the cocaine for them. One in five of the respondents who
had lied acknowledge having done so about the frequency of use to friends, because they wanted to
avoid informal social control by others (social disapproval), or because they wanted to mask their own
inability to control the substance’ .
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c) Social groups, geographical factors
From Decorte study : ‘Fewer than 5% of the total sample report feelings of being 'pushed' and almost
all respondents report that trying out cocaine was their own (often conscious) choice. The stereotype
of the drug dealer or drug pusher actively recruiting new cocaine users to expand his market did not
feature in our sample. Curiosity about cocaine and association with significant others who use it, bring
the uninitiated in a situation where cocaine is being used ‘.
‘ Informal comments can provoke a wide range of reactions, from aggression and indifference, to
feigned consent and simulated remorse, to indulgence and behavioural change.  Whether or not a
remark or comment from another person is perceived as well-founded, depends on many factors: the
source or maker of the remark (non-user or user), the (perceived) pattern of his/her cocaine use, the
form and content of the remark (serene versus paternalistic, joking versus angry, verbal versus non-
verbal), the situation in which the comment is made, the emotional state of the receiver, whether the
receiver is under the influence of cocaine, etc. Most of the respondents' accounts show that a
prerequisite for effective informal social control is a strong or intimate bond between the maker of the
comments and the receiver. Our participants emphasize that only the remarks of close friends can
help to adjust their cocaine use. Comments by acquaintances, strangers, and non-users in general go
in one ear and out the other ‘..
13.2.  Problems and needs for services
a) Health consequences and negative effects
TABLE 45. Problematic use of cocaine : treatment demands, intravenous
administration, taken in for questioning, Belgium,1993-1999
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
PROBLEMATIC USE
Treatment demands CCAD 34 2.3 2.5 2.7 2.9 3.8 5.9 
(% cocaine = main drug) VAD 33 7.1 9.0
Current injecting use (%) CCAD 34 22.2 25.9 34.6 22.9 34.8 29.5 
Coor.Drog.Charl 37 10.8 
VAD 34 8.9
PEOPLE TAKEN IN  for
questioning
(% cocaine/all  offence)
SGAP 46 5.9 5.0 4.6 4.3 =
It is uneasy to generalise these figures to the whole country, to compare between data and to find out
trends, nevertheless one observes that :
- the proportion of patients starting treatment when cocaine is the main problematic drug seems
increasing ; in 1998, cocaine users represent around 6% of clients in centres participating to
French Community CCAD and 9% in the Flemish VAD monitoring system;
- injection behaviour among cocaine users starting treatment seems slightly increasing (in
contrast to the global decreasing trend in treatment centres due to the relative increase of
people treated for non-injectable drug) and varies between monitoring systems (remaining
lower to heroin injecting behaviour though almost equal in French Community reporting
systems).
- Treatment centres
The most recent data from the treatment demand registration systems of the French Community
(CCAD, 1993 to 98), the Flemish Community (VAD, 1996 and 98) and Brussels (CTB-ODB, 1997 and
98) were compared.  In 1998, cocaine was considered the main drug by 9% of treated patients of the
VAD Flemish Community database and by 6% of the French Community (increasing trend from 2% in
1993) where this proportion is higher in males (6.8%) than in females (3.2%).  In Brussels, cocaine is
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registered together with ‘stimulants’ and represented 10%.  Among first treatment demands (French
Community), cocaine as main drug is 8% in 1998 (males 10%, females 2%).
Among patients undergoing treatment in centres of Charleroi 37, the average age at the first use of
cocaine was 20.2 years (1997).  The proportion of daily users among cocaine users for the years
1995-96-97 were respectively 13, 15 and 18%.
From Decorte study : ‘ A large majority of the respondents (80%) did not have any contact with drug
treatment agencies or with medical doctors for a drug problem.  Only two respondents of the Antwerp
sample (n=111) had sought help for cocaine-related problems ‘.
‘ lt is striking that in the case of an overdose or emergency, most respondents indicate they prefer to
look for solutions themselves, rather than appear to a general practitioner or a first-aid-team, or call for
an ambulance.  Most bystanders try to reassure the one who has an overdose: they try to 'talk him/her
down', give him/her something to drink, keep him/her company, etc. Some respondents, however,
report particular ploys to put someone back on his/her feet after an overdose (a glass of milk, a glass
of orange or lemon juice, a glass of salty water). These 'detoxification techniques' are probably part of
user lore about adverse effects and how to 'treat' them, but they are relatively ineffective and
sometimes even counterproductive’ .
‘ Cocaine use may escalate, but it does not do so endlessly.  About half of all users reach a high
use level in their period of heaviest cocaine use, but only 5% had stayed at that level in the three
months prior to interview.  Almost 1 in 5 Antwerp respondents had not used at all during the last three
months. A proportion of cocaine users (18% in the Antwerp sample) is able to maintain a low level of
use throughout their whole use career. Furthermore, high-level use of cocaine during certain (top)
periods of use does not exclude later abstinence or decreased frequency of use at all ‘.
 ‘ Most of the risks (binge use, feelings of craving, obsession, unpleasant mental and physical effects,
difficulties with periodical abstinence or cutting back,  ... ) are related to more direct routes of
ingestion, such as freebasing or injecting. Furthermore, it was shown that the number of negative
effects increases with level of use.  A level of use higher than 2.5 grains a week definitively asters
the balance between positive and negative effects ‘.
b) Social consequences
Cocaine is the cause of a low proportion of the cases in which people are taken in for questioning :
stable from 1993 to 1999 around 5% ( Table 45).
From Decorte study : ‘ It has been suggested that the desire for a drug may be so strong that many, if
not most, people are unable to resist, even if they have to engage in criminal activities to buy or use it.
Yet, three in four respondents had never engaged in any criminal activity to obtain (money for)
cocaine.  The activities most frequently mentioned by the Antwerp respondents were: tolerating the
presence of unpleasant persons to obtain cocaine and selling cocaine (usually to friends). One third of
all crimes reported had been committed only 'once', indicating opportunistic and accidental criminal
behaviour. Most of these crimes had been committed by a small group of 12 respondents, who were
mainly recruited from snowball chains with higher proportions of registered respondents, regular
injections, and respondents reporting difficulties with abstaining or cutting back ‘.
13.3.  Market
a) Physical description, b) Price/Purity at user’s level, Availability
TABLE 46. Cocaine seized: number of seizures and quantities, Belgium, 1985-1999 45
1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Seizures (N) 132 226 254 380 422 375 513 933 897 927 1,046 NA NA 799 547
Quantity (kg) 62 116 270 404 89 537 756 1,222 2,892 479 576 838 3,321 2,028 1,761
Belgian National Report on Drugs 2000 - Belgian Information Reitox Network123
TABLE 47. Prices of (EURO) and accessibility to cocaine, Belgium,1993-1999 45
INDICATORS ORGANISATION
(reference nb)
1993 1994 1995 1996 1997 1998 1999 Trend
PRICES : Wholesale SGAP 32 18 25 18 22 =
Retail 55 49 40 50 55 =
AVAILABILITY (% adults) ULB/Promes 45.6 50.8 41.1 40.0 =
It is uneasy to generalise these figures to the whole country, to compare between data and to find out
trends, nevertheless one observes that :
- the number of seizures seems decreasing during recent years y ;
- the wholesale and retail prices have been stable since 1993;
- the accessibility to cocaine in adults is strikingly high : nearly half of adults stated that they
could get cocaine quite easily near to their home.
c) Open scenes, local markets, trafficking/dealing/distribution patterns, supply routes/countries
Cocaine comes mostly from Latin-American Andes-countries. The drugs come mostly via Colombia,
Brazil, and Venezuela or from Trinidad and Tobago to Belgium using boats and planes. The airport of
Brussels (Zaventem), the harbours of Antwerp and Zeebrugge are known for this. Most of the cocaine
is in transit and is meant for other countries like The Netherlands, France, Germany and United
Kingdom. Seizures of cocaine have constantly increased for the last ten years, with a record of about
3 tons in 1993.
13.4.  Intervention projects
v Recommendations for policy making
From Decorte study : ‘ The data of the study suggest that the view that pharmacology is somehow an
instantly addicting destiny is an oversimplification, given the many complex patterns of use and
outcomes ‘.
Dr. Tom Decorte therefore proposes : ‘ to abandon the classical distinction between 'soft drugs' and
'hard drugs, and to introduce a new distinction between 'soft use' and 'hard use' of any drug.  This
approach allows us to assess the overall impact of any substance, without overreacting to the dangers
it poses. It does not downplay the pharmacological power of drugs, but it does not consider them the
only important factor either. It accepts that drag use does not occur in a social vacuum, and that
psychological, social, economic, and cultural factors play important roles in shaping a person's drug
use behaviour.  Every possible effort should be made -legally, medically, and socially- to distinguish
between the two basic types of drug use: the experimental, recreational, and circumstantial, with
minimal social costs; and the dysfunctional, intensified, and compulsive, with high social costs.  In
order to distinguish 'soft use' from 'hard use', greater attention will have to be paid to how drugs are
used. We should study both the conditions under which dysfunctional or 'hard' use occurs and how
these can be modified, and the conditions that maintain control for the 'soft users' and how these can
be promulgated. To study the conditions of use for each drug will require consideration of the following
                                                
y Additionnaly to elements for discussion of the trends in term of number of seizures, one should mention that
the large variation between years in the quantities seized in Belgium could be the result of the collaboration
between countries in the fight against trafficants : the current policy/strategy when a traffic is discovered, is to
postpone the intervention (arrest of the trafficants and seizure of the drugs) and to follow the travel  in order to
be more efficient by discovering the organization of the distibution, the partners in crime…  So such data on
quantities will be better interpreted at larger (European) level.
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topics: dosage, method of administration, pattern of use (including frequency), and social setting, as
well as the pharmacology of the drug itself ‘.
‘ Drug policy should encourage the development and dissemination of information control
mechanisms among those who are already using drugs. Any abrupt shift in the present policy would
probably be inappropriate.  Informal social controls cannot be provided to users ready-made, nor can
formal policy create them ‘.
‘ The sudden legalization of cocaine, for instance, would leave in limbo those who have not yet had
the time to internalise information social controls. There are, however, several steps that can be taken
to demystify drug use and thus to encourage the development of informal control mechanisms.
These steps include disseminating realistic information (education), less police activity towards users,
decriminalizing all use of any drug, correcting negative attitudes toward drug users, and undertaking
legal reform. In the long run a more liberal and tolerant drug policy should remove drugs from their
criminal context and make users themselves responsible for their drug use, rather than the State.
However, such a tolerant policy must include state-controlled availability and purity of drugs, while at
the same time it must discourage the use of drugs in general ‘.
v Services (Prevention, Treatment interventions, Harm reduction)
From Decorte survey : ‘ Treatment agencies could develop models of informal control mechanisms,
and 'types' of drug users based on the social rituals and sanctions they have adopted. A better
understanding of the genesis and transfer of informal control mechanisms among drug users, may
help the treatment specialists to draw lessons from those who are able to control their cocaine use
('soft users') for the benefit of those who seem unable to manage their use ('hard users') ’.
Research and evaluation : -.
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Chapter 14. Infectious diseases
14.1.  Prevalence and of HIV, HBV and HCV among drug users
14.1.1 HIV/AIDS
14.1.1.1 AIDS and HIV-seropositives register
There are eight AIDS-reference laboratories in Belgium. One of their duties is to perform confirmation
tests on sera found positive during the screening tests.  Since they are the only laboratories
subsidised for these tests, their reporting of new HIV-positive individuals gives a global picture of the
total number of newly diagnosed seropositives in Belgium.
The AIDS-patients are reported in an independent way by the doctor who provides treatment. These
reports which are anonymous, are also written on a standardised form, and sent to a commission of
clinicians, virologists and epidemiologists. This Commission guarantees data confidentiality.
The current AIDS-definition in Belgium is the one proposed by the Centres for Disease Control and
Prevention (CDC) in 1987 (modified in 1993).
Since a common code is used to record each case, whether HIV-positive or AIDS, it is possible to
avoid multiple counting and also to link the two databases.
From the beginning of the epidemic till December 1999, 11 891 HIV infected patients have been
registered. Among these,  2 670 have reached the clinical stage of AIDS 63. Between 1987 and 1999,
the average number of new HIV-cases registered were 1.9 to 2.7 per day.
TABLE 48. Number of new HIV-cases, number of new cases with IVDU as risk status
and proportion of IVDU risk status among all new cases, in Belgium, per
year, from the beginning of the epidemic to 1999 63
Year Total HIV-diagnosis HIV with
IVDU
(HIV with IVDU)
/ all HIV+
with information on risk
status
HIV with
IVDU
15-24 y.
(HIV with IVDU)
/ all HIV+
with information
15-24 y.
(N) (N) (%) (N) (%)
1986 and before 1 393 102 10.1 64 34.8
1987 929 47 8.2 17 21.5
1988 747 65 13.6 20 27.9
1989 752 55 9.6 19 26.9
1990 809 41 7.1 9 13.8
1991 803 38 7.1 11 13.3
1992 977 37 6.0 9 11.5
1993 944 31 5.5 5 5.7
1994 802 38 7.2 7 11.7
1995 765 15 3.4 2 3.4
1996 717 14 3.8 4 10.3
1997 690 16 4.5 3 6.8
1998 750 11 2.9 1 2.4
1999 795 12 3.4 2 5.9
Total 1987-1999 10 480 420 6.6 109 13.4
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Information on the risk factor status is globally available for 63% of cases. Considering by year, the
number of new HIV-cases in relation to intravenous drug use (IVDU) among heterosexuals,
homosexuals and bisexuals is slightly decreasing reaching 16, 11 and 12 new IVDU-HIV-cases
respectively in 1997, 98 and 99.
The number of HIV infected people is much greater among males than among females.  Infection via
intravenous drug use is the highest among young people.  Meanwhile among infected people aged
between 15 to 24 years the number of new cases stating IVDU is quite low, respectively 3, 1 and 2
cases in 1997, 1998 and 1999.  Although the proportion of intravenous drug users was higher than in
older age groups, it becomes more comparable in the last three years (Table 48).  This declining trend
will have to be confirmed in the long run.
The proportion of IVDU-HIV-cases decreased reaching 3.4% in 1995 and then remain relatively stable
(2.9% in 1998 and 3.4% in 1999).  It is striking that the proportion of drug users among seropositives
and AIDS cases is very low in Belgium compared to some European countries (reaching 60% or more
in Spain) 64.
FIGURE 15 :  Proportion (%) of IVDUs among new HIV-cases from 1987 to 1999 in Belgium
14.1.1.2 HIV sero-positivity among treated patients
Most of monitoring systems register information on the infectious status of their patients.  Usually the
information is reported by the patient him/her-self.  We present data of the CCAD and VAD systems
and from other sources.
De Sleutel 38 is an organisation with several ambulatory and residential  treatment centres in Flanders
(1997 : 862 unique and new clients; 1998  n=1186; 1999 n=1945) (prevention interventions are also
conducted).  According to the information required for this 'Infection' synthesis, only a part of clients
have been selected combining data from different files and mainly the medical file : criteria for seeing
a doctor are not linked to the type and/or the way of product-use, but it is sure that all clients getting
substitution and/or other medication do see a doctor.  Biological testing was performed for these
patients.   There is an overlapping between the data of 'De Sleutel' and data of VAD, but its extent is
not estimated.
GEMT (Groupe d’Etude des Maladies liées à la Toxicomanie) is a group of GPs with family practice
and caring also for drug user patients (mostly by methadone maintenance) in Charleroi (Wallonia).
Biological testing was performed for the GEMT studies (1992-93 65 and 1995 66).
In the framework of the Flemish GIG project (health and injecting drug users), a six-month study was
conducted in 1996-97 67 : 248 IVDUs were interviewed according to an European questionnaire on
AIDS and IV drug use.  Respondents were users having contact with ambulatory or residential centres
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or users recruited by the snowball method.  An HIV test was offered to everybody. Among 225 people
tested for HIV, 5 were positive (2.2%) (all five had stated that they were HIV-seropositive).
n 1994, 523 questionnaires were filled in by drug users treated by general practitioners participating in
the ALTO programme 68.  Patients (males:78%) were mainly heroin users (mean age: 26 years, mean
age at start: 20 years, mean duration of use: 6,2 years). 77% (n=348) stated that they have been
tested for HIV :  2,2% stated to be HIV-positive.  In this study, there was no association with IVDU.
TABLE 49. Proportion (%) of HIV- infected patients among IVDU* patients starting
treatment (numbers into brackets), reported by various systems, in Belgium,
from 1992 to 1999
Source Ref Area Method IV drug
use 19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
GEMT –
Charleroi
65,66 French
Com.
Biological
Diagnosis
At least
once
1.6
(249)
0.9
(228)
ALTO 68 French
Com.
Self-
report
All users 2.9
(348)
CCAD 34 French
Com.
Self-
report
At least
once
4.9
(245)
5.7
(230)
3.0
(230)
1.4
(284)
2.6
(270)
1.6
(252)
GIG-
project
67 Flemish
Com.
Biological
diagnosis
At least
once
2.2
(225)
De
Sleutel
38 Flemish
Com.
Biological
Diagnosis
At least
once
0.8
(120)
5.4
(56)
0.5
(186)
VAD 33 Flemish
Com.
Self-
report
Last 12
months
1.9
(373)
* : except in the ALTO study
Underlining that caution should be taken as the numbers of tested IVDUs are low, Table 49 shows
relatively comparable HIV-infection rates among IVDUs.  Meanwhile the GEMT studies reported low
rates in 1992 and 1995, one observes a declining trend in the CCAD figures that is compatible with
recent data of VAD and De Sleutel, except the figure of 1998 (5.4%) but this is calculated on a low
number of patients (n=56).
Table 50 presents the proportion of self-reported HIV-seropositive among users demanding for
treatment in centres in the French Community 34.
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TABLE 50. Proportion of self-reported HIV-seropositive among IVDUs starting treatment
in centres of the French Community for years 1993-1998 34
Year 1993 1994 1995 1996 1997 1998
Number of treatment demandsz 1,618 1,212 1,176 1,570 1,681 1,466
Number tested IVDUs (self-
reported)
245 230 230 284 270 252
Number of HIV+ (self-reported) 12 13 7 4 7 4
% HIV+ of tested IVDUs 4.9% 5.7% 3.0% 1.4% 2.6% 1.6%
% in males 5.2% 5.5% 2.9% 0.9% 2.1% 1.5%
% in females 3.9% 6.3% 3.6% 2.7% 3.8% 7.7%
% in age <25 4.0% 2.4% 2.6% 1.2% 0.0% 2.5%
% in age 25-34 5.6% 8.7% 3.1% 1.7% 3.2% 2.5%
% in age >34 5.0% 4.5% 4.3% 0.0% 4.3% 2.3%
% in opiate using IVDUs 3.8% 7.3% 4.5% 1.8% 0.8% 4.4%
% in IVDUs not using opiates 5.5% 4.2% 1.7% 0.9% 4.3% 1.4%
% in capital/metropolitan area 5.6% 7.9% 12.5% 0.0% 0.0¨% 9.1%
% outside capital/metrop. area 4.7% 4.2% 1.7% 0.8% 2.2% 2.2%
14.1.1.3 HIV sero-positivity among prisoners
The health service of the penitentiary administration provides figures about the HIV infection among
prisoners 69.
In the ‘prison hospital’ service acting as hospital of the prisons of the Flemish region, systematic
screening of all 'hospitalised' prisoners is performed.  Drug use status and thus IVDU status are not
known.  Only the last test for each patient was taken into account.  In 1999, 1 patient was HIV-positive
among the 316 tested (0.3%).  In 1998, the proportion was 0.6.
In the prison of Lantin (Wallonia), testing are performed when asked for by prisoners or doctors.  Drug
use and administration route are not known.  Only the last test for each patient was taken into
account.  In 1999, 8 prisoners were diagnosed HIV-positive among 668 having been tested (1.2%).
In 1997, a study was carried out in the prison of the city of Namur 62.  Among  175 prisoners, 115
participated.  Fifty-one percent stated having been HIV-tested previously, of whom 5.4% (3/56)
reported a positive result.  HIV-testing of the saliva was performed.  Results are known for 112 HIV
tests: none was positive (0%).
In 1997, the penitentiary administration estimated that the prevalence of HIV among prisoners was 2%
70.  In 1987, it was estimated as 1.3% 71.  Two studies carried out in 1992 and 1993 produced  similar
prevalences : the one in Antwerp (prevalence 1.2%) 24, the other in 14 Belgian prisons (0.8% among
males and 1.7% among females) 72.   Besides differences according to sex, this second study showed
the highest prevalence among the 25-34 age group (2.2%).
                                                
z Demands for which alcohol is the main subtance were excluded.
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14.1.2 Hepatitis B and C
The IV use of drugs and transfusion of blood and its derivatives, are the two main risk factors
associated with the transmission of hepatitis C.  In Belgium, IV drug use seems to be the first cause of
HCV contamination at this time 73.  The other sources of transmission, such as mother-child
exchanges, sexual and family contamination and medical care are less frequent.  It is estimated that a
cirrhosis will occur in 20% of patients with hepatitis C after a mean delay of 15 years.  Patients with
cirrhosis are exposed to liver cancer that occurs in 3%.
In Belgium, current hepatitis C prevalence in the general population is estimated to be around 1% : the
most precise seroprevalence estimate to date is 0.87% (95% Cl : 0.5-1.1) based on a survey carried
out in 1993 74.  HCV seroprevalence associated with defined risk groups would be a better set of data
to use.
14.1.2.1 HBV- and HCV sero-positivity among treated patients
Since 1997 information on hepatitis status of drug user starting a treatment is registered in centres of
the French Community (CCAD monitoring system) 34 and in the treatment centres of De Sleutel
(Flanders).  Prevalence studies were carried out by GEMT-Charleroi in 1992-93 and 1995 (more
details on these organisations are given  in 3.3.a.2).
Hepatitis C virus is more prevalent among IVDUs than HBV.   Although based on different methods,
respectively self-reports and biological diagnosis, the CCAD and De Sleutel figures are quite similar
without any particular trend over the last 3 years : for HBV around 20-25% and for HCV 40-50% of
patients have been infected (Table 51).  The prevalence rates reported by the GEMT studies are
higher particularly for HCV : the explanation could be due to a selective recruitment of patients or to a
true local higher level of the HCV epidemics among the IVDUs of Charleroi.
TABLE 51. Proportion (%) of HBV- and HCV- infected patients among IVDU patients
starting treatment (numbers between brackets), reported by various
systems, in Belgium, from 1992 to 1999
Source Ref Area Method IV drug
use 19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99 Trend
H B V
GEMT –
Charleroi
65
66
French
Com.
Biological
Diagnosis
anti-HBc
At least
once
16.0
(232)
36.0
(238)
CCAD 34 French
Com.
Self-
report
At least
once
22.4
(107)
23.6
(237)
=
De
Sleutel
38 Flemish
Com.
Biological
Diagnosis
anti-HBc
At least
once
20.5
(73)
24.1
(54)
23.9
(155)
=
H C V
GEMT –
Charleroi
65
66
French
Com.
Biological
Diagnosis
At least
once
82.0
(181)
78.0
(244)
ALTO 68 French
Com.
Self-
report
At least
once
56.0
(252)
CCAD 34 French
Com.
Self-
report
At least
once
46.7
(107)
51.9
(237)
=
De
Sleutel
38 Flemish
Com.
Biological
Diagnosis
At least
once
39.5
(114)
46.4
(56)
37.9
(195)
=
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Figures were also collected by the VAD system 33 (Flemish Community) showing the same higher
prevalence of HCV compared to HBV : 7 patients stated HBV- and 19 HCV- seropositivity among 619
patients but the number of tested patients is not known.
In 1997 and 1998 respectively 22% and 24% of tested IVDUs registered by the CCAD system (having
injected at least once) were infected by hepatitis B (Table 52).  The proportion of HBV infected is
higher in females (29%) than males and increases with age (one out off three among patients aged 35
or more).
In 1997 and 1998 respectively 47% and 52% of tested IVDUs (having injected at least once) were
infected by hepatitis C (Table 53).  Contrary to HBV, the proportion of HCV infected patients is more
comparable between males and females and between the different age groups.
TABLE 52. Proportion of hepatitis B infected among IVDUs asking for treatment, in
centres of the French Community, 1997-1998 34
HBV 1997 1998
Number of treatment demands aa 1,681 1,466
Total number tested IVDUs (self-reported) 107 237
Number hepatitis+ (self-reported) 24 56
% hepatitis+ of total IVDUs 22.4% 23.6%
% infected in males 18.8% 22.0%
% infected in females 28,9% 29.4%
% infected in age <25 14.3% 18.9%
% infected in age 25-34 22.5% 21.6%
% infected in age >34 33.3% 35.6%
% infected in opiate using IVDUs 22.5% 26.8%
% infected in IVDUs not using opiates 22.4% 20.8%
% infected in capital/metropolitan area 25.0% 23.1%
% infected outside capital/metrop. area 23.6% 22.8%
TABLE 53. Proportion of hepatitis C infected among IVDU asking for treatment, in
centres of the French Community, 1997-1998 34
HCV 1997 1998
Number of treatment demands bb 1,681 1,466
Total number tested IVDUs (self-reported) 107 237
Number hepatitis+ (self-reported) 50 123
% hepatitis+ of total IVDUs 46,7% 51.9%
% infected in males 46,4% 48.9%
% infected in females 47,4% 60.8%
% infected in age <25 42,9% 48.6%
% infected in age 25-34 47,9% 49.3%
% infected in age >34 46,7% 57.8%
% infected in opiate using IVDUs 37,5% 53.6%
% infected in IVDUs not using opiates 52,2% 50.4%
% infected in capital/metropolitan area 37,5% 38.5%
% infected outside capital/metrop. area 48,3% 51.0%
                                                
aa Demands for which alcohol is the main subtance were excluded.
bb Demands for which alcohol is the main subtance were excluded.
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In 1994, 523 questionnaires were filled in by drug users treated by general practitioners participating in
the ALTO programme 68  Among the 366 IVDUs (at least once) 69% stated that they have been tested
for HCV :  56% stated to be HCV-positive.  The association with IVDU was obvious : only 9% of non
IVDUs were infected.
14.1.2.2 HBV- and HCV sero-positivity among prisoners
The health service of the penitentiary administration provides figures about the HIV infection among
prisoners 69 (see 3.3.a.3).
In the ‘prison hospital’ service acting as hospital of the prisons of the Flemish region, systematic
screening of all 'hospitalised' prisoners is performed.  Drug use status and consequently IVDU status
are not known.  Only the last test for each patient was taken into account.  In 1999, 7 patients were
HBV (HBs ag)-positive among the 314 tested (2.2%).  In 1998, the proportion was 2.1.
The infection rate is most striking for hepatitis C.  In 1999, among prisoners systematically screened
(without regarding any risk factor as drug use) 56/321 (17%) were positive (13% in 1998).
In the prison of Lantin (Wallonia), testing are performed when asked for by prisoners or doctors.  Drug
use and administration route are not known.  Only the last test for each patient was taken into
account.  In 1999, respectively 51/692 prisoners (8%) and 191/692 (a very high proportion of 28%)
were diagnosed HBV- (HBs ag) and HBC-positive.
In 1997, a study was carried out in the prison of the city of Namur 62.  Among 26 prisoners, 10 (38%)
were HCV-positive based on saliva test.
14.1.3 Tuberculosis
Two organisations are in charge of the epidemiological follow-up of patients with tuberculosis: FARES
(Fondation contre les Affections Respiratoires et pour l'Education à la Santé) and VRGT (Vlaamse
Vereniging voor  Respiratoire Gezondheidzorg en Tuberculosebestrijding).
In Belgium, 1,270 new cases with tuberculosis were registered in 1999 (incidence rate : 12.5/100,000
inhabitants) 75.  Risk factors were recorded: drug addiction was stated for 9 cases, representing 0.7%
of new tuberculosis cases.  Table 54 indicates that the number and proportion of drug users among
new cases of tuberculosis is stable over the recent years.  The drug addiction risk factor is more
frequent in Brussels : respectively 5 (1.5%), 4 (1.2%), 3 (0.9%), 6 (1.7%), 5 cases (1.7%) and 4 cases
(1.5%) for years 1994 to 1999.
TABLE 54. Number and proportion of drug addicts among new cases with tuberculosis,
Belgium, 1994-1999 75
1994 1995 1996 1997 1998 1999
Number of new cases 1,521 1,380 1,352 1,289 1,203 1,270
  Addiction stated             N 8 8 8 7 10 9
                                         % 0.5 % 0.6 % 0.6 % 0.6 % 0.8% 0.7%
  No addiction stated        N 1,499 1,361 1,334 1,275 1,188 1,210
  Not specified                  N 14 11 10 7 5 51
14.2.  Determinants and consequences
Injecting and sharing
- Treatment centres, 1993-1998
Injecting behaviour is asked to patients starting treatment and in 1998 this information is available for
4,182 patients of the VAD and CCAD databases (66%).  A third (35%) of patients, males more than
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TABLE 55. Intravenous administration in users at the time of starting treatment
according to gender and first or not first treatment, CCAD34 and VAD33
databases, 1998
All treatments First treatments
M F T M F T
N with information on IVDU 3,196 980 4,182 1,378 446 1,825
     Currently injecting any drug (%) 9.6 7.2 9.0 7.5 4.9 6.9
     Ever injected any drug but not currently (%) 27.4 20.3 25.7 14.7 15.7 14.9
     Ever injected any drug (%) 37.0 27.6 34.8 22.1 20.6 21.8
females, injected a drug at least once among which a quarter was ‘current injector’ (last month IVDU)
at the time of the contact for treatment (Table 55).  Among people undergoing a treatment for the first
time, these proportions were lower : respectively 22 and 7%.
The CCAD database contains data from 1993 to 1998.  Globally, the proportion of IV drug use in users
undergoing treatment shows a decreasing trend from 30% in 1993 to 20% in 1998 34 (Table 56).
However, it seems that the main cause of this trend is the change in the pattern of the drugs
(increasing relative proportion of cannabis and stimulants) used by patients starting a treatment :
indeed, IV route among opiate users is nearly stable and fluctuating (maybe increasing) among
cocaine users.
The proportion of current IV use stated by patients treated in Flemish centres is lower 33: respectively
27 and 9% of heroin and cocaine users.
Since 1999, injection behaviour is recorded in the medical database of the centres of De Sleutel :
51% of the patients undergoing medical treatment had injected at least once 38.
TABLE 56. Intravenous administration in users at the time of starting treatment, French
Community of Belgium, 1993-1998 34
1993 1994 1995 1996 1997 1998
Nr. of  treatment demands 1,618 1,212 1,176 1,570 1,681 1,466
Current IV route of ad. main drug (%) 30.2 34.3 28.7 24.0 24.0 19.9
Ever injected any drug (%) 35.1 45.0 45.0 44.0 43.2 37.9
Opiates  (total) % IVDU 34.4 39.1 36.2 32.1 34.3 32.9
   Heroin 35.9 40.9 39.9 37.0 37.3 35.3
Cocaine 22.2 26.9 34.6 22.9 34.8 29.5
Restricting to patients starting a drug treatment for the first time (446 in 1998), one observes a lower
proportion of 'current injectors' (10%) as well as 'ever injected' (16%):  'only' 18% of heroin users and
12% of cocaine users were currently injecting their drug.
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TABLE 57. Intravenous administration in users at the time of starting the first treatment,
French Community of Belgium, 1993-1998 34
1993 1994 1995 1996 1997 1998
Nr. of  first treatment demands 507 381 338 483 517 446
Current IV route of ad. main drug (%) 18.2 23.8 21.5 13.6 13.9 9.5
Ever injected any drug (%) 22.8 30.6 31.8 22.5 22.0 16.5
Opiates  (total)  % IVDU 20.9 30.1 28.8 22.1 24.6 17.1
   Heroin 21.4 30.8 29.7 23.7 24.5 17.9
Cocaine 13.6 12.5 33.3 19.0 14.3 12.1
- Rock festival, 1996-1999 31
In 1998, the intravenous drug users (IVDUs) represented 13% of users.  The proportion of IVDUs
corresponds to 1997 (13% injected, of whom half shared) and is lower than the figure of 1996 (25%
injected).
TABLE 58. Proportion of IVDUs, Rock festival, French Community of Belgium, 1996-
1999 31
1996 1997 1998 1999
N interviews 123 167 157 686
 Drug use (%) 87 96 88 88
IVDU / users (%) 25 13 13 4
The lower % of IDU among observed in 1999 compared to the previous years can be explained by two
reasons.  First, the population has changed as the musical programme changed from a mainly rock
oriented festival to a more “house” festival.  Secondly, in 1999, the survey was carried out in the whole
festival and not in the camping only.
- Snowball survey (French Community), 1993-1998 76
Snowball surveys were carried out in 1993-94, 94-95, 96, 97 and 98 : drug use, its pattern and some
knowledge and attitudes were investigated.  In 1998, 1,243 users were interviewed : 370 in Brussels,
501 in Charleroi, 254 in Liège, 118 in Namur.  The mean age is 28 years ; females represent 33%,
migrants 31%, homeless 17% and users without any social welfare allowances 26%.  65% used drug
by IV at least once (of whom 46% shared syringes) and 43% during the last 6 months. The mean age
at first injection is 20 years.
In 1996, injection rate was quite similar : 1,294 users were contacted 77 in Brussels, Liège, Charleroi,
Namur, Verviers and Wavre, among which nearly  80% used heroin and half used cocaine.  68% used
IV at least once; current IV use (last 6 months) was 53%.
In 1996, half of users lend often or occasionally their syringes.  The frequency of borrowing is slightly
lower.  Only 40% of users never share.  In 1997, this proportion was a little bit higher : 50% of IV users
reported never sharing (borrowing or lending)  syringes 78.
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TABLE 59. Proportion of current IVDU (injection during the last 6 months) and sharing
of syringes among current IV users, French Community, 1993-1997 77
1993-94 1994-95 1996 1997
N users 456 1,123 648 1,247
IVDU/drug users 69% 57% 56% 46%
Sharing/IVDU - 60% 60% 54%
- Treatment centres (Charleroi), 1995-1997 37
Half the heroin users have at least once injected and figures of 1995-1999 do not show any trend, as
well as regarding cocaine users (40% injecting).  In 1999, current or past injection behaviour is
recorded : 32% of heroin injectors are still currently injecting, representing 17% of heroin users.
TABLE 60. Proportion of injecting users, Charleroi, 1995-1999 37
Drug N cases with information Injecting (%)
Ever Current
95 96 97 98 99 95 96 97 98 99 99
Heroin 554 481 531 588 660 52.5 54.7 50.3 56.3 53.2 17.1
Cocaine 286 320 350 465 547 36.7 30.6 37.4 42.6 40.8 10.8
Medicines 163 233 226 93 230 1.2 1.3 1.8 5.4 2.6 -
- ALTO GPs (French Community), 1994 79
In 1994, 523 questionnaires were filled in by drug users treated by general practitioners participating in
the ALTO programme.  Patients (males:78%) were mainly heroin users (mean age: 26 years, mean
age at start: 20 years, mean duration of use: 6,2 years).  52% were previously treated in a specialised
centre.  50% had already stayed in prison.
70% had injected at least once, 39% during the last 6 months, 23% during the last month (possible
bias could be due to the fact  that the questions were asked by the GP).  46% of the last 6 months IV
drug users shared some material and 30% of the last month IV drug users.
14.3.  New developments and uptake of prevention, harm reduction and care
· Legislation regarding harm reduction and access to material : see Part I Chapter 2 - 2.1.c
· Legal basis for substitution treatment : see Part I Chapter 2 - 2.1.h
· Epidemiological data on substitution treatments : see Part II Chapter 3 - 1.4
· Substitution and maintenance interventions : see Part III Chapter 9 - 4.2
· Criteria for starting a substitution treatment : see Annex D.
14.3.1 Outreach work
Flemish Community
· Many outreach workers are actively involved in the drug scene and in working with high risk groups
and neighbourhoods.  Their approach is individual as well as structural.  The outreach workers are
based in various programmes and projects and they still lack a work specific sector of their own.
Vlastrov is the umbrella organisation which provides training programmes for outreach workers.
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French Community
· The DELTA  programme (1998) aims at youth outside school environment: DELTA  is an outreach
work by transfrontier street corner work between Liège (French Community of Belgium) and
Maastricht (The Netherlands).  Two social educators were half time employed in this program,
realised in collaboration with Hasselt (Belgian Limburg) and Aachen (Germany) in the frame of an
euregional partnership.   Creation of contacts, listening, orientation and youth support in certain
proceedings are part of the proposed activities.
· The ‘Opération BOULE DE NEIGE’, programme oriented to drug users, aims to reach target
groups not easily reachable, by the snowball’s effect, in other words, by the peer prevention’s
method.  It means to employ former drug users in short-term contracts ('jobist'), training them to
drug prevention and harm reduction.  After some time, they go back to the “ drug stage ” to make
an underground work with drug users. In some cities the intervention includes an evaluation activity
about behaviour’s changes among the drug users or the 'jobists'.
14.3.2 Low threshold services
Flemish Community
· Some shelter houses accept drug users in their setting.
· In 1997, 4 medico-social centres (MSOC/MASS) have started their activities in Ghent, Antwerp,
Genk and Ostend.  They offer low-threshold medical and social assistance : their activities are
linked with the treatment facilities which are available in the province or region where they are
situated. Methadone programmes are offered.
French Community
· The medico-social centres (MASS/MSOC) started their activities in Charleroi (1997), Liège (1998)
and Mons (1998).  They offer low-threshold medical and social assistance : their activities are
linked with the treatment facilities which are available in the province or region where they are
situated. Methadone programmes are offered.
·  DELTA community approach as low threshold programme is addressed to drug users, principally
who injected.  This programme is currently evaluated.
14.3.3 Prevention of infectious diseases
Flemish Community
· ‘Omgaan met risico’s’ (Free Clinic): educational package for low educated youngsters (game,
video and manual).
Free Clinic is a low threshold drug service integrating prevention, drug related research and care
(medical care, methadone programs, psycho-social follow-up).
Stategies : harm reduction methodology (Prevention in the Flemish region, care only in the Antwerp
region).
Principal interventions
· Needle and syringe exchange : though the legal framework has now been established (law of
23/12/1998, implementation modalities on 07/07/2000) there is, as yet, no funding for needle
exchange. More clarity regarding funding by the Ministry of Health from the Flemish community is
expected in September 2000. Free Clinic is chairman of the steering group to implement needle
exchange in the city of Antwerp. Prevention material (a.o. a safer injecting leaflet, prevention
messages on ‘Sterikits’ to be distributed by pharmacists, …) has been developed.
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· Safer sex/safer education : prevention material (leaflets on safer injecting, hepatitis C, cocaine,
woman and drugs, speed and overdoses) has been developed and is regularly updated. A leaflet
on methadone is under preparation.
· All materials focuses on risk reduction and safer use/ safer sex and is also integrated (with more
information) in a so-called ‘Peer Support handbook’. This harm reduction handbook is used within
the peer support-network started by Free Clinic, from whom the participants are low threshold
workers (drug workers, street corner workers) and drug users themselves.
· There is no funding by the Flemish Aids coordination for HIV-prevention by drug users. Condoms
are supplied if possible (depending on the available budget).
· Testing, vaccination : are not done by the prevention service. Testing and hepatitis B vaccination
are sometimes done by the care services.
· Treatment :  Treatment occurs on a occasional basis. HIV-positive drug users are admitted in the
methadone programme on a preferential basis
Training sessions (using a.o. slides) focusing on HIV and hepatitis B and C prevention are organised
on a regular basis for drug users and personnel. A lot of the attention has been given during the past
years  on prisons (inmates and personnel). Free Clinic is also member of the Belgian Hepatitis C
forum.
An epidemiological research tool has been developed for the prison focusing on health problems, with
a large attention on infectious diseases (HIV/Hepatitis)
French Community
Several actions are conducted regarding harm reduction.
Modus Vivendi is a NGO mainly in charge of harm reduction in Brussels and in the Walloon Region.
Various specific interventions : syringe exchange, providing equipment, harm reduction in prison.
Principal interventions
· Modus Vivendi set up an exchange desk  in Brussels.
In 1998, the number of syringes distributed (20,423) increased when comparing with previous
data 80.  The evaluation showed that the age of the users contacting the exchange desk is also
increasing.  Consequently it was decided to better circulate information on the existence of the
desk which should also specially focus on younger users.  Considering the same period
(November 1997 - October 1998),   20,423 syringes were distributed  by the CCLA cc exchange
desk through 1 300 contacts (mean age : 33 years - range : 20-55).  Compared to 1997, this
corresponds to an increase of 47% in the number of distributed  syringes.
11,967 syringes were recovered, corresponding to 53% of distributed syringes.  The difference
between the numbers of distributed and recovered syringes is increasing, which is opposite to the
expected results.  More qualitative research in order to explain these trends are in progress.
· An intervention called 'Opération Stérifix' was initiated in Brussels by Modus Vivendi that is a
NGO mainly in charge of harm reduction. Stérifix aims reducing infections transmitted by sharing of
syringes.  The objectives are the improvement of access to syringes, the improvement of relationships
between pharmacist and drug users, and the promotion of the citizenship of drug user81.
· Stérifix is a package containing 2 syringes/needles and information on the risk of transmission by
syringe sharing.  The package is distributed by pharmacies (491 pharmacies -excluding hospital
                                                
cc CCLA: Citoyen Comme Les Autres (citizens as  others) is a non-profit organisation fighting against the
segregation towards drug users.
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pharmacies- in the Region of Brussels) and by one exchange desk.  The price is 20 BEF (0.5
EURO).
· An evaluation was performed covering the period November 1997 -  October 1998.  The
participation rate of pharmacies was 29% and is quite comparable to previous years (1997: 30%
and 1996: 31%).  As a global result of the Operation Stérifix, 49 277 syringes were sold or
distributed : 57% by pharmacists, 41% by an exchange desk and around 2 % by other activities
(snowball interventions).  This represents 8% increase compared to the previous period.  Compared
to previous years (1996 and 1997), an obviously increasing proportion (67%) of IV drug users
interviewed (snowball enquiry) stated having purchased a Stérifix (40% often purchase, 28%
rarely).
· The non-access to Stérifix during the night is one of the main limits stated by interviewed drug
users.  It is the reason why alternative solutions are being investigated (automatic distribution of
syringes, exchange desk available by night).
· For harm reduction activities, the DELTA programme concerns syringe/needle exchange and
information diffusion about HIV and Hepatitis virus.
· In 1996-97, a new programme in the framework of the 'Opération BOULE DE NEIGE ' carried out
by Modus Vivendi was set up about infectious diseases prevention : it recommended regular
detection testing and gave preventive information about risk behaviours.  The leading principle was
the concept of health education and promotion.  Particular attention was also given to the basic
psychological needs.  The programme provided few material for the drug users, but allowed their
orientation to drugstores and needles exchange desks that already exist (see Part epidemilogy :
risk and protective factors).  The results of this programme were evaluated.
· A programme about infectious diseases prevention in the judicial system was also initiated by
prisoners in Brussels aiming to facilitate the circulation of information leaflets about those diseases
and the availability of preservatives.  These tools were available at the prison of St Gilles
(Brussels).  The programme was leaded by Modus Vivendi in co-operation with the prison’s
management and with other institutions in the field of prevention and harm reduction activities.
· Most institutions working in the drug field have participated actively to the ELEWYT program, an up
to date of actual knowledge about hepatitis C, prevention, treatment and epidemiology, and
information about foetal risks.  This program, against hepatitis C permits to vaccinate drug users
(or addicts), their husband or wife and their children.
· Against hepatitis B, hepatitis C, and HIV virus, about 60 pharmacists have agreed to hold a deposit
of prevention packages.  The collection of used syringes and needles was also organised in this
ELEWYT project.
· For AIDS prevention, several associations have co-operated to the dissemination of information
leaflets.
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The present Report,
short versions in Dutch and French
and additional information on the activities of the BIRN
are available on demand
and on the Belgian Focal Point Web site
REITOX Belgian Focal Point
at
http://www.iph.fgov.be/reitox
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ANNEX A : Description of the Belgian National Focal Point and partners
The Belgian Information Reitox Network (BIRN) was created in 1995 and links the National Focal
Point (FP) with the Sub-Focal, umbrella organisations for a region or community specialised in drug
matters.   The Focal Point is the direct link between the EMCDDA and the BIRN.
The Belgian Information REITOX Network (BIRN) BIRN members meet almost every month. Expert
working groups (reference groups) on the key indicators, on demand reduction and on the Early
Warning System meet regularly.
A Steering Committee, meeting at least once a year, ensures the follow-up of the REITOX network
activities. Representatives of the administrations and ministers from different governmental levels
(federal, regional and community), as well as the Belgian representatives in the Management Board
and Scientific Committee of the EMCDDA are members of this steering committee.  Exchange of
information between Focal Point and member of the Management Board is regular, such as for
instance before and after EMCDDA meetings.
A member of the BIRN participates in the meetings of the group Epidemiology of the Pompidou
Group.
EMCDDA
BELGIAN REPRESENTATIVES EMCDDA
STEERING COMMITTEE
Management Board
Scientific Committee
BIRN
IPH
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THE FOCAL POINT : ORGANISATION, STRUCTURE AND BUDGET
The Focal Point is located at the Scientific Institute of Public Health (I.P.H.), formerly Institute of
Hygiene and Epidemiology. It is the  scientific research institute of the ministry of Social Affairs, Public
                                                
dd UNDCP : United Nations for Drug Control Programme.
ee CCAD : up to 31/08/2000 and EUROTOX : from 01/09/2000
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Health and the Environment. The Focal Point is funded and managed in collaboration with the
Communities and the federal ministries.
The Focal Point's mission is to respond to queries from EMCDDA, to collect and synthesise
epidemiological data on the drug problem, to participate in activities of the BIRN, and to ensure
dissemination of information both between the Belgian partners, and between these partners and the
EMCDDA.
In 1999, the budget of the Focal Point is 5.6 million BEF (140,000 EURO). The whole of this amount
comes from the Flemish and French Communities.  A financial support is also available from
EMCDDA (shared between the Focal Point and the Sub-Focal Points for the completion of some core
tasks).  A feasibility on the transformation of the Belgian Focal Point in a Belgian Monitoring Centre is
supported by the Federal Ministry of Public Health.
THE SUB-FOCAL POINTS
Vereniging voor Alcohol- en andere Drugproblemen  - VAD
The VAD (Association for Alcohol and other Drug Problems) was established in 1982 and is active in
the Flemish Community (5,9 million inhabitants in Flanders and around 0.2 million Flemish in
Brussels).
Objectives
The goals of the VAD are
- the study, the prevention and treatment of problems related to alcohol and other drug use through:
- the organisation of training
- the organisation of discussion platforms and networks
- the co-ordination and support of existing and innovative initiatives in the field of study, prevention and
treatment
- the organisation of a telephone help line
- the collection of data.
Structure and organisation
The VAD is a non-profit organisation grouping 47 member organisations which have preventive and
curative goals.  The members constitute the General Assembly which designates a Committee of
Directors.  The members of this Committee of Directors designate a Management Committee and
allocate the responsibilities.  The daily operations of the VAD are carried out by staff under the
supervision of a director.
Financing and budget
The VAD is an official institution within the Flemish Institute for the Promotion of Health.  As such, for
1998, it received a fixed subsidy of 20 million BEF (500,000 EURO).  In addition to this basic subsidy,
the VAD receives subsidies for the preparation and implementation of specific projects, which are
often short-term.  For European projects, VAD receives funds from EMCDDA through the BIRN.
External relations and collaborations
As the Flemish Sub-Focal Point, together with the Focal Point and the other Sub-Focal Points,  it is
part of the Belgian Information Reitox Network (BIRN), and ensures that its engagements with the
European Monitoring Centre for Drugs and Drug Addiction in Lisbon, are honoured.  There is active
participation with the Pompidou Group, with the European Drug Prevention Week and with WHO.
Comité de Concertation sur l’Alcool et les autres Drogues - CCAD
The CCAD (Consultation committee for alcohol and other drugs) was created in 1978 and was given a
Community character in 1980. Its jurisdiction covers the French Community (3.3 million inhabitants in
Wallonia and 0.8 million French-speaking inhabitants in Brussels).  It was charged to act as Sub-Focal
Pöint of the French Community up to August 2000.
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Objectives
The goals of the CCAD regarding prevention are:
-  to co-ordinate groups and/or persons involved in problems connected with the abuse of alcohol and
other drugs
- to make available pedagogical modules adapted to the various target populations (in collaboration
with community departments specialised in communication and methodology) and to advise them
concerning the most suitable pedagogical material
- if necessary, to create or organise the creation of this material
- to collaborate with the ‘Data bank Department’ and the ‘Documentation Department’ of the French
Community to gather and distribute specialised data and documents
- to collect data and to create a database about treatment demands.
Structure and organisation
The CCAD is a non-profit organisation. It is composed of three departments:
- the Community Department for Prevention provides assistance in methodology, assures the
development and adaptation of material for prevention and organises Community-wide awareness and
information campaigns;
- the Centre for Documentation and its Library distributes specialised information: books and
collections of specialist reviews on the topic of addiction, as well as international reports (EU, Council
of Europe, WHO, EMCDDA, etc.), press review on alcohol and drugs and a quarterly information letter
with a bibliography of new acquisitions;
- the Permanent Unit for Sanitary and Social Observation of Alcohol and Drug Problems gathers
epidemiological data in the field of drug addiction in general, and data relative to the monitoring of the
“first treatment demand and treatment demand” indicators.
Financing and budget
The CCAD is funded on the basis of Decrees of the Government of the French Community (annual
funding : 7.5 million BEF (187,500 EURO)).  Its mission has Sub-focal Point of the French Community
stopped on 31/08/2000.  For European projects, CCAD receives funds from EMCDDA through the
BIRN (up to 31/08/2000).
External relations and collaborations
Collaboration is pursued at all levels with specialised institutions and departments, practitioners and
research teams, locally, at a Regional and Community level, as well throughout Europe and
internationally.  There is participation in the activities of the EU, the Pompidou Group, the WHO, etc.
CCAD is the French Community’s Sub-Focal Point for the Belgian Information REITOX Network
(BIRN) of the EMCDDA in Lisbon.
EUROTOX -EUROTOX
EUROTOX was established in 1990 and regroups three organisations active in different fields linked to
drug use:
- Infor-Drogues telephone help line, prevention, and outpatient treatment
- Modus Vivendi : AIDS prevention, harm reduction, training, liaison and research
- Prospective Jeunesse : prevention, training and assistance.
Objectives
The specific objectives of Eurotox are :
- to carry out research projects in the field of drug use
- to organise conferences, seminars
- to observe drug use phenomenon in the French Community of Belgium.
Structure and Organisation
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Eurotox is a non profit organisation.  Its General Assembly and  Executive Board is composed of
representatives  of the three organisations, Infor-Drogues, Modus Vvendi and Prospective Jeunesse.
Financing and budget
In addition to the funds in each of the members association, current funding level of Eurotox is 5,5
million BEF (137 500 EURO) a year.
External relations and collaborations
Since September 2000, Eurotox is part of the BIRN, as Sub-Focal Point for the French Community of
Belgium.
Concertation Toxicomanies Bruxelles - Overleg Druggebruik Brussel - CTB-ODB
The CTB-ODB (the Brussels Drug Addiction Programme) was set up by a ministerial Decree of 15
September 1994.  The programme covers the Brussels-Capital Region which is made up of 19 urban
municipalities, representing a population of almost one million inhabitants.
Objectives
The Brussels Drug Programme, with an emphasis on reducing demand, brings together those
involved in helping drug addicts in prison, treatment centres, crisis centres and short stay centres,
hospital centres, 24-hour hot-line services, prevention, mental health care centres, assistance,
rehabilitation, day centres and ambulatory care.
Two objectives of CTB/ODB deal with external collaborations (with the various authorities in Belgium
and with international collaborators).
Structure and organisation
A co-ordinator has been engaged by the association to implement the programme; he is assisted by a
part-time secretary.  The co-ordinator regularly reports to a Steering Committee made up of
representatives of the associations, of the competent ministers, of the "Concert ation and Co-ordination
Committee” (see below) and of observers representing the Minister-President of the Region and the
ministers competent for Assistance to persons.  The Concertation and Co-ordination Committee is
made up of experts from the field (social and medical), as well as lawyers, delegates from the Justice
Department, from the Public Prosecutor's office, and the federal and local police forces.
Financing and budget
The programme's budget is established annually.  The amount for the first year was 5 million BEF
(125,000 EURO), and for the current year 6 million BEF (150,000 EURO).  A part of this amount helps
to fulfil European obligations.  Additional support from EMCDDA through the BIRN is available for
specific EMCDDA core-tasks.
Arbeitsgemeinschaft für Suchtvorbeugung und Lebensbewältigung -ASL
The ASL (Association for drug use prevention and for a better quality of life) is an autonomous NGO
since 1997 (it was part of the Centre for Mental Health since 1980), and officially recognised by the
Government of the German-speaking Community.  The care activity of the ASL extends to the 70,000
inhabitants of the nine municipalities of the German-speaking Community of Belgium.
Objectives
The ASL is responsible for drug use primary prevention in the German-speaking Community.  It is also
partially involved in secondary prevention.  The goals of the ASL are to make the entire population
aware of the dangers of addiction of all kinds and to improve the quality of life.  It encourages healthy
activities for the well being of the population and co-ordinates current activities.  With regard to its area
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of responsibility, the ASL makes efforts in order to establish a dynamic relationship with the political
decision makers in the German-speaking Community.
The ASL, in its role as co-ordination institution within the German-speaking Community in Belgium, is
responsible for co-ordinating the registration of statistical data, including the record of the first
treatment demand.
Structure and Organisation
The ASL is mainly made up of voluntary workers.  At every level of society, there is a team of workers
developing and co-ordinating the prevention effort.  All the teams are co-ordinated by a central co-
ordination team.  In recent years, the ASL has concentrated its activities at the level of the
municipality.  It aims to create a working group in each municipality which will bring together, in the
heart of the municipality, all those people who are interested in active prevention.
The prevention model developed by ASL was evaluated by a group of experts (University of Fribourg,
Switzerland) in 1997: it was certified effective and consistent through its global and community
approach.
Financing and budget
The ASL is subsidised by the government of the German-speaking Community.  It receives the
amount of 4.7 million BEF (120,000 EURO) to cover staff and operating costs.  The staff consist of a
full-time co-ordinator, a therapist in drug addiction, and several secretaries (70 hours per week).
Additional support from EMCDDA through the BIRN is available for specific EMCDDA core-tasks.
External relations and collaborations
It is part of the Belgian Information REITOX Network.
The ASL collaborates with partners in eleven West and East European countries.  The objective is to
adopt a long term, global community approach to preventive actions in the municipalities of these
countries.  This project is supported by the EU.
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ANNEX B : Alternative measures : diversion to treatment and alternatives to prison
AT POLICE LEVEL 82 :  THE THERAPEUTICAL ADVICE
'Therapeutical advice' is a practice/method of early detection in which police services offer drug users,
who have been arrested, the possibility to go in a Centre for Mental Health Care for one or more
exploring conversations.  Nevertheless the public prosecutor has to decide (article 29 of the Code of
criminal law making compulsory the police to refer to the judicial authority) whether the drug user can
take advantage of an alternative measure.
Some public prosecutor's departments (among others Mechelen and Hasselt) work differently. They
have developed a system of «therapeutical advice» enabling police services to propose, for defined
categories of delinquents, an alternative treatment, when remaining under the supervision and the
responsibility of the public prosecutor’s department.
When the drug user agrees, he/she is summoned to the mental health care centre for a first interview.
If the treatment is possible, the care centre notifies the public prosecutor’s department, to which
further reports will be forwarded at the end of the first and the sixth month.  If the treatment works out,
the case file will be terminated 83.
AT PUBLIC PROSECUTOR’S DEPARTMENT LEVEL
Praetorian probation (probation prétorienne / pretoriaanse probatie)
This measure (progressively developed since 1950) is also called 'judicial contract'.  It intends to stop
judicial prosecutions if the user agrees to change his/her behaviour (not to use any drug, to accept
urine control, to look for a job, to have active leisure time, to get treatment aiming at definitely stopping
drug use...).  If the user agrees, the public prosecutor transmits his/her file directly to a care service.
This extension of possibilities for the individualisation of judicial measures (and this is applicable to all
alternative measures and penalties) makes it possible to avoid short term imprisonment, which goes
against social rehabilitation, and enables the judicial power to take action on the causes of the
criminality by means of individualised clauses and to support the social rehabilitation of the delinquent.
Penal mediation (mediation pénale / strafbemiddeling) f f  gg
This measure can be applied by the public prosecutor (Art. 216 ter of rules of criminal (Code
d'instruction criminelle/Wetboek van strafvordering) and aims at settling a difference without the
judge's intervention.  It is a voluntary procedure requiring the agreement between the perpetrator of
the offence and the victim and active participation of all parts (the victim is actively associated).
Requirements:
- offence for which the public prosecutor should not call for a imprisonment penalty longer than 2
years
- having reached one's majority.
The system of praetoriane probation provides large possibilities for individualisation and makes it
possible to act quickly taking into account the individual circumstances.  Together with the mediation
process aiming at making atonement to the material or moral damage, additional clauses can be
specified : treatment or other relevant therapy (maximal duration: six months), unpaid work for the
benefit of the community (duration : max 120 hours in one to six months), training (duration : max 120
hours in one to six months) or combination of these measures.
The respect of the agreement automatically results in the definite and complete termination of the
public prosecution.  The non-respect justifies the forwarding of the file to the Court.
Alternative measures at the juvenile court level (mesures de diversion / diversiemaatregelen) hh
                                                
f f  Circulaire Ministérielle du 12 septembre 1995 remplaçant la circulaire du 7 mars 1995 relative au recrutement par les
communes de personnel supplémentaire pour l’encadrement des mesures judiciaires alternatives au sein du Plan global
pour l’emploi, la compétitivité et la sécurité; Moniteur belge / Belgisch Staatsblad, 09/11/1996.
gg Arrêté Royal 24/10/1994 in Moniteur belge / Belgisch Staatsblad, 01/11/1994.
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The public prosecutor (juvenile court public prosecutor) can decide not to prosecute if the youngster
(under 18 years of age) agrees to execute a diversion measure as to make atonement to the damage,
to perform a small unpaid work for the benefit of the community, or to participate in a measure with a
socio-educative effect.
Alternative to detention on suspicion ii
The alternative to (first order or maintenance) detention on suspicion is a release on licence.
Requirement: offence for which the public prosecutor should call for an imprisonment penalty of one
year or more.
During the first five days of the detention on suspicion, the examining magistrate decides to apply or
not the alternative measure.  After the decision can be taken by the 'Chambre du conseil/Raadkamer'
which re-evaluates the situation every month.  The Court (judge) can also take alternative measures to
detention on suspicion.
The duration of the release on licence is 3 months at the maximum, but can be extended up to the
judgement by 3-month periods.  A social enquiry is often performed regarding personal, relational, and
social aspects.
The measures (that can be stopped, extended or modified) can be :
- mandatory or prohibition measures (supervision made by the police)
- compulsory treatment or assistance.
During the 'alternative' period, interviews with the perpetrator of the offence (eventually relatives) are
regularly held with the help of specialised services if necessary.  Regular reporting is made. An active
involvement can influence the judge's decision.  However the release on licence is not an alternative
measure as such and cannot cause an extinction of the public prosecution.  On the other hand a lack
of collaboration can cause the arrest of the person and influence negatively the judgement.
At the level of the judgement (Court)
Suspension, reprieve and 'probation'
The ' simple suspension ' is a way to test the delinquent giving his/her approval.  The judge can state
the fact proved without any verdict.  The 'simple suspension' stops the prosecution as long as the
decision of the judge is not modified.
Regarding the ‘simple reprieve’, the penalty is inflicted but is not carried out.
The terms of the law dated 29/06/1964 jj regarding the suspension, the retrieve and the ‘probation’
have been made specifically more flexible for drug users by the law dated 9/07/1975 modifying the law
dated 24/02/1921 kk.
In all cases, the suspension, the reprieve and the 'probation' can be applied only if the offence cannot
cause a criminal penalty longer than five years of imprisonment.  Concerning drug users, previous
judgements are not taken into account regarding the suspension, the reprieve and the ‘probation’ (in
other cases, the perpetrator cannot have been previously sentenced to more than a 2-month
imprisonment in order to obtain the suspension, to more than a 12-month imprisonment concerning
the reprieve).
In both cases (suspension, reprieve), the judge decides the duration of the test period (from at least
one to five years).  Some clauses can be added: active collaboration in the social guidance, treatment
or other relevant therapy, unpaid work for the benefit of the community, training, not drinking in a bar...
A social enquiry is often performed regarding personal, relational, and social aspects.
During the 'suspension/reprieve' period, interviews with the perpetrator of the offence (eventually
relatives) are regularly held with the help of specialised services if necessary.  Regular reporting is
made to a 'probation' commission.  The commission can adapt the clauses (but without making them
more severe).
                                                                                                                                                        
hh Circulaire Ministérielle du 12 septembre 1995 remplaçant la circulaire du 7 mars 1995 relative au recrutement par les
communes de personnel supplémentaire pour l’encadrement des mesures judiciaires alternatives au sein du Plan global
pour l’emploi, la compétitivité et la sécurité; Moniteur belge / Belgisch Staatsblad, 09/11/1996.
ii  Articles 35 to 38 of the law dated 20/071990 in Moniteur belge / Belgisch Staatsblad, 14/08/1990.
jj Moniteur belge / Belgisch Staatsblad,  17/07/1964.
kk Moniteur belge / Belgisch Staatsblad, 26/09/1975.
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When the evolution is positive, the prosecution stops at the end of the test period.  Nevertheless in the
reprieve situation, the sentence is maintained in the conviction record.  When the evolution is negative
the public prosecutor can forward the file to the Court.
Works for the benefit of the community and trainings in the framework of the law on 'probation' ll
Concerning suspension and reprievemm, the Court nn can decide to impose an unpaid work for the
benefit of the community (duration from 20 to 240 hours to be executed in 12 months), or an
occupational or socio-educative training (undetermined duration)oo.
The socio-educative training is particularly relevant for experimental users.  Information is given on
drugs as well on health risks, legislation, consequences of addiction and assistance resources.
Another objective is the correction of the system of social values and of legal rules.
The level of the enforcement of the penalty 82
The fact that problematic drug users are imprisoned is largely contested by prevention and treatment
actors as well as by authorities.  Nevertheless one notices that the prison environment is more and
more confronted to the drug problem : in Belgian prisons, 30% of prisoners (even 50% in some
prisons) are imprisoned because of a drug offence 82.
On the other hand, it is not recommendable to sentence fines to delinquent having committed a drug
offence because it leads to a down spiral phenomenon.
Release on licence (libération conditionnelle/voorwaardelijke invrijheidstelling)
Release on licence means that a person sentenced to prison is released earlier under specified
clauses.  Release on licence is not automatic : it is a favour measure.
A first sentenced person should have spent at least a third of the duration; a recidivist at least two-
thirds; a person sentenced to imprisonment for life at least 10 years and, if recidivist, at least 14 years.
Different partners are involved in the release process.  The prisoner him/herself proposes a
rehabilitation plan.  The prison staff and a steering multidisciplinary staff express some advice and
then the public prosecutor and the Minister of Justice.  Based on this advice, the final decision is taken
by a commission that can eventually also consult the victim and other people.
The commission determines the clauses associated to the release (good behaviour, collaboration with
the judicial assistant, not to get in contact with former prisoners, to work or look for a job, ambulatory
or residential treatment...) and is responsible for the follow-up.
If the evolution is positive, the definite release is awarded.  If not, the release on licence can be
rescinded, suspended or revised.
Confinement
The Court pp (usually with the help of a psychiatrist) sentences the confinement if the offence
perpetrator is a danger for the community being his/her incapacity to control his/her actions.
The confinement is not a penalty but a measure (judicial measures are not notifies in the certificate of
good character).
The commission of social defence decides the way and clauses of the confinement (from maintenance
in freedom to internment in a psychiatric hospital) and can modify them (lighter or more severe).
The confinement aims at improving the mental status of the person as well as the development of
necessary status for his/her rehabilitation.  The justice assistant co-ordinates the follow-up, involves
specialised services and regularly reports to the commission.
The commission can decide a test release associated to clauses (treatment or therapy).
                                                
ll Circulaire Ministérielle du 12 septembre 1995 remplaçant la circulaire du 7 mars 1995 relative au recrutement par les
communes de personnel supplémentaire pour l’encadrement des mesures judiciaires alternatives au sein du Plan global
pour l’emploi, la compétitivité et la sécurité; Moniteur belge / Belgisch Staatsblad, 09/11/1996.
mm Law 10/02/1994 in Moniteur belge / Belgisch Staatsblad, 27/04/1994.
nn cour d’appel, du tribunal correctionnel ou du tribunal de police
oo Arrêté Royal 24/10/1994 in Moniteur Belge / Belgisch Staatsblad, 15/10/1994.
pp Examining magistrate room or tribunal court.
Belgian National Report on Drugs 2000 - Belgian Information Reitox Network 148
FLOW CHARTS OF DIVERSION TO TREATMENT AND ALTERNATIVE MEASURES TO PRISON
TABLE 61. Expected attitudes/decisions of the various actors involved after a drug
related offence in Belgium
Involved actors
Scenarios Police Public prosecutor Examining
magistrate
Judge Prison staff
Commissions
Isolated (first
arrest) use/
possession for
personal use of
cannabis
Simplified
policeman’s
report
à police       
listingààà
OR
(decision of the
policeman)
¯
Checks the
persons listed
à no
prosecution
(case definitely
disposed of)
OR
if recidivist…
àààààà
(see
Prosecution)
- - -
No prosecution
(mostly for the
first
infringement)
OR
¯
- - -Use/possession
for personal use
of cannabis
- associated
with other
infringement
or nuisance
OR
- recidivist
OR
Use/possession
for personal use
of other drugs
OR
Property crime
related to drug
use
OR
Retail distribution
of drugs
Policeman’s
report àààà
(individual)
+ seizure
+ corporal
search
+ search of the
vehicle
+ house
search (with
perpetrator’s
agreement)
+ phone call to
the public
prosecutor
OR
¯
¯
¯
¯
¯
¯
¯
¯
¯
Prosecution à
OR
¯
Mediation
- Mediation
perpetrator-
victim
- Treatment
- Work for
the
community
- Training
Arrest mandate
à
OR
¯
Alternative to
detention on
suspicion
- Mandatory
or
prohibition
measures
- Treatment
Judgement à
OR
¯
- ‘Simple’
suspension
(test delay)
- Suspensio
n or reprieve
‘to the test’
- Work
penalty
- Training
penalty
- Treatment
Prison / fine
OR
¯
- Probation
- Release
on licence
- Confineme
nt
Compulsory
treatment  in  a
specialised
centre + phone
call àà
In collaboration
with the public
prosecutor
Comments : Large variations in the appreciation of the situation by the policeman and in the
implementation of the alternative measures and penalties between judicial districts !!
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TABLE 62. Differences in expected attitudes/decisions of the various actors involved
after a drug related offence by a minor (less than 18 years old) in
Belgium
Involved actors
Scenarios
Police Juvenile court
public Prosecutor
Examining
magistrate
Juvenile court
Judge
Institution
Isolated (first
arrest)
use/possession
for personal use
of cannabis
Simplified
police report
à police
listingààà
OR
(decision of the
policeman)
¯
Checks the
persons listed
à no
prosecution
(case definitely
disposed of)
OR
if recidivist,…
àààààà
(see Prosecution)
- -
Use/possession
for personal use
of cannabis
- recidivist
OR
- associated
with other
infringement
or nuisance
OR
Use/possession
for personal use
of other drug
OR
Property crime
related to drug
use
OR
Retail distribution
of drugs
Policeman’s
report àààà
(individual)
+ seizure
+ corporal
search
+ search of the
vehicle
+ house
search (with
parents’
agreement)
+ phone call to
the public
prosecutor
No prosecution
(case definitely
disposed of)
OR
¯
Meeting/
Interview
with the
perpetrator
+ parents
à serious
warning
- - -
If recidivist  or
severe àààà
OR
¯
Diversion
measures
- atonement
- small
unpaid work
- socio-
educative
action
ààààààà
(no examination)
Meeting/  àà
interview minor +
parents
+ juvenile court
public
prosecutor
OR
¯
Supervision by
the judge until
majority  àà
Placing in an
institution
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ANNEX C : National Monitoring and Information Systems
The institutional structure of the Belgian State comprises the federal level (House of Representatives,
Senate), the Community level (Flemish, French, and German Community Council) and the Region
level (Flemish and Walloon Region, Brussels-Capital).  Each entity has its own government.  Each
government has variable competencies in the different areas related to drug policy.
In order to conduct their drug policies, the different Communities and Regions (Flemish, French and
German-speaking Communities and Brussels Region) need data on treatment and prevention
interventions and developed their own monitoring system.  At the moment, a national monitoring
system does not exist.
Current efforts are focused on the set up of a global (at national level) data base in order to obtain the
required data for the valorisation of the EMCDDA treatment demand indicator.  Of course this
development will be helpful for the health authorities.  This global system is to be build upon the
existing treatment demand databases.   Preventing any duplication of registration systems  and
collaborations between the different systems is stressed.
In 1998, in the framework of the Belgian Information REITOX Network a feasibility study of the pooling
of the data from the centres of the different parts of the country started.  The aim is to provide figures
on the situation at national level.  Data registered by 3 systems (VAD, CCAD, CTB/ODB) were
compared by analysing the questionnaires and the definitions of the variables.  The next steps will be
the selection of the variables according to the EMCDDA request and their precise definitions.
In 1999, the Belgian Focal Point co-ordinated the participation of the Belgian registration systems
(VAD, CCAD, CTB/ODB) in the field trial of implementation of a standard protocol to collect
information on treatment demand in the EU Member States.
RELEVANT INSTITUTIONS IN CHARGE OF DATA COLLECTION, PROCESSING AND REPORTING AT NATIONAL
LEVEL
The two institutions involved in data collection, processing and reporting at national level belongs to
the Federal Ministry of Social Affairs, Public Health and Environment.
The Belgian National Focal Point
The objective of the Focal Point is to provide a global view on the drug situation in Belgium based on
objective, reliable and comparable data at Belgian level but also at European level.
Two of its main current tasks are:
· to collect and  synthesise epidemiological data as well as to harmonise the data produced in the
country;
· to implement European standard epidemiological indicators in Belgium about  drug use in the
general population, the prevalence of problematic drug use, as well as the mortality and infectious
morbidity related to drug use.
The Direction of Health Care Policy processes data from hospital discharges: RCM/MKG and
RPM/MPG
RCM/MKG (Résumé Clinique Minimum / Minimale Klinische Gegevens / minimal clinical data set) and
RPM/MPG (Résumé Psychiatrique Minimum / Minimale Psychiatrische Gegevens / minimal
psychiatric data set) are registration systems operating respectively in general hospitals, and in
psychiatric hospital and psychiatric units of general hospitals.
The data of RCM/MKG of 1995 and RPM/MPG of 1996-1997 were analysed and published as the first
issue of the RCM/RPM Flash 36.  The hospital stays where the diagnoses (main or associated) are
related to the use of illicit drugs, amphetamines or solvents were selected.  This figure based on
hospital stays may represent an over-estimate of the number of patients as one patient can stay
several times in hospital during one year.
There are several limitations.  It was designed for clinical and administrative purposes and some items
are based on different definitions (compared to those used by regional systems (see hereafter)).  It is
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a compulsory notification (that can create some underreporting as most of drugs are illicit).  Probably
as a consequence, a large part of the data are not well specified (e.a. the type of drug).  The used unit
is the hospital stay and not the person.
On the other hand, efforts are made to ensure as well as possible the reliability and completeness of
the data (the data are randomly checked by health administration inspectors at hospital level).
The use of this source of information from an epidemiological point of view should be evaluated.
The RTM project
The Laboratory of Medical Psychology (ULB) is charged by the federal Minister of Public Health to
study the feasibility of RTM (Résumé Toxicomanie Minimum / minimal drug addiction data set): this
summary should be integrated in the RPM/MPG for cases related to drug addiction in order to improve
the demand reduction policy based on detailed and accurate information from patients in treatment.
An inventory of epidemiological tools used in Belgium and in European (and other) countries is in
progress.  EMCDDA requirements are taken into account.  Comparisons will be performed and degree
of compatibility will be analysed.  Proposals and recommendations will be provided.
RELEVANT COMMUNITY OR REGIONAL TREATMENT INFORMATION SYSTEMS
Flemish Community
In 1996, the Flemish Minister of Health has developed her policy priorities. Among them is registration
of treatment contacts.  The goal of the project (started in 1996) is to collect data at the start of
treatment.  The number of (new) patients starting treatment in specialised settings for drug related
problems (alcohol, medicines, and illicit drugs) and their characteristics are registered.  The project
integrate most of the variables from the Pompidou Protocol on the 'First demand and treatment
demand' indicator in the existing computerised systems.
The first data (1996) were collected in 10 specialised residential settings (therapeutic communities and
crisis centres) and in 83 outpatient settings (centres for mental health) : among these  83 mental
health care centres there are 5-10 centres in charge of most of outpatient treatment demands 84.
Collaboration with other settings was developed (Table 63).  MEDAR, DARTS and a number of MPG-
services have agreed to register a common database (VRM). This is co-ordinated by VAD. In 1998, 15
psychiatric hospital joined and so did 24 additional psychiatric hospitals in 1999, as well as outreach
work programmes and medico-social relief centres.  General practitioners working in health centres of
large cities have been contacted for participation.  The system is called VRM (Vlaamse Registratie
Middelengebruik - Flemish Registration of (il)licit drug use). By the beginning of 1999 about 135
services are participating.
On top of this, a computer programme to register prevention activities is developed.  Prevention
workers from the mental health care centres took part in the VAD project.  Provincial and local actions
will join later. The project has also links with the European EDDRA project (Exchange on Drug
Demand Reduction Actions).
The coverage of the system is being estimated in the framework of the Treatment Demand Indicator-
EMCDDA project.
French Community
The system (called Fiche Commune CCAD) is operational since 1992. It  has been set up according to
the Pompidou Protocol on the ‘First demand and treatment demand’ indicators qq. Participants are
using  paper or computerised forms. The registration form was computerised in 1996 and tested
among 10 treatment services during 1997.  The last version  EPITOX 2.0 (Version 2.17) was made
available in 1998 and treatment centres were encouraged to use it instead of the paper version.
                                                
qq In 1994 the epidemiologists of the Pompidou Group finalised a definitive protocol for drug treatment reporting
systems. It is based on the results of the collaborative pilot projects conducted in 11 European cities from
1989 to 1992 and on the Multi-City-Project from 1982 onwards.
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TABLE 63. Evolution of the number of treatment units participating in VAD(1996-99),
CCAD (1995-98) and CTB/ODB (1996-97)registration systems, Belgium
CCAD CTB/ODB VAD
Years 1995 1996 1997 1998 1996 1997 1996 1998 1999
Number participating
centres
28 35 36 34 11 14 92 107 135
Residential centres
Specialised centres 7 7 4 6+3rr 6+3 6+3+4ss
Hospitals 3 15 39
Out-patient centres
Specialised centres 22 21 10
Mental health centres 1 1 83 83 83
General practitioners 3 2 1
Low threshold/street 2 2
Prison 1 1 1
For the year 1998, 34 centres or services located in the French Community (Walloon Region and
French Brussels Region) participated in the registration (Table 63).  Most of them are specialised
outpatient services (n=21), the half being specialised mental health services.  Two facilities are low
threshold services.  As inpatient services, there are 3 therapeutic communities and 4 psychiatric
hospitals or services. At last, 2 organised GPs networks, 2 day centres and 1 structure that works
inside of the prisons are covered.  The city of Charleroi developed its own registration system but the
CCAD receives each year the output of data provided by the 10 participating services 37.
In the registration process, to avoid double or multiple counting, a patient code was used till the end of
1996, built in from the name and Christian name initials, gender and date of birth; sometimes the
residential postcode was added to better identify actual multiple counting.  The new Belgian law about
private life protection obliged CCAD to eliminate this patient code.  In the protocol "Fiche Commune",
version 1998, the initials and the day of birth are not used any longer. The CCAD hopes soon to adopt
a common process - based for example on an algorithm - which would be suggested by EMCDDA.
It is quite difficult to give, for all the French Community, an estimation of the registration coverage by
the CCAD system.  The specialised centres which are subsidised by the Ministry of the French
Community or the Walloon Regional Ministry of Social Affairs are obliged, by Decree, to participate to
the registration of this indicator.  More than 80 % of those centres are participating, but this figure
varies from one province to another.  For example, the coverage for Liège is higher than 95%, which
represents more than 55 % of the total treatment demands in the French Community.
Brussels-Capital Region
Brussels programme developed its own registration system :  some 29 core items are recorded by the
participants, using similar definitions, criteria and coding instructions. Most items are compatible with
those recorded by other registration systems used throughout the country.
The coverage of the Brussels area was progressively extended (14 out of 16 specialised centres in
1997).  For the implementation of the EMCDDA treatment demand indicator, the coverage of the
system (coverage of the different types of treatment unit, overlapping with other -CCAD-VAD-
systems) should be assessed.
In Brussels, ADDIBRU software has been modified according to the recommendations of the 1996
working group 'Toxicomanie'.  Those modifications took effect on 1 January 1997 35.
                                                
rr  Crisis centre.
ss  MASS/MSOC.
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German-speaking Community
In the German-speaking Community, the centre for mental health care registers the requests for
ambulatory and stationary treatment using its own system (based on the system used in the country
Luxembourg) and has done so since its creation.
At the request of the Ministry of the German Community, the Centre for Mental Health and the
physicians are preparing the implementation of a registration system 'RELIS/LINDDA' developed by
the Luxembourg information network on drugs and drug addiction.
The coverage of the system (geographical coverage, coverage of the different types of treatment unit,
eventual overlapping with CCAD system) should be assessed.
TABLE 64. Typology of treatment units participating in VAD, CCAD and CTB/ODB
registration systems, Belgium
TYPE OF TREATMENT UNIT VAD 1998 84 CCAD 1998 34 CTB/ODB 1998 35
N of units % of cases N of units % of cases N of units % of cases
covered Registered Covered registered covered registered
1. Specialised  residential Res : 29% -
1. hospital inpatient unit 4 units 3 units 7 %
2. therapeutic community 7 units 10% 3 units
3. other specialised residential 3 units 22% 4 units 19%
2. Specialised non-residential Non-Res :
58%
1. hospital outpatient treatment centre
2a. structured day care centre/day hospital 2 units
2b. specialised outpatient treatment centre 12 units 10 units 74 %tt
3. local health centre/social service centre 4 units
4. low threshold/drop-in/street agency 2 units LT : 5%
5. other specialised non-residential 2 units
3. Based in general Services
1. inpatient psychiatric hospital
2.outpatient mental health care centre 83 units 68% 1 unit Incl. in NR
3a. primary health care service (+G.P.)
3b. General Practitioners (GP) 3 units GPs : 6% 1 unit -
4. residential social care facility
5. non-residential social care facility 1 unit Incl. in NR
6. other non-specialised residential
7. other non-specialised non-residential
4. Treatment Unit in Prison 1unit Pris. : 1% 1 unit -
5. Other (self-help service) 1 unit Incl. in NR
Comparison of Community/Regional systems
Table 64 compares the type of centres covered by VAD, CCAD and CTB/ODB systems.  In the three
systems, around one third of treatment demands are located in specialised residential centres.  Most
of patients (68%) registered by VAD in 1998 demanded for treatment in units based in general
services (mental health care centres) whereas 63% and 74% of patients registered respectively by
CCAD (1998) and CTB/ODB (1997) are treated in specialised non-residential centres.
The geographical coverage of the different systems, the coverage of the types of treatment unit and
the eventual overlapping between CCAD-, VAD-, CTB/ODB- and RELIS-systems are currently being
assessed in the framework of the Treatment Demand Indicator - EMCDDA project.
                                                
tt All ambulatory facilities together including specialised outpatient treatment centres, the general practitioner unit
and the unit active in prisons
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ANNEX D : Criteria for substitution treatment
LEGAL BASIS FOR SUBSTITUTION
An official reference document related to the methadone substitution treatment was prepared by the
experts of the Sub-Committee on Addiction of the Hygiene High Council (Health Council - Ministry of
Social Affairs, Public Health and Environment) and published in 1994 uu.  The four-page document
' Consensus Conference sur la Méthadone/Consensusconferentie over Methadon ' (Consensus
Conference on methadone substitution treatment) presents the benefits and limits of the methadone
treatment and the indications and rules to be followed.
A follow-up of the 'Consensus Conference on methadone substitution treatment' has been organised.
Between 1997 and 1999, about one hundred experts discussed the state of Art of methadone
substitution treatment in the light of recent developments in Belgium v v .   Therapeutic efficiency of
methadone was reassessed.
The limited and minor changes in the 'Conférence de Consensus' document underline its very high
acceptance/adoption by all actors in the field of the drug addiction therapy.
Reductions of heroin use, of IV use, of the spread of the HIV virus and of the mortality related to
opiates use, are the major results generally attested by all Belgian practitioners through their
professional experience.
Some minor changes only have been brought to the original text of the “ Consensus Conference ” and
recommendations have been issued to strengthen the development of this therapeutic orientation in
the interest of the patient, his/her surroundings and the Community in general.  These
recommendations focus on therapeutic practice and relationships between practitioners and
evaluation.
The basic assumptions of the 'Consensus de Conference' text are as follows:
- Methadone is an effective medicine for the treatment of the addiction to heroin and other opiates
- Methadone substitution treatment
- reduces the heroin use and the intravenous drug use
- reduces the mortality associated to heroin use
- reduces the risk of transmission of the HIV and hepatitis B and C virus
- improves the general physical condition of the heroin user patient
- makes it easier to find out problems associated to the heroin use and facilitates the
development of health education strategies
- is associated with an improvement of the socio-occupational skills and with a reduction of drug
related public nuisance
CRITERIA AND TARGET GROUPS FOR SUBSTITUTION TREATMENT
The rules and indications of the prescription of the methadone substitution treatment were determined
by a group of experts in 1994 ('Conférence de Consensus sur la méthadone / Consensusconferentie
over methadon').
Target groups
                                                
uu   Traitement de substitution à la méthadone : Conférence de Consensus du 8 octobre 1994. Conseil Supérieur
d'Hygiène-Commission des Médicaments. Ministère de la Santé Publique et de l'Environnement, 1994.
vv  Suivi de la conférence de consensus méthadone de 1994 : évaluation des recommendations formulées en
1994 et propositions complémentaires. Conseil Supérieur D’hygiène, Sous-Section I.1.1 Assuétude, Ministère
des Affaires Sociales, de la Santé Publique et de l’Environnement. Novembre 1999.
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The substitution treatment is indicated for patients addicted to heroin or to other strong opiate-
agonists.  The dependence diagnosis should be based on intake and on clinical examination and
supported by additional investigations if necessary (urine dosages for example).
Criteria for inclusion
The criteria are as follows:
the patient should be aged 18 years or over
a confirmed history of addiction longer than a year
with failure of spontaneous or assisted tentative of withdrawal.
Exceptionally, in case of specific assistance and with advanced expertise, these requirements can be
rejected (substantiate documentation is necessary).
There are no contraindications but associated psychiatric morbidity (alcoholism, polyaddiction,
depression, psychosis...) requires a specific approach and adapted treatment.
The pregnancy is not a contraindication : it is not recommended to interrupt the substitution treatment,
but it requires a specific expertise.  The issues related to substitution and pregnancy, breastfeeding,..
are tackled in the key-issue 3 'Women, children and drug use'.
CHOICE AND DOSAGE OF DRUGS FOR SUBSTITUTION
Choice of drugs
In the document 'Conférence de Consensus sur la méthadone / Consensusconferentie over
methadon', substitution refers to the use of methadone or buprenorphine.  This choice was limited to
methadone and buprenorphine (Temgesicâ) because the experts observed that no other medicine
was convincingly experimented and cannot be recommended for usual practice at the moment.
Special limitation is mentioned for the prescription of psychotropes other than methadone or
buprenorphine : these substances are to be avoided for a substitution treatment (except when the
case is a double diagnosis requiring a treatment with specific psychotropes).  Some psychotropes are
immediately dangerous and are susceptibly causing dependence.  In particular, Flunitrazepam
(Rohypnolâ) or Vesparaxâ induce unwanted paradoxal effects (mainly excessive stimulation on
addicts) should be proscribed.  Moreover, the prescription of theses substances is not at all a
substitution treatment.
Actually the main substance used for substitution in Belgium is methadone.  This is confirmed by a
questionnaire survey on substitution treatment conducted in 7 Flemish treatment centres ww (4
MSOC/MASS and 3 low-threshold treatment centres were interviewed on several aspects related to
their substitution treatment programmes).  Temgesicâ, Naltrexoneâ of Depronalâ are exceptionally
prescribed.
Sometimes short-term reduction treatment are used, mainly on request of the patient or after a short
relapse :  for this indication, methadone is generally used but occasionally Codicontinâ or
Buprenorphineâ is prescribed.
Combination with other psychotropes are restricted to indications other than 'isolated' addiction, mainly
for patients with a double-diagnosis.
Dosage
It is recommended to start treatment with a methadone dosage of about 30 mg/day.  The patient
should be examined the same day or the day after (at the latest 48 hours after the first administration)
in order to evaluate the effect on the patient and eventually to adjust the dose.
If the patient has been highly sleepy, it indicates that there is no severe dependence to heroin.  The
physician should then modify his/her pharmacological approach.  This could be an indication to
prescribe Buprenorphine as this psychotrope combines agonist and antagonist effects towards
opiates.
                                                
ww Wydoodt JP. Personal communication.
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Usually the mean stabilization dose will be higher around 60 to 80 mg/day.  It should be adapted to the
individual evolution.  Some medicine associations call for a dose adjustment.
Based on the survey in the 7 Flemish treatment centres, methadone was always orally administrated
as a syrup.  For most cases, the daily dose was between 40 en 70 mg (range : 14  - 150 mg).
CHARACTERISTICS AND EXTENT OF SUBSTITUTION PROGRAMMES
 
Location of delivery
At the beginning of the treatment and until stabilization, it is recommended that the patient gets his/her
daily dose in the pharmacy or in the treatment centre.  The prescription of take home doses should be
avoided at least during the first 6 weeks (the concept of 'beginning of the treatment' is precariously
defined -as well as 'stabilization'-; . however, a minimal term of 6 weeks seems reasonable to define
the concept of 'beginning of the treatment).
Exceptions are meaningful, a.o. in order to maintain the social insertion of the patient.
The survey in the 7 Flemish treatment centres confirms that the doses are provided daily at the
pharmacy or in the centre : methadone is taken on the spot.  A convenience is offered to patients
whose urine tests have been negative during one month : these patients can then take away their
methadone 3 times a week (with spot check  urine analysis).
 
 Patient information
The patient and his/her environment should always be informed about the risks of accidental use of
methadone for him/herself and for his/her circle of acquaintances (particularly children).
 
 Duration
The duration of methadone substitution treatment is mid-term (2-5 years) or undetermined.  A medium
or long period of treatment is necessary for a positive evolution and the practitioner should strengthen
therapeutic compliance of his/her patient.
The short-term reduction treatments (3 weeks - 3 months) are frequently associated with a change of
the environment with a reduction of the exposition of the patient to heroin.
ORGANISATION, REGULATION AND MONITORING OF DELIVERY SYSTEMS
Organisation and accessibility to the delivery system
The type of approach and the psychosocial support are the basic determinants for improved
therapeutic results of methadone substitution treatments.  The assistance should fit the individual
needs of each patient.
The accessibility to methadone substitution treatment should be increased according to the needs.  It
should involve all primary level actors (GPs, psychiatrists, pharmacists, health centres).  Substitution
treatments are offered by specialized centres but a large proportion are actually provided by GPs.
Progressively since 1995, 10 low-threshold centres have been set up (MSOC/MASS).  One of their
roles is to provide low-threshold care to users of illicit drugs : methadone substitution treatment is one
of their therapeutic tools.
From a public health point of view, local pharmacists are full actors in the assistance to addicts.  The
front role of the local pharmacist is an asset in the development of a positive evolution of the patient,
for example as a “ gate keeper ” between the practitioner, the patient and the community.
The communication between the penitentiary physician and the medical network outside the prison (at
least the physician in charge of the patient) is stressed.  Moreover the contacts between the
imprisoned patient and his/her usual physician should be facilitated.
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The number of patients treated by a physician cannot be determined with authority.  Nevertheless a
number too high of patients (around several dozens) usually causes an exhaustion of the physician
also harmful for the patients.  This practice should be avoided.
The survey in the 7 Flemish treatment centres confirms that contacts all involve multidisciplinary
teams with which patients have regular contacts (mainly weekly).  Contacts between the teams of the
centres and the external actors were also established.
Regulation : exclusion of the patient
The occasional use of heroin could not be a reason to interrupt the treatment or to reduce the dose.
The exclusion criteria varied between the interviewed Flemish centres.  Repeated  offences to the
known internal rules usually lead to exclusion.  The consumption of additional substances is generally
not an exclusion criteria, but produces an intensification of the treatment programme.
Regulation : exclusion of the physician
The physicians, consulted as expert during the work of the 'Consensus Conference', are of the opinion
that one should react (repressive or disciplinary measures) to eventual serious discrepancies of
practitioners towards the rules of the 'Consensus Conference'.
Data registration, monitoring and evaluation
Lastly, the continuous evaluation of therapeutic practices can only be efficient with a parallel
development of recording systems through the voluntary participation of all concerned professionals
(doctors, pharmacists, specialised treatment settings).  They should participate by handling out
relevant data in a concerted way, in due respect of the patient’s private life.
It is recommended that a standardized registration system should be developed (useful at federal
level).  The global system should involve the data of the 'General Pharmaceutical Inspectorate
(Ministry for Social Affairs, Public Health and Environment) and from the 'Provincial Council of
Doctors', both are not yet systematically computerized.  Data from pharmacists should also be
integrated in the system.
Education and networking
The scattering of the patients means that a large number of physicians have relatively low numbers of
addicted patients.  Nevertheless these physicians treating addicted patients should be appropriately
educated and trained.  They should be supported through exchanges with a specialized centre or
through a network of other therapists in order to avoid any isolation that is harmful to a good medical
practice.
Continuous professional education and training should be developed, taking into account the need of
'light' education programme (for physicians with a few addicts undergoing treatment).  Forums,
symposiums and workshops should be developed.  The information on public health strategies should
be improved, and particularly, its diffusion should reach all involved actors.
Networking and consultation (concertation) between practitioners sharing their mutual experiences is
stressed.  Such a network (ALTO) is involving around 600 GPs giving care to drug users in the French
part of Belgium (more than 3000 patients are undergoing a substitution treatment, basically
methadone).
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ANNEX E : List of Standard Epidemiological Tables
Table AREA COVERED PERIOD COVERED
01a- Population Surveys French Community 1996-97 and 1998-99
01b- Population Surveys Flemish Community 1994-95
02a- School Surveys Flemish Community 1999
02b- School Surveys Flemish Community 1998
02c- School Surveys Flemish Community 1996
02d- School Surveys Flemish Community 1994
02e- School Surveys French Community 1998
03a - Treatment Belgium 1998
03b - Treatment French Community 1997-1998
03c - Treatment Flemish Community 1998
03d - Treatment Brussels-Capital Region 1998
04a - Treatment Evolution French Community 1993-1998
04b- Treatment Evolution Flemish Community 1996,1998
04c - Treatment Evolution Brussels-Capital Region 1997-1998
05 - Deaths Direct Belgium 1995
06 - Deaths Evolution Belgium 1991-1995
07 - National Prevalence Belgium 1995
08 - Local Prevalence French Community 1993-94
09a - Infections French Community 1993-1998
09b - Infections Flemish Community 1998
09c - Infections Area of Charleroi 1992,1995
09d - Infections Flemish Community 1997-1999
09e - Infections Prisons / Flemish Community 1998-1999
09f - Infections A prison / French Community 1999
09g - Infections A prison / French Community 1997
10a - Harm Reduction Infect Belgium, mainly French Com.
10b - Harm Reduction Infect Flemish Community
10c - Harm Reduction Infect Charleroi (French Community)
11 - Arrests Belgium 1998-1999
12a - Prison Belgium 1999
12b - Prison French Community 1997
13 - Seizures Belgium 1995-99
14 - Purity Not available
15a - Tablet Contents Belgium 1999
15b - Tablet Contents French Community 1998-1999
16 – Price Belgium 1995-99
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LIST OF ABBREVIATIONS
APSD/SGAP Algemene Politiesteundienst / Service Général d’Appui Policier
ALTO Alternatives aux Toxicomanies
ASBL Association Sans But Lucratif (non-profit organisation)
ASL Arbeitsgemeinschaft für Suchtvorbeugung und Lebensbewältigung
AVAT Aide Vervietoise aux Alcooliques et Toxicomanes
BCR/CBO Bureau Central de Recherche - Programme Drogue / Centraal Bureau voor Opsporing
– Programma Drugs / Central investigation office – Drug programme
CAD Centrum voor Alcohol- en andere Drugproblemen (Hasselt)
CAPA Centre d’Actions de Prévention des Assuétudes
CAT Centrum voor studie, behandeling en preventie van Alcoholisme en andere
Toxicomanieën (Ghent)
CBO/ BCR Centraal Bureau voor Opsporing – Programma Drugs / Bureau Central de Recherche -
Programme Drogue / Central investigation office – Drug programme
CCAD Comité de Concertation sur l’Alcool et les autres Drogues
CCLA Citoyen Comme Les Autres
CGG Centrum voor Geestelijke Gezondheidszorg
CIC CrisisInterventieCentrum
COCOF Commission Communautaire Française (Communauté française à Bruxelles)
CPAS/OCMW Centre Public d’Aide Sociale / Openbaar Centrum voor Maatschappelijk Welzijn
CTB/ODB Concertation Toxicomanies Bruxelles / Overleg Druggebruik Brussel
CFWB Communauté française Wallonie Bruxelles
DWTC/SSTC Federal Diensten voor Wetenschappelijke, Technische en Culturele aangelegenheden
/ Services fédéraux des affaires Scientifiques, Techniques et Culturelles
EDDRA Exchange On Drug Demand Reduction Action
EMCDDA European Monitoring Centre for Drugs and Drug Addiction
FNRS Fonds National de Recherche Scientifique
GEMT Groupe d’Etude des Maladies liées à la Toxicomanie
GERRMM Groupe d'Etude pour une Réforme de la Médecine Rhin-Meuse
HBSC Health Behaviour in School-aged Children
INAMI/RIZIV Institut National d’Assurance Maladie-Invalidité/RijksInstituut voor Ziekte- en
Invaliditeitsverzekering
IPH/ISP/WIV Scientific Institute of Public Health/ Institut Scientifique de la Santé Publique/
Wetenshappelijk Institut Volksgezondheid
ISP/WIVIPH Institut Scientifique de la Santé Publique/Wetenshappelijk Institut Volksgezondheid/
Scientific Institute of Public Health
IVDU Intra-Venous Drug Use
IVDUs Intra-Venous Drug Users
LOGO Loco-regionaal Gezondheidsoverleg en -Organisatie  (Flemish Community)
MASS /
MSOC
Maison d’Accueil Socio-Sanitaire / Medisch-Sociale Opvang Centra
MKG/RCM Minimale Klinish Gegevens / Résumé Clinique Minimal
MPG/RPM Minimale Psychiatrische Gegevens / Résumé psychiatrique Minimal
MSOC/MASS Medisch-Sociale Opvang Centra / Maisons d’Accueil Socio-Sanitaire
OCMW/CPAS Openbaar Centrum voor Maatschappelijk Welzijn / Centre Public d’Aide Sociale
OCRTIS Central Office for the Repression of Illicit Narcotics Trafficking
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PZ Psychiatrisch Ziekenhuis
PPP Provinciale Preventieplatforms (Flemish Community)
PAAZ Psychiatrische Afdeling van een Algemeen Ziekenhuis
RCM/MKG Résumé Clinique Minimum / Minimale Klinish Gegevens
REITOX Réseau Européen d'Information sur les drogues et Toxicomanies /  European
inform ation network on drugs and drug addictions
RIZIV/INAMI RijksInstituut voor Ziekte- en Invaliditeitsverzekering/Institut National d’Assurance
Maladie-Invalidité
RPM/MPG Résumé Psychiatrique Minimum / Minimale Psychiatrische Gegevens
SGAP/APSD Service Général d’Appui Policier / Algemene Politiesteundienst
SODA Stedelijk Overleg Drugs – Antwerpen
SPZ Sozial Psychologisches Zentrum
SSTC/DWTC Services fédéraux des affaires scientifiques, techniques et culturelles / Federal
diensten voor wetenschappelijke, technische en culturele aangelegenheden
TG Therapeutische Gemeenschap
TIMC Toxicomanies et Interventions en Milieu Carcéral
ULB Université Libre de Bruxelles
UNDCP United Nations International Drug Control Programme
UG Universiteit Gent
ULG Université de Liège
VAD Vereniging voor Alcohol- en andere Drugproblemen
VIG Vlaamse Instituut voor Gezondheidspromotie
VLOR Vlaamse Onderwijs Raad (Flemish Community)
VRM Vlaamse Registratie Middelengebruik
VSPP Vast Secretariaat voor het Preventiebeleid / Secrétariat Permanent à la Politique de
Prévention
VAD Vereniging voor Alcohol en andere Drug problemen
VVBV Vlaamse Vereniging voor Behandelingscentra in de Verslaafdenzorg
VZW Vereniging Zonder Winstoogmerk (non-profit organisation)
WIV/ISP/IPH Wetenshappelijk Institut Volksgezondheid/ Institut Scientifique de la Santé Publique//
Scientific Institute of Public Health
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